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Latrophilin1 (LPHN1) is a presynaptic adhesion G protein-coupled 
receptor involved in the control of spontaneous exocytosis of neurotransmitters. 
The effects of LPHN1 activation on exocytosis have been described on several 
model systems, such as cultured hippocampal neurons and neuromuscular 
junction (NMJ) using its well known agonist LTX
N4C
, and include a massive 
increase in exocytosis characterised by periods of intense release (bursts) 
interspersed with periods of moderate activity (interburst intervals).  
However, the molecular mechanisms underlying these effects were yet to 
be determined. Based on previous observations that LPHN1 is associated to G 
proteins, and that its activation leads to activation of PLC and increased IP3, we 
hypothesize that LPHN1 controls exocytosis via the Gαq protein pathway, whose 
activation ultimately results in the release of Ca
2+
 from IP3-sensitive Ca
2+
 stores.  
Using a pharmacological approach and the current clamp method at the 
mouse NMJ, we first used LPHN1 KO preparations to study the role of LPHN1 
on spontaneous exocytosis in resting conditions, and to show that LPHN1 is the 
only receptor mediating the effects observed upon stimulation by LTX
N4C
. 
Then, we interfered with several molecules involved in the Gαq pathway to test 
their involvement in LPHN1 activation, and we investigated the role of store-
operated (SOCCs) and voltage-gated (VGCCs) Ca
2+
 channels in mediating the 
Ca
2+
 influx that is necessary for the development of LPHN1 effects. 
Our results support the hypothesis LPHN1 is involved in the regulation of 
spontaneous exocytosis at rest and that it is the receptor mediating the increased 
exocytosis following stimulation by LTX
N4C
; the suggestions that Gαq and its 
intracellular pathway mediate the effects of LPHN1 activation on spontaneous 
exocytosis, and that SOCCs and VGCCs (particularly Cav2.1) mediate the Ca
2+
 
influx necessary for the development of LPHN1 effects are also supported by our 
findings. 
Altogether, this work uncovered the mechanisms by which G protein-
coupled receptors, in this case LPHN1, can regulate the rate of spontaneous 
neurotransmitter release at the mouse NMJ. 
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Figure 1.1. Schematic representation of the molecular machinery 
involved in vesicle exocytosis. On the top right, a synaptic vesicle is 
shown, being docked to the active zone (Südhof 2013). 
 
8 
Figure 1.2. Full fusion model of vesicle exocytosis. The vesicle 




Figure 1.3. Kiss and run model of vesicle exocytosis. The vesicle 
membrane only partially fuses with the plasma membrane, generating an 
omega structure and a fusion pore. After the closure of the pore the 
vesicle is back at the active zone where it can be exocytosed again. 
 
10 
Figure 1.4. Schematic representation of αLTX processing in the venom 
gland. The precursor of αLTX is a protein of 157 kDa. It is then cleaved 
at furin-like sites both at the N- and the C-termini to produce the mature 
αLTX, with a molecular mass of 131 kDa. 
 
13 
Figure 1.5. αLTX primary and domain structure. Letters C denote 
conserved cysteines at the N-terminal domain; boxes correspond to 
ankirin-like repeats. The identified 3D structure domains are indicated 
below. 
14 
Figure 1.6. 3D reconstructions of the α-LTX monomer, dimer and 




Figure 1.7. Section of α-LTX pore crossing the membrane and allowing 





Figure 1.8. Structure of LTX
N4C
. (a) Representation of the domain 
structure of LTX
N4C
. The position of the insert is shown by an arrow. (b) 
Cryo-EM of native and mutant toxins showing that α-LTX, but not 
LTX
N4C
, is able to form tetramers (Volynski et al. 2003). 
 
18 
Figure 1.9. Schematic representation of a general heterotrimeric G 
protein-coupled receptor, composed of an extracellular N-terminal ligand 
binding domain, 7 TMRs connected by 3 intracellular and 3 extracellular 
loops, and an intracellular C-terminal domain attached to an 
heterotrimeric G protein. When inactive, the α subunit of the G protein is 
associated with GDP. 
 
22 
Figure 1.10. LPHN1 domain structure.  SP, signal peptide; GBL, 
galactose-binding lectine; STP, Ser- Thr- and Pro-rich domain; HRM, 
hormone receptor motif; GPS, GPCR proteolysis site domain; 7 TMRs, 
seven transmembrane domains and correspondent loops; green arrow, 
cleavage site; red brackets, α-LTX binding site. 
 
26 
Figure 1.11. A. Domain structure of Lasso. Lasso is a monomeric 
protein with a single TMR; it can form homodimers by S-S bonds. 
It can be cleaved at the EGF-repeats, causing the release in the medium 
when the cleavage occurs on both monomers. B. Representation of the 
putative interaction between LPHN1 and Lasso at the synapses. LPHN1 
(presynaptic) GBL domain is thought to interact with the TCAP domain 
of Lasso (postsynaptic). 
 
29 
Figure 1.12. STIM 1 domain structure. SP, signal peptide; EFs, Ca
2+
-
binding EF-hand domains; SAM, sterile α motif; TMR, transmembrane 
region; CC1-3, cytosolic coiled-coil domains; P/S, Pro-Ser-rich region; 






Figure 1.13. Orai 1 structure. The N- and C-terminal domains are both 
located in the cytosol, the four TMRs (transmembrane domains) are 
connected by two extracellular and one intracellular loops. 
 
33 
Figure 1.14. Components of SOCE. STIM 1 located at the ER is 
associated to EB 1 when intraluminal Ca
2+
 concentration is high enough 
to allow its binding to Ca
2+
. Upon stores depletion STIM 1, unbound 
from Ca
2+
, travels to puncta close to the PM, where associates with 
SERCA pump and SOCCs initiating Ca
2+
 influx. TRPC can function as a 
ROC, associated to IP3R. Activated SOCCs are located in lipid rafts.  
 
35 
Figure 1.15. VGCCs quaternary structure and subunit composition. 
VGCCs are formed of a α1 pore forming subunit that determines the 
characteristics of the current; an intracellular β subunit and an 
extracellular α2δ subunits that confer appropriate gating properties; a 
transmembrane γ subunit. Neuronal VGCCs have all the subunit except 











Figure 2.2. Plasmid for expression of LPHN1 on the basis of pcDNA3.1. 
 
44 
Figure 2.3. Plasmid for expression of GST-Lasso. 
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Figure 3.2. Map of the GST-LTX
N4C
 plasmid used for bacterial 
expression. The toxin cDNA carried additional modifications: GST is 
attached at the N-terminal and V5 and Myc epitopes are attached at the 
C-terminal. These modifications allow the recognition of both the N- and 
C-termini of the recombinant fusion protein in order to identify and 
isolate the full size protein. 
 
 
Figure 3.3. Restriction analysis of α-LTX
N4C
. Plasmid containing the 
GST-LTX
N4C
 cDNA insert was cleaved with Xho I restriction enzyme. 
The reactions were analysed on a 1 % agarose gel at a constant voltage of 
120V for 1 hour to yield the expected fragments. Lanes 1-3 contain 
plasmid preparations from three test cultures. Blue arrows indicate the 
position of the 6.22 kb and 2.36 kilobase-pair (Kbp) fragments as 
determined using the DNA size markers. The green arrow represents the 
position of the pRARE plasmid endogenously present in the Rosetta-
Gami 2 cells. 
 
Figure 3.4. Restriction analysis of α-LTXN4C. Individual plasmid 
containing GST_LTX
N4C
 cDNA insert were cleaved Xho I (lane 1), Pst I 
(lane 2) and the combination of Xho I and Pst I (lane 3) restriction 
enzymes. The reactions were analysed on a 1 % agarose gel at a constant 
voltage of 120V for 1 hour to yield the expected fragments. The 






















Figure 3.5. Analysis of the leaky expression of the GST-LTX
N4C
 fusion 
protein. A.  Coomassie staining of GST-LTX
N4C
 expression. The position 
of the protein of interest is shown by the arrow. B. Comparison of total 
GST-LTX
N4C
 expression in induced and non induced cultures. Leaky 
expression is present, however the induced culture expresses 
approximately 7.5 times more protein than the non-induced. C. 










the two conditions considered. Whilst only 1.6 % of the total fusion 
protein expressed is soluble in induced cultures, in non induced cultures 





Figure 3.6. Optimisation of the time of induction of GST-LTX
N4C
 
expression. A. Coomassie staining of the gel (top) and a respective 
Western blot (bottom) showing the amount of LTX
N4C
 expressed in the 
cultures induced at different OD600, in induced and non induced 
conditions.  Note that sample loading on the gel was proportionate to the 
volumes of the soluble and insoluble fractions, while 10-fold lower 
amounts of cell pellets were loaded on the blot. B-C. Quantification of 
the expression of soluble LTX
N4C
 in induced cultures. In the induced 
conditions, with increasing OD600 at induction, the amount of fusion 
protein in the pellet greatly increases (B), while the amount of soluble 
protein increases and then falls (C). 
 
69 
Figure 3.7. Optimisation of the leaky expression. A high amount of 
soluble protein is expressed without induction in both the experimental 
conditions. The best condition to express LTX
N4C
 without induction 
seems to be at RT for 20 hours. 
 
71 
Figure 3.8. Comparison between the best conditions of expression 
without and with induction. The condition producing the larger amount 
of soluble LTX
N4C
 is the one with induction at 0.5 OD600. 
 
72 
Figure 3.9. GSH-column affinity chromatography of LTX
N4C
. The 
purified protein (lanes 5, 6 and 7) presents signs of degradations. The 
protein is also visible in the flow through (lane 2) and in the washes 




Figure 3.10. Binding test. Bound LTX
N4C 
is present to some extent also 74 
 !
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in untransfected cells (first five lanes), suggesting that the binding is non 





Figure 4.1. Examples of representative individual traces of MEPPs 







Figure 4.2. Single traces of MEPPs recorded at the mouse NMJ in the 





Figure 4.3. A. Average frequencies of MEPPs in the presence and 
absence of Ca
2+
e (2 mM). B. Average amplitude of MEPPs with and 
without the presence of 2 mM Ca
2+
e. The difference between the 
conditions is not statistically significant (n = 23 individual cells with 
Ca
2+
 and 12 without Ca
2+
; ***, P < 0.001, Mann – Whitney U test). 
 
79 







Recordings were done in the presence and absence of 2 mM Ca
2+
e. The 
difference between the WT and KO frequency is statistically significant 




 and 28 
-/- 
individual cells in the presence of 
Ca
2+




 and 29 
-/-
 individual cells in Ca
2+
-free 
buffer. **, P < 0.01, One-way ANOVA). The difference in the average 
amplitudes between the conditions is not statistically significant (B). 
 
81 
Figure 4.5. Primary cultures of LPHN1 WT (A) and KO (B) pyramidal 
neurons on day 1 of culture. Cells were plated with an average of 10-25 x 
10
3
 cells per well. The difference in number between the two cultures is 
not statistically significant (C). 
 
83 
Figure 4.6. Primary cultures of WT (A) and LPHN1 KO (B) pyramidal 84 
 !
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neurons after 14 days in culture. 
 




 pyramidal neurons primary cultures. B. Average amplitude of ESPCs 




 pyramidal neurons primary cultures. The 
difference between the conditions is not statistically significant (n = 25 






Figure 4.8. ESPCs and ISPCs analysis. In both cultures, the majority of 
the postsynaptic currents recorded were upward-going inhibitory currents 
(87% ISPCs and 13% ESPCs in WT neurons, 97% ISPCs and 3% ESPCs 
in LPHN1 KO neurons). 
 
85 
Figure 4.9. Individual traces of IPSCs (A, C) and EPSCs (B, D) recorded 
in WT (A, B) and KO (C, D) pyramidal neuron primary cultures. Note 
the presence of an IPSC in D. 
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hippocampal primary cultures (n = 25 LPHN1
+/+
 cells and 26 
-/-
 cells. 
**, P<0.010; ***, P < 0.001, Mann Whitney U test). 
 
86 
Figure 4.11. A. The frequency of MEPPs in Ca
2+
-free buffer, after the 
addition of LTX
N4C





only able to induce and increase in the frequency of exocytosis when 
Ca
2+
e was present. B. Average frequency of MEPPs in Ca
2+
-free buffer, 




 (n = 5 cells in Ca
2+
-free buffer, 5 
cells after the addition of LTX
N4C
, and 4 cells after further addition of 2 
mM Ca
2+




Figure 4.12. Frequency of MEPPs in the presence of 2 mM Ca
2+
e and 90 
 !
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after the addition of LTX
N4C
. The effects of LPHN1 stimulation do not 
develop immediately after the addition of LTX
N4C
, but after 17 minutes 
on average. 
 
Figure 4.13. Individual traces of MEPPs recorded at the mouse NMJ 
after the addition of 0.25 nM LTX
N4C
. The frequency of spontaneous 
neurotransmitter release dramatically increased compared to the 
frequency in Ca
2+





the appearance of bursts of release (underlined in red) that can reach 
frequencies of 100 Hz, interspersed with periods of moderate activity 
where the frequency goes back closer to control. B. A magnified section 








Figure 4.14. Average frequency of MEPPs during bursts and interburst 
intervals. B. Average amplitude of MEPPs in bursts and interburst 
intervals. The difference between the conditions is not statistically 
significant (n = 14 bursts, 13 interburst intervals; ***, P < 0.001, Mann – 
Whitney U test). 
 
93 
Figure 4.15. Distribution of frequencies in Ca
2+





, the majority of events are concentrated 
between 0 and 1 Hz. After the addition of LTX
N4C
, instead, due to the 
bursting behaviour I have three groups of frequencies: one corresponding 
to the interburst periods (0 – 0.75 Hz), one to corresponding to the bursts 
(10 – 100 Hz), and one corresponding to undefined bursts where the 
limits of the bursts were not completely clear (1 – 3 Hz). 
 
93 
Figure 4.16. Representation of the frequency (A) and duration (B) of the 





Figure 4.17. A. Representation of the protocol used in the experiments 





-free buffer treated with BAPTA-AM and after Ca
2+
 was 
added to the buffer (C). The addition of LTX
N4C
 is not able to elicit its 
effects when intracellular Ca
2+
 is chelated. 
 
96 
Figure 4.18. Average frequency of MEPPs induced by LTX
N4C
 in 
terminals filled with BAPTA-AM. Ca
2+
 influx is needed to elicit the 
increase in exocytosis typical of the activation of LPHN1, as chelation of 
intracellular Ca
2+
 fully inhibits exocytosis even when the cation is added 
to the extracellular buffer. A control treated with LTX
N4C
 but not with 
BAPTA-AM is shown (n = 5 cells in Ca
2+
-free buffer, 8 cells in Ca
2+
-
free buffer after the addition of BAPTA-AM, 4 cells after subsequent 
addition of LTX
N4C
 and 12 cells after addition of 2 mM Ca
2+
. 7 cells 
have been used for the control with LTX
N4C
; ***, P < 0.001, Mann – 
Whitney U test). 
 
97 
Figure 4.19. Individual traces of MEPPs in Ca
2+
-containing buffer after 
the addition of GST-Lasso. This stimulation was not able to significantly 
change the rate of spontaneous exocytosis. 
 
98 
Figure 4.20. A. Average frequency of MEPPs in Ca
2+
-containing buffer 
before and after the addition of 100 nM GST-Lasso. The difference is not 
statistically significant. B. Average amplitude of MEPPs before and after 
the addition of GST-Lasso in Ca
2+
-containing buffer. The difference is 
not statistically significant (n = 19 cells in Ca
2+
 buffer, 31 cells after the 
addition of GST-Lasso; N = 3). 
 
99 
Figure 4.21. Individual traces of MEPPs in Ba
2+
 buffer after the addition 
of LTX
N4C
. A burst (A) and an interburst interval (B) are shown. C. 




 buffer without Ca
2+
, 
and after the addition of LTX
N4C






buffer, 16 cells in Ba
2+
 buffer, and 70 cells after the addition of LTX
N4C
; 
***, P < 0.001, Mann – Whitney U test).  
 
Figure 4.22. Individual traces of MEPPs in Sr
2+
 buffer after the addition 
of LTX
N4C
. A burst (A) and an interburst interval (B) are shown. C. 




 buffer without Ca
2+
, 
and after the addition of LTX
N4C
 (N = 2, n = 8 cells recorded in Ca
2+ 
buffer, 5 cells in 2 mM Sr
2+
, and 45 cells after the addition of LTX
N4C
; 
***, P < 0.001, Mann – Whitney U test). 
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 (A) and 
-/-
 (B) NMJ preparations. 
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containing buffer (n = 19 LPHN1
+/+
 and 3 
-/-
; **, P < 0.01). B. Number of 









 buffer (n = 3 LPHN1
+/+
 and 3 
-/-
; **, P < 0.01, Mann – 
Whitney U test). 
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Figure 4.25. Solubilisation of LPHN1 NTF and CTF from rat brain 
synaptosomes by different concentrations of Thesit and PFOA. A. Thesit 
removes both fragments from the membrane equally (4 °C); both NTF 
and CTF start to go in solution at 0.05% and are completely solubilised 
at 0.5% Thesit. PFOA differentially solubilises NTF and CTF at RT (B) 
and at 4 °C (C). At both temperatures the NTF goes in solution at 0.5% 
PFOA; the CTF is solubilised at 1% PFOA at RT, but never at 0° C. 
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Figure 4.26. The percentage of cells bursting after the addition of 
LTX
N4C
 (A) and the time elapsed from the addition of the toxin and the 





Figure 4.27. A. Average frequency of MEPPs during bursts at different 
concentrations of PFOA. The difference between the conditions is not 
statistically significant (n = 33 bursts in Ca
2+
 buffer, 22 in 0.2 µM PFOA, 
11 in 1 µM PFOA, 6 in 10 µM PFOA and 4 in 50 µM PFOA). B. Overall 
average frequency of exocytosis after the addition of LTX
N4C 
at different 
concentrations of PFOA (n = 38 cells in Ca
2+
 buffer, 28 in 0.2 µM 
PFOA, 25 in 1 µM PFOA, 27 in 10 µM PFOA, 32 in 50 µM PFOA and 
44 in 100 µM PFOA). 
 
110 
Figure 4.28. Average frequency of MEPPs in Ca
2+
 buffer and after the 
addition of LTX
N4C
 and 100 µM PFOA. PFOA significantly inhibits the 
effects on exocytosis caused by the activation of LPHN1 (n = 19 cells 
recorded after the addition of LTX
N4C
 and 18 after subsequent addition of 
PFOA; **, P < 0.01, Mann – Whitney U test). 
 
111 
Figure 4.29. Single traces of MEPPs during bursts after the addition of 
LTX
N4C
 in 0.2 (A), 1 (B), 10 (C), and 50 (D) µM PFOA. The frequency 
of MEPPs inside the burst does not change between these conditions. No 
bursts develop in 100 µM PFOA (E).  
 
112 
Figure 4.30. Western blot analysis of unbound (U) and bound (B) 
samples of αLTX to LPHN1 expressing cells. In LPHN1 expressing 
cells, αLTX band is visible only in the pellets containing the cells. By 
contrast, in WT cells most αLTX is present in the supernatant. As the 
purpose of this experiment was not to compare the amount of binding of 
the toxin to LPHN1 in the presence of different concentrations of PFOA, 
but only its presence or absence, a loading control was not included. 
 
113 
Figure 4.31. Changes in the frequency of MEPPs after the sequential 
addition of 20 mM KCl and 2 mM Ca
2+
. Recordings were made on 
multiple individual fibres as indicated by the breaks in the otherwise 




causing an increased resting membrane potential. B. Average frequency 
of MEPPs in Ca
2+
-free buffer, and after the sequential addition of 20 mM 
KCl and 2 mM Ca
2+ 
(n = 10 cells recorded in Ca
2+
-free buffer, 21 cells 
after addition of KCl, and 38 cells after subsequent addition of Ca
2+
; ***, 
P < 0.001, Mann – Whitney U test). 
 
Figure 4.32. A. Average frequency of MEPPs after the addition of 20 
mM KCl in the presence of different concentrations of PFOA. To elicit a 
response in the presence of 100 µM PFOA it was necessary to double the 
amount of KCl used (n = 55 cells recorded in the presence of 20 mM KCl 
in Ca
2+
 buffer, 33 in 10 µM PFOA, 11 cells in 100 µM PFOA; 9 cells 
were recorded in the presence of 40 mM KCl in 100 µM PFOA; ***, P < 
0.001, One-way ANOVA). The resting membrane potential was slightly 
increased after the addition of KCl. B. Time from the addition of KCl to 
the start of increased exocytosis. With 100 µM PFOA and 40 mM KCl, 
the difference is statistically significant (n = 2 experiments using 20 mM 
KCl in 10 µM PFOA and 2 experiments using 40 mM KCl in 100 µM 
PFOA; **, P < 0.01, Mann – Whitney U test). 
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Figure 4.33. Single trace of a MEPPs recording showing a burst in the 
presence of 1 µM TTX. 
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Figure 4.34. A. Average frequency of MEPPs in Ca
2+
-containing buffer 
and after the addition of TTX and LTX
N4C
. 1 µM TTX does not inhibit 
the increase in exocytosis caused by the activation of LPHN1 by 
LTX
N4C
. B. Average amplitude of MEPPs in Ca
2+
 buffer and after the 
addition of TTX and LTX
N4C
. The difference between the conditions is 
not statistically significant (n = 6 cells in Ca
2+
 buffer, 5 cells after 
addition of TTX and 12 cells after addition of LTX
N4C
; ***, P < 0.001, 









Figure 5.1. Single traces of MEPPs recordings in Ca
2+
 buffer after the 
addition of UBO-QIC (A) and LTX
N4C
 (B). The addition of LTXN4C 
does not cause increased exocytosis in the presence of UBO-QIC. 
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Figure 5.2. A. Frequency plot of a recording of MEPPs in Ca
2+
 buffer (2 
mM), after the addition of UBO-QIC and LTX
N4C
. The presence of 
UBO-QIC in the buffer prevents the activation of Gαq/11 protein and the 
effects usually observed upon addition of LTX
N4C
 do not develop. B. 
Average frequency of MEPPs in Ca
2+
 buffer, after the addition of UBO-
QIC and of LTX
N4C
. The difference between the conditions is not 
statistically significant. C. Scatter plot of the data summarised in B. Each 
point represents the frequency of a single fibre recorded under the given 
condition. Note that about 30% of the recorded cells still respond to the 
toxin with increased frequency. D. Average amplitude of MEPPs in Ca
2+
 
buffer, after the addition of UBO-QIC and LTX
N4C
. The difference 
between the conditions is not statistically significant (N = 3, n = 20 cells 
recorded in Ca
2+






Figure 5.3. Single traces of MEPPs recordings in Ca
2+
 buffer after the 
addition of LTX
N4C
 (A) and UBO-QIC (B). UBO-QIC is able to stop the 
increased exocytosis caused by the stimulation of LPHN1. 
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Figure 5.4. A. Frequency plot of a recording of MEPPs in Ca
2+
-
containing buffer (2 mM) where UBO-QIC was added once LTX
N4C 
already started to exert its effect. UBO-QIC is able to significantly 
reduce the frequency of exocytosis due to the activation of LPHN1. B. 
Average frequency of MEPPs in Ca
2+
 buffer, after the addition of 
LTX
N4C
 and subsequent addition of UBO-QIC. C. Average amplitude of 
MEEPs in Ca
2+
 buffer and after the addition of LTX
N4C




The difference between the conditions is not statistically significant (N = 
3, n = 19 cells recorded in Ca
2+
 buffer, 36 after the addition of LTX
N4C
, 
and 29 after the addition of UBO-QIC; **, P <0.010, Mann – Whitney U 
test). 
 
Figure 5.5. Single traces for MEPPs recordings in Ca
2+
 buffer in the 
presence of U73122 (A) and after the addition of LTX
N4C
 (B). 
Stimulation of LPHN1 by LTXN4C is not able to produce the typical 
increase in spontaneous exocytosis when U73122 is present. 
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Figure 5.6. A. Frequency plot of a MEPPs recording in Ca
2+
 buffer (2 
mM), after the addition of U73122 and of LTX
N4C
. The presence of 
U73122 in the buffer successfully inhibits the activation of LPHN1. B. 
Average frequency of MEPPs in buffer A, after the addition of U73122 
and subsequent addition of LTX
N4C
. The difference between the 
conditions is not statistically different. C. Average amplitude of MEPPs 
in Ca
2+
 buffer, and after the sequential addition of U73122 and LTX
N4C
. 
The difference is npt statistically significant (N = 2, n = 9 cells recorded 
in Ca
2+






Figure 5.7. Single traces of MEPPs recordings in Ca
2+ 
buffer after the 
addition of LTX
N4C
 (A) and subsequent addition of U73122 (B). U73122 
is able to abolish the effects of LPHN1 activation. 
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Figure 5.8. A. Frequency plot of a MEPPs recording in Ca
2+
 buffer (2 
mM), after the addition of LTX
N4C
 and of U73122. U73122 successfully 
reduces the increase in exocytosis caused by LTX
N4C
. B. Average 
MEPPs frequency in Ca
2+
 buffer, after the addition of LTX
N4C
 and 
subsequent addition of U73122. C. Average amplitude of MEPPs in Ca
2+
 
buffer, and after the sequential addition of LTX
N4C
 and U73122. The 




= 13 cells recorded in Ca
2+
 buffer, 19 after the addition of LTX
N4C
, and 
38 after the addition of U73122; **, P < 0.010, Mann – Whitney U test).  
 
Figure 5.9. A. Average frequency of MEPPs in Ca
2+
 buffer (2 mM) and 
after the sequential addition of U73343 and LTX
N4C 
(N = 1, n = 6 cells 
recorded in Ca
2+
 buffer, 6 after addition of U73343,and 12 after addition 
of LTX
N4C
; ***, P < 0.001, Mann – Whitney U test ) . B. Average 
frequency of MEPPs in Ca
2+
 buffer (2 mM) and after the sequential 
addition of LTX
N4C
 and U73343. The difference between the conditions 
is not statistically significant (N = 1, n = 5 cells recorded in Ca
2+
 buffer, 
10 afetr addition of LTX
N4C
, and 9 after addition of U73343, Mann – 
Whitney U test). 
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Figure 5.10. Single traces of MEPPs recordings in Ca
2+
 buffer after the 
addition of LTX
N4C
 (A) and 2APB (B). Addition of 2APB fully stops the 
effects due to the activation of LPHN1. 
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Figure 5.11. A. Frequency plot of a MEPPs recording in the presence of 
2 mM Ca
2+
, after the addition of LTX
N4C
 and of 2APB. 2APB is able to 
significantly reduce the elevation in exocytosis caused by LTX
N4C
. B. 
Average frequency of MEPPs in Ca
2+
 buffer, after the addition of 
LTX
N4C
 and subsequent addition of 2APB. C. Average amplitude of 
MEPPs in Ca
2+
 buffer and after the sequential addition of LTX
N4C
 and 
2APB. The difference is not statistically significant (N = 2, n = 6 cells 
recorded in Ca
2+
 buffer, 13 after addition of LTX
N4C
 and 11 after the 
addition of 2APB; ***, P < 0.001, Mann – Whitney U test). 
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Figure 5.12. Individual traces of MEPPs recordings in Ca
2+
-free buffer 
after the addition of TG (A), and after the addition of LTX
N4C
 (B) and 2 
mM Ca
2+
 (C) once the effects of TG had ceased. In the presence of 
LTX
N4C
, the addition of Ca
2+
 after the effects of TG subsided is not able 




Figure 5.13. Average frequency of MEPPs in Ca
2+
-free buffer and after 
the sequential addition of TG, LTX
N4C
, and 2 mM Ca
2+
(N = 2, n = 5 cells 
recorded, in Ca
2+
-free buffer, 5 after the addition of TG, 5 after the 
addition of LTX
N4C
 and 9 after the addition of Ca
2+
; ***, P < 0.001, 
Mann – Whitney U test). 
 
144 
Figure 5.14. Comparison between the average frequency of MEPPs in 
Ca
2+
-containing buffer (2 mM) after the addition of LTX
N4C
, and in Ca
2+
-
containing buffer with ryanodine after the addition of LTX
N4C
 (N = 1, n 
= 7 cells recorded in Ca
2+
 buffer, 5 cells after the addition of LTX
N4C
, 
and 11 cells after the addition of LTX
N4C
 in the presence of ryanodine; 
**, P < 0.010, Mann – Whitney U test). 
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Figure 5.15. Schematic representation of the intracellular pathway 
activated by LPHN1. Upon binding of LTX
N4C
, LPHN1 activates Gαq 
protein, which in turns activates PLC on the plasma membrane (arrow 1). 
PLC then promotes the cleavage of PIP2 in DAG and IP3 (arrow 2); 
whilst the first activates PKC, the latter binds to IP3Rs on the ER, 
causing the release of Ca
2+
 from intracellular Ca
2+
 stores into the cytosol 
(arrow 3). The elevation in cytosolic Ca
2+
 concentration in turn starts the 







Figure 6.1. Single traces of MEPPs recordings in the presence of Gd
3+ 
(A) and after the addition of LTX
N4C
 (B). Addition of LTX
N4C
 in the 
presence of Gd
3+
 does not elicit the typical effects of LPHN1 activation. 
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Figure 6.2. A. Frequency plot of a MEPPs recording in the presence of 2 
mM Ca
2+






 inhibits the 






 buffer, after the addition of Gd
3+
 and subsequent addition 
of LTX
N4C
. The difference between the conditions is not statistically 
significant. C. Average amplitude of MEPPs in Ca
2+





. The difference is not statistically 
significant (N = 2, n = 7 cells recorded in Ca
2+
 buffer, 9 cells with Gd
3+
, 




Figure 6.3. Single traces of MEPPs recordings in Ca
2+
 buffer after the 
addition of LTX
N4C
 (A) and 2APB (B). 2APB is able to stop the 
elevation in exocytosis that follows activation of LPHN1. 
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Figure 6.4. A. Frequency plot of a MEPPs recording in the presence of 2 
mM Ca
2+
, after the addition of LTX
N4C
 and subsequent addition of 
2APB. 2APB significantly reduced the elevation in exocytosis caused by 
LTX
N4C
. B. Averaged frequency of MEPPs in Ca
2+
 buffer, after the 
addition of LTX
N4C
 and 2APB. C. Average amplitude of MEPPs in Ca
2+
 
buffer and after the sequential addition of LTX
N4C
 and 2 APB. The 
difference between the conditions is not statistically significant (N = 2, n 
= 6 cells recorded in Ca
2+
 buffer, 13 cells after addition of LTX
N4C
, and 
11 cells after addition of 2APB; ***, P < 0.001, Mann – Whitney U test). 
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Figure 6.5. Single traces of MEPPs recordings in Ca
2+
 buffer after the 
addition of LTX
N4C
 (A) and of SKF96365 (B). Addition of SKF96365 is 
able to fully stop the effects due to the activation of LPHN1. 
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Figure 6.6. A. Frequency plot of a MEPPs recording in the presence of 2 
mM Ca
2+
, and after the addition of LTX
N4C
 and SKF96365. SKF96365 
successfully inhibits the increase in exocytosis caused by LPHN1 
activation. B. Average frequency of MEPPs in buffer A, and after the 
addition of LTX
N4C
 and SKF96365. C. Average amplitude of MEPPs in 
Ca
2+
 buffer and after sequential addition of LTX
N4C
 and SKF96365. The 
difference is not statistically significant (N = 1, n = 5 cells recorded in 
Ca
2+
 buffer, 7 cells after addition of LTX
N4C




SKF96365; ***, P < 0.001, Mann – Whitney U test). 
 
Figure 6.7. Single traces of MEPPs recordings in Ca
2+
 buffer after the 
addition of LTX
N4C
 (A) and of YM58483 (B). YM58483 is able to 






Figure 6.8. A. Frequency plot of a MEPPs recording in buffer containing 
2 mM Ca
2+
, and after the addition of LTX
N4C
, and YM58483. YM58483 
significantly reduced the frequency of exocytosis caused by LPHN1 
activation by LTX
N4C
. B. Average frequency of MEPPs in Ca
2+
 buffer, 
and after the addition of LTX
N4C
, and YM58483. C. Average amplitude 
of MEPPs in Ca
2+
 buffer, and after the sequential addition of LTX
N4C
 and 
YM58483. The difference between the conditions is not statistically 
significant (N = 1, n = 6 cells recorded in Ca
2+
 buffer, 15 cells after 
addition of LTX
N4C
, and 11 after addition of YM58483; **, P < 0.010, 
Mann – Whitney U test). 
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Figure 6.9. Summary of the average frequency of MEPPs upon addition 
of drugs directed to inhibit or block components of the SOCE (Gd
3+
, 
2APB, SKF96365, and YM58483). The values of MEPPs frequency in 
each condition were compared to the effects of LTX
N4C
 using the Mann – 
Whitney U test (**, P < 0.01; ***, P < 0.001). The graph shows the 
results of four independent series of experiments, where the effects of 
LTX
N4C
 under treatment conditions were compared to their own negative 
and positive control values, recorded on the same preparations prior to 
the treatments. The graph does not attempt to compare each treatment to 
an average control value, but only serves to illustrate the scale of effects 
of different treatments (note, however, that the control values are 
remarkably similar in all experiments). For these reasons, no correction 





Figure 6.10. Single traces of MEPPs recorded in Ca
2+
 buffer after the 
addition of 10 µM TG. This drug caused a 35 fold increase in 





Figure 6.11. A. Frequency plot of a MEPPs recording in 2 mM Ca
2+
 and 
after the addition of TG. B. Average frequency of MEPPs in Ca
2+
 buffer 
and after the addition of TG. C. Average amplitude of MEPPs in Ca
2+
 
buffer and after the addition of TG (N = 3, n = 25 cells in Ca
2+
 buffer, 27 




Figure 6.12. Single traces of a MEPPs recording in Ca
2+
-free buffer after 
the addition of TG. The elevation in frequency of exocytosis in the 
absence of Ca 
2+
 in the extracellular buffer is the same as in the presence 
of Ca
2+
. In this case, however, the elevation stops after about 10 minutes. 
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Figure 6.13. A. Frequency plot of a MEPPs recording in Ca
2+
-free 
buffer, after the addition of TG and subsequent addition of 2 mM Ca
2+
. 
B. Average frequency of MEPPs in a Ca
2+
-free buffer, after the addition 
of TG and subsequent addition of 2 mM Ca
2+
. C. Comparison between 
the average frequency of MEPPs induced by 10 µM TG in the presence 
and in the absence of extracellular Ca
2+
. The difference is not statistically 
significant. D. Average amplitude of MEPPs caused by TG in the 
presence and in the absence of extracellular buffer. The difference is not 
statistically significant (N = 2, n = 15 cells recorded after the addition of 
TG in Ca
2+
buffer, and 18 cells in Ca
2+
 free buffer). 
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Figure 6.14. Single traces of MEPPs in Ca
2+
 buffer after the addition of 
LTX
N4C 
(A) and after the addition of TG (B). TG is able to stop LPHN1-






Figure 6.15. A. Frequency plot of a MEPPs recording in the presence of 
2 mM Ca
2+
, and after the sequential addition of LTX
N4C
 and TG. 
Addition of TG, after LTX
N4C
 had triggered an increase in exocytosis, 
caused a sudden cessation of neurotransmitter release. B. Average 
frequency of MEPPs in Ca
2+
 buffer, after the addition of LTX
N4C
 and TG 
(N = 3, n = 12 cells recorded in Ca
2+
 buffer, 15 cells after the addition of 
LTX
N4C
, and 17 cells after the addition of TG; ***, P < 0.001, Mann – 
Whitney U test). 
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Figure 6.16. Single traces of MEPPs recording in Ca
2+
-free buffer after 
the addition of TG (A), and after the addition of LTX
N4C
 (B) and Ca
2+
 
(C) once the effects of TG has ceased. The effects of LTX
N4C 
are not able 






Figure 6.17. Frequency plot of a MEPPs recording in Ca
2+
-free buffer, 
and after the addition of TG, LTX
N4C
, and 2 mM Ca
2+
. When added once 
the peak of exocytosis caused by TG ceased, LTX
N4C
 was not able to 
increase the frequency of exocytosis even if 2 mM Ca
2+
 was added. B. 
Average frequency of MEPPs in Ca
2+





 (N = 2, n = 5 cells recorded in Ca
2+
-free buffer, 5 
cells after addition of TG, 5 cells after the addition of LTX
N4C
, and 9 
after the addition of 2 mM Ca
2+




Figure 6.18. Single traces of MEPPs recordings in Ba
2+
 buffer (A) and 
after the addition of LTX
N4C





 in the extracellular buffer. 
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Figure 6.19. A. Average frequency of MEPPs in Ba
2+
 buffer before and 
after the addition of LTX
N4C
. B. Average amplitude of MEPPs in Ba
2+
 
buffer before and after the addition of LTX
N4C




statistically significant (N = 2, n = 16 cells recorded in Ba
2+
 buffer and 
70 cells recorded after addition of LTX
N4C
. ***, P<0.001, Mann – 
Whitney U test). 
 
Figure 6.20. Single traces of MEPPs in Sr
2+
 buffer (A) and after the 
addition of LTX
N4C





 in the extracellular buffer. 
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Figure 6.21. A. Average frequency of MEPPs in Sr
2+
 buffer before and 
after the addition of LTX
N4C
. B. Average amplitude of MEPPs before 




-containing buffer. The 
difference is not statistically significant (N = 2, n = 5 cells recorded in 2 
mM Sr
2+
, 45 cells recorded after the addition of LTX
N4C
; ***, P<0.001, 
Mann – Whitney U test).  
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Figure 6.22. Time elapsed between the addition of LTX
N4C
 and the start 






 buffer. The 










Figure 6.23. Schematic representation of the molecular mechanisms 
involved in LPHN1 activation. As described previously (Chapter 5, 
Figure 5.15), activation of LPHN1 activates the Gαq protein pathway, 
involving activation of PLC (arrow 1), stimulation of IP3Rs by IP3 (arrow 
2), and release of Ca
2+
 from the ER intracellular stores (arrow 3). 
Depletion of the stores is sensed by STIM1, a transmembrane protein 
located at the ER, that under these circumstances dimerises and 
translocates close to the plasma membrane (arrow 4). Here, STIM1 
contacts and opens store-operated Ca
2+ 
channels (TRPCs and Orais), that 
start the influx of Ca
2+
 that allows the refilling of the stores (arrow 5). At 








Figure 7.1. Single traces of MEPPs recordings in Ca
2+
 buffer after the 
addition of LTX
N4C
 (A) and Nimodipine (B). Nimodipine does not stop 




Figure 7.2. A. Frequency plot of a MEPPs recording in a buffer 
containing 2 mM Ca
2+
, and after the consecutive addition of LTX
N4C
 and 
Nimodipine. The block of L-type VGCCs is not able to suppress 
LPHN1-mediated exocytosis. B. Average frequency of MEPPs in Ca
2+
 
buffer, and after the addition of LTX
N4C
 and Nimodipine. The difference 
between the conditions is not statistically significant. C. Average 
amplitude of MEPPs in Ca
2+
 buffer and after the addition of LTX
N4C
 and 
Nimodipine (N = 2, n = 5 cells recorded in Ca
2+
 buffer, 17 cells after 
addition of LTX
N4C
, and 11 cells after the addition of Nimodipine; ***, P 
< 0.001, Mann – Whitney U test). 
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Figure 7.3. Single traces of MEPPs recordings in Ca
2+
 buffer in the 
presence of Nimodipine (A) and after the addition of LTX
N4C
 (B). The 
presence of Nimodipine in the buffer does not prevent the development 
of LPHN1effects on exocytosis. 
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Figure 7.4. A. Frequency plot of a MEPPs recording in a buffer 
containing 2 mM Ca
2+
, and after the addition of Nimodipine and 
LTX
N4C
. Nimodipine is not able to prevent the manifestation of the 
effects due to LPHN1 activation. B. Average frequency of MEPPs in 
Ca
2+
 buffer, and after the addition of Nimodipine and LTX
N4C
. C. 
Average amplitude of MEPPs in Ca
2+
 buffer, and after sequential 
addition of Nimodipine and LTX
N4C
 (N = 1, n =7 cells recorded in Ca
2+
 
buffer, 6 cells recorded with Nimodipine, and 10 cells after the addition 
of LTX
N4C




Figure 7.5. A. Single traces of MEPPs in Ca
2+
 buffer after the addition 
of ω-Con MVIIC (A) and of LTX
N4C
 (B). When LPHN1 is stimulated in 
the presence of ω-Con MVIIC, no increase in exocytosis develops. 
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Figure 7.6. A. Frequency plot of a MEPPs recording in the presence of 2 
mM Ca
2+
, and after the consecutive addition of ω-Con MVIIC and 
LTX
N4C
. ω-Con MVIIC successfully inhibits the increase in exocytosis 
due to the activation of LPHN1. The LTX
N4C
 control was recorded on the 
same day on a different preparation not treated with ω-Con MVIIC. B. 
Average frequency of MEPPs in Ca
2+
 buffer and after the addition of ω-
Con MVIIC and LTX
N4C
. The difference between the conditions is not 
statistically significant. C. Average amplitude of MEPPs in Ca
2+
 buffer, 
and after sequential addition of ω-Con MVIIC and LTX
N4C
 (N = 3, n = 
19 cells recorded in Ca
2+
 buffer, 21 cells with ω-Con MVIIC, and 39 
cells after the addition of LTX
N4C




Figure 7.7. Single traces of MEPPs recordings in Ca
2+
 buffer after the 
addition of LTX
N4C
 (A) and ω-Con MVIIC (B). ω-Con MVIIC is not 




Figure 7.8. A. Frequency plot of a MEPPs recording in a buffer 
containing 2 mM Ca
2+
, and after the addition of LTX
N4C
 and ω-Con 
MVIIC. ω-Con MVIIC added once the increase in exocytosis took place 
is not able to successfully inhibit it. B. Average frequency of MEPPs in 
Ca
2+
 buffer, and after the addition of LTX
N4C
 and ω-Con MVIIC. The 
difference between the conditions is not statistically significant. C. 
Average amplitude of MEPPs in Ca
2+
 buffer and after sequential addition 
of LTX
N4C
 and ω-Con MVIIC. The difference is not statistically 
significant (N = 2, n = 13 cells recorded in Ca
2+
 buffer, 20 cells after the 
addition of LTX
N4C




Whitney U test). 
 
Figure 7.9. Comparison between the average frequency of MEPPs 





and in the presence of both LTX
N4C
 and ω-Con MVIIC (n = 5 cells for 
the control condition and 5 with ω-Con MVIIC; *, P < 0.05, Mann – 
Whitney U test). 
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Figure 7.10. Single traces of MEPPs recordings in Ca
2+
 buffer in the 
presence of ω-Con GVIA (A) and after the addition of LTX
N4C
 (B). The 
effects of LPHN1 activation are not inhibited by ω-Con GVIA. 
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Figure 7.11. A. Frequency plot of a MEPPs recording in a buffer 
containing 2 mM Ca
2+
, and after the addition of ω-Con GVIA and 
LTX
N4C
. The presence of ω-Con GVIA in the buffer does not inhibit the 
effects of LPHN1 activation. B. Average frequency of MEPPs in Ca
2+
 
buffer, and after the addition of ω-Con GVIA and LTX
N4C
. C. Average 
amplitude of MEPPs in Ca
2+
 buffer, and after the sequential addition of 
ω-Con GVIA and LTX
N4C
. The difference is not statistically significant 
(N = 2, n = 11 cells recorded in Ca
2+
 buffer, 12 cells with ω-Con GVIA, 
and 30 cells after the addition of LTX
N4C
; ***, P < 0.001, Mann – 
Whitney U test). 
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Figure 7.12. Single traces of MEPPs recordings in Ca
2+
 buffer in the 
presence of ω-Aga IVA (A) and after the addition of LTX
N4C
 (B). The 




Figure 7.13. A. Frequency plot of a MEPPs recording in a buffer 
containing 2 mM Ca
2+
, and after the addition of ω-Aga IVA and LTX
N4C
. 
ω-Aga IVA is able to fully abolish the effects due to the activation of 




addition of ω-Aga IVA and LTX
N4C
. The difference between the 
conditions is not statistically significant. The control of N4C was 
recorded on the same day on a different preparation not treated with ω-
Aga IVA. C. Average amplitude of MEPPs in Ca
2+
 buffer and after the 
sequential addition of ω-Aga IVA and LTX
N4C
 (N = 3, n = 18 cells 
recorded in Ca
2+
 buffer, 14 cells with ω-Aga IVA, and 31 cells after the 
addition of LTX
N4C
; ***, P< 0.001, Mann – Whitney U test). 
 
Figure 7.14. A. Comparison between the averaged frequencies of 
MEPPs after the addition of LTX
N4C 
in 2 mM Ca
2+
, and after the addition 
of VGCCs inhibitors (Nimodipine, ω-Con GVIA, and ω-Aga IVA). Only 
ω-Aga IVA, a specific blocker of P/Q VGCCs, is able to inhibit the 
activation of LPHN1 (***P<0.001, Mann – Whitney U test). B. The 
block of P/Q VGCCs is effective in inhibiting the activation of LPHN1 
only when added prior to the addition of LTX
N4C
. If added once the 
effects of LPHN1 already developed, blocking these channels does not 
interfere with the increase in exocytosis normally observed upon 
activation of LPHN1. 
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Figure 7.15. Single traces of MEPPs recordings in Ca
2+
 buffer in the 
presence of UBO-QIC and ω-Aga IVA (A) and after the addition of 
LTX
N4C
 (B). Whilst when only UBO-QIC is present about 30% of the 
cells continue responding to LTX
N4C
 with increased exocytosis, the 
concomitant presence of ω-Aga IVA completely abolishes the effect. 
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Figure 7.16. A. Frequency plot of a MEPPs recording in 2 mM Ca
2+
 and 
after the addition of UBO-QIC and ω-Aga IVA, with subsequent 
stimulation with 0.25 nM LTX
N4C
. B. Average frequency of MEPPs in 
Ca
2+
 buffer and after the addition of UBO-QIC and ω-Aga IVA, and 
LTX
N4C
. The difference between the conditions is not statistically 
significant. The control for LTX
N4C
 was recorded the same day on a 




Average amplitude of MEPPs in Ca
2+
 buffer, and after the addition of 
UBO-QIC and ω-Aga IVA, and after stimulation with LTX
N4C
. The 
difference between the conditions is not statistically different (N = 1, n = 
5 cells recorded in Ca
2+
 buffer, 12 cells with UBO-QIC and ω-Aga IVA, 
and 9 cells after the addition of LTX
N4C
; ***, P < 0.001, Mann – 
Whitney U test). 
 
Figure 7.17. A. Frequency plot of a MEPPs recording in 2 mM Ca
2+
 and 
after the addition of UBO-QIC, LTX
N4C
 and ω-Aga IVA. B. Average 
frequency of MEPPs in Ca
2+
 buffer, and after the addition of UBO-QIC, 
LTX
N4C
 and ω-Aga IVA (N = 1, n = 6 cells recorded in Ca
2+
, 6 with 
UBO-QIC, 10 after stimulation with LTX
N4C




Figure 7.18. A. Single traces of MEPPs recorded at the mouse NMJ in 2 
mM Cd
2+




 buffer. The 
difference between the conditions is not statistically significant. C. 




 buffer. The difference is 
not statistically significant (N = 6, n = 23 cells recorded in Ca
2+






Figure 7.19. Single traces of MEPPs recorded at the mouse NMJ in Cd
2+
 
buffer after the addition of LTX
N4C
. This buffer completely supports the 
increase in exocytosis caused by the activation of LPHN1. 
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Figure 7.20. A. Frequency plot of a MEPPs recording in Cd
2+
 buffer and 
after the addition of LTX
N4C
. B. Average frequency of MEPPs in Cd
2+
 
buffer and after the addition of LTX
N4C
. C. Average amplitude of MEPPs 
in Cd
2+
 buffer and after addition of LTX
N4C
 (N = 6, n = 18 cells recorded 
in Cd
2+
 buffer and 35 after the addition of LTX
N4C
; ***, P < 0.001, Mann 





Figure 7.21. A. Frequency plot of a MEPPs recording inCa
2+
-free buffer, 




. B. Average frequency of 
MEPPs in Ca
2+





= 2, n = 7 cells recorded in Ca
2+
-free buffer, 9 cells after the addition of 
LTX
N4C
, and 26 cells after the addition of Cd
2+
; ***, P < 0.001, Mann – 




Figure 7.22. Single traces of MEPPs recordings in Cd
2+
 buffer after the 
addition of LTX
N4C
 and 2APB (A) or SKF96365 (B). These SOCCs 
blockers are successful in inhibiting LPHN1-mediated increase in 
exocytosis when Ca
2+
 is replaced by Cd
2+
 in the extracellular buffer. 
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Figure 7.23. Comparison between the averaged frequency of MEPPs in 
Cd
2+
 buffer, and after the addition of LTX
N4C
 and of SOCCs blockers 2 
APB and SKF96365. Both drugs successfully inhibit LPHN1-mediated 
exocytosis (n = 15 cells recorded in Cd
2+
, 29 cells after the addition of 
LTX
N4C
, 32 cells after the addition of 2APB, and 15 after the addition of 
SKF96365; **, P < 0.010; ***, P < 0.001, Mann – Whitney U test). 
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Figure 7.24. Single traces of MEPPs recording in Cd
2+
 buffer in the 
presence of ω-Con MVIIC before (A) and after (B) the addition of 
LTX
N4C
. The inhibition of exocytosis exerted by ω-Con MVIIC is Cd2+ 





Figure 7.25. A. Average frequency of MEPPs in 2 mM Cd
2+
, and after 
the addition of ω-Con MVIIC and LTX
N4C
. B. Average amplitude of 
MEPPs in Cd
2+
 buffer and after the addition of ω-Con MVIIC and 
LTX
N4C
. The difference is not statistically significant (N = 1, n = 6 cells 
recorded in 2 mM Cd
2+
, 8 cells after the addition of ω-Con MVIIC, and 
20 after the addition of LTX
N4C
; ***, P < 0.001, Mann – Whitney U 
test). C. Comparison between the effects on frequency of MEPPs after 













buffer and 8 cells in the presence of ω-Con MVIIC; *, P < 0.05, Mann – 
Whitney U test). 
 
Figure 7.26. Single traces of MEPPs recordings in Cd
2+
 buffer after the 
addition of TG. Under this condition, exocytosis goes through a gradual 
increase, then reaches a pick that remain stable for some time before 
decreasing until cessation. 
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Figure 7.27. A. Frequency plot of a MEPPs recording in 2 mM Cd
2+
 and 
after the addition of TG. B. Average frequency of MEPPs in Cd
2+
 buffer 
and after the addition of TG. C. Average amplitude of MEPPs in Cd
2+
 
buffer and after the addition of TG (N = 3, n = 18 cells recorded in Cd
2+
 
buffer and 24 cells after the addition of TG; ***, P > 0.001, Mann – 
Whitney U test). 
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Figure 7.28. Single traces of MEPPs recordings in Cd
2+
 buffer after the 
addition of LTX
N4C
 (A) and TG (B). TG causes the immediate cessation 
of release when LTX
N4C
 effects have developed. 
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Figure 7.29. A. Frequency plot of a MEPPs recording in 2 mM Cd
2+
, and 
after the addition of LTX
N4C
 and TG. Addition of TG after the rise in 
exocytosis due to LTX
N4C 
causes a sudden block of release. B. Average 
frequency of MEPPs in Cd
2+
 buffer, and after the addition of LTX
N4C
 and 
TG (N = 2, n = 8 cells recorded in Cd
2+
 buffer, 12 cells after the addition 
of LTX
N4C
, and 15 cells after the addition of TG; ***, P < 0.001, Mann – 
Whitney U test). 
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Figure 7.30. Single traces of MEPPs recordings in Ca
2+
-free buffer (A), 








Figure 7.31. Average frequency of MEPPs in Ca
2+
-free buffer, and after 
the addition of 20 mM KCL and 2 mM Ca
2+
. The increase in exocytosis 
does not start until Ca
2+
 is added to the extracellular buffer (N = 5, n = 10 
cells recorded in Ca
2+
-free buffer, 21 cells after the addition of KCl, and 
38 cells after the addition of Ca
2+




Figure 7.32. Single traces of MEPPs recordings in the presence of 20 
mM KCl after the addition of Nimodipine (A), ω-Aga IVA (B), ω-Con 
MVIIC (C), Nimodipine + ω-Con MVIIC (D), 2 mM Cd
2+






Figure 7.33. Average frequency of MEPPs in 20 mM KCl, and after the 
addition of VGCCs blockers Nimodipine, ω-Aga IVA, ω-Con MVIIC, 
Nimodipine and ω-Con MVIIC, and Cd
2+
 (*, P < 0.05; ***, P < 0.001, 
Mann – Whitney U test). 
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Figure 7.34. Schematic representation of the full mechanism activated 
by LPHN1.  As extensively discussed previously (Chapter 5, Figure 
5.15) the stimulation of LPHN1 causes the activation of the Gαq protein 
signalling pathway, ultimately leading to the release of Ca
2+ 
from IP3Rs 
located at the ER (arrows 1 to 5). The decreased concentration of ER 
intraluminal Ca
2+ 
is detected by STIM1, that dimerises in proximity to 
the plasma membrane and contacts SOCCs (TRPCs and Orais), opening 
them and allowing influx of Ca
2+
 (arrows 4 – 5, Chapter 6, Figure 6.23).  
In parallel, activation of LPHN1 causes the opening of P/Q VGCCs 
(arrow 6), that supply the initial influx of Ca
2+
 necessary to elevate the 
intracellular Ca
2+
 concentration to a level sufficient to further stimulate 










Figure 8.1. Block diagram summarising the molecular mechanisms 
responsible for the increased exocytosis observed after stimulation of 
LPHN1 with LTX
N4C
. Activation of LPHN1 causes the stimulation of the 
Gαq protein signalling pathway and, in parallel, the opening of P/Q 
VGCCs. The first leads to the efflux of Ca
2+
 from IP3-sensitive 
intracellular Ca
2+
 stores and subsequent opening of SOCCs and initiation 
of SOCE; the periodic opening/closing of SOCCs is what give rise to the 
bursts, and it will go on as long as LPHN1 is stimulated. The latter 
causes the initial influx of Ca
2+
 needed to further stimulate the release of 
Ca
2+
 from IP3Rs and start the increase in the frequency of exocytosis; the 
constant influx of Ca
2+
 from P/Q VGCCs is responsible for the increased 
frequency of spontaneous release observed during interburst intervals. 
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Figure 8.2. Dissociation of LPHN1 NTF and CTF by PFOA. LPHN1 
NTF and CTF normally exist as separate fragments independent from 
each other, and they associate upon binding of an agonist. PFOA 
supposedly disrupts this association, preventing the effects of LPHN1 


































Table 4.1. Percentage of cells bursting, time to burst (min) and overall 
frequency (Hz) in the presence of different concentrations of PFOA after 
















aGPCR adhesion G protein-coupled receptor 
ALR ankirin-like repeat 
AP action potential 
ATP adenosine triphosphate 
BDNF brain derived neurotrophic factor 
CaM calmodulin 
CC coil-coiled domain 






CTF C-terminal fragment 
EB 1 microtubule end binding protein 1 
EFs Ca
2+
 binding EF-hands 
EGF epidermal growth factor 
EM  electron microscopy 
EPSCs excitatory postsynaptic currents 
ER  endoplasmic reticulum 
GABA gamma-aminobutyric acid 
GAPs GTPase activating proteins 
GBL galactose binding lectin 
GDP guanosine diphosphate 
GPCR G protein-coupled receptor 
GPS GPCR proteolysis site 
GTP guanosine triphosphate 






IP3 inositol triphosphate 
IP3R inositol triphosphate receptor 
 !
xlii 
IPSCs inhibitory postsynaptic currents 
IPTG isopropyl b-D thiogalactoside 
Kd equilibrium dissociation constant 
KO  knock out 
LDCV large dense core vesicle 
LNS laminin G/NRX/sex hormone-binding like 
LPHN latrophilin 
LTX  latrotoxin 
MEPPs miniature end-plate potentials 
mEPSCs  miniature excitatory postsynaptic currents 
NMJ neuromuscular junction 
NRX neurexin 
NSF N-ethylmaleimide sensitive factor 
NTF N-terminal domain 
PFOA perflourooctanoic acid 
PIP2 phosphatidylinositol 4,5-biphosphate 
PKC protein kinase C 
PLC phospholipase C 
PM plasma membrane 
PNS peripheral nervous system 
PTPσ protein tyrosine phosphatase σ 
RIM Rab3 interacting molecule 
ROCs receptor operated channels 
RT room temperature 
SAM Sec1-Munc18 like 
SNAP-25 25 kDa synaptosomal-associated protein 
SNAPs soluble NSF attachments proteins 
SNARE soluble NSF attachment receptor 
SOCCs store-operated calcium channels 
SOCE store-operated calcium entry 
SP signal peptide 
SSV small synaptic vesicle 
 !
xliii 
STIM stromal interaction molecule 
STP Ser-, Thr- and Pro-rich domain 
TCAP teneurin C-terminal associated peptide 
TG thapsigargin 
TMR transmembrane region 
TRPCs transient receptor potential channels 
TTX  tetrodotoxin 
VAMP vesicle associated membrane protein 
VGCCs voltage-gated calcium channels 
WT  wild type 
 









Exocytosis is the process by which cells release the content of an 
intracellular vesicle to the extracellular space. It is a fundamental process in 
multicellular organisms that permits the passage of material and information from 
cell to cell.   
Exocytosis can be constitutive or regulated; the first type occurs continuously in 
all eukaryotic cell types without the need of any stimulus and it is necessary to 
maintain the plasma membrane identity. Through constitutive exocytosis, for 
example, a cell delivers its surface proteins that will be incorporated in the plasma 
membrane. In contrast, regulated exocytosis only occurs when cells are 
stimulated, and is limited to specialised cells such as neurons or endocrine cells. 
In this case, the content of intracellular vesicles is released when the stimulation 
of the cell triggers an elevation of intracellular Ca
2+
 or other second messengers. 
Constitutive and regulated exocytosis can coexist in the same cell (Burgess and 
Kelly 1987). 
Regardless of the cell type involved, the final stage of the exocytosis is the 
fusion of the membrane belonging to the vesicle and the membrane belonging to 
the cell, with consequent release of material in the extracellular space. This whole 
process is highly regulated and mediated by specific proteins that define the 
exocytic apparatus. 
 
1.1.1 Early evidences of vesicular release 
 
The first evidences that cells, more specifically neurons at the synaptic 
terminals, contain membrane-bound vesicles come from electric micrographs of 
lizard neuromuscular junctions (NMJs) showing that small vesicles were always 




present in each preparation at the presynaptic side  (Robertson 1956; De Robertis 
1958). 
These early observations constituted the foundation of the “vesicle 
hypothesis”, according to which neurotransmitters are stored inside synaptic 
vesicles that are released in the synapse upon their fusion with the plasma 
membrane and get then recycled in a Ca
2+
-dependent manner (del Castillo and 
Katz 1956; Hubbard and Kwanbunbumpen 1968; Ceccarelli and Hurlbut 1980a; 
Ceccarelli and Hurlbut 1980b) 
However, the correlation between synaptic vesicles and synaptic activity 
was not directly obvious, as the chances of observing by electron microscopy 
(EM) one of these vesicles fusing with the plasma membrane and releasing its 
content were very small (Birks, Huxley and Katz 1960). The situation was 
resolved with the discovery that La
3+
 is able to stimulate massive neurotransmitter 
release at the frog NMJ. Using this stimulation, for the first time it was possible to 
establish a link between increased neurotransmitter release and reduction in 
synaptic vesicle number (Miledi 1966). 
Another evidence in support of the vesicular hypothesis of neurotransmitter 
release came from studies at the frog NMJ using α -latrotoxin (αLTX), a black 
widow spider venom’s toxin that is able to trigger a dramatic increase in 
neurotransmitter release; when observed using EM, terminals treated with αLTX 
appear swollen and, most importantly, depleted of synaptic vesicles, confirming 
the hypothesis that these structures are the ones implicated in the exocytosis of 
neurotransmitter (Frontali et al. 1976). 
 
1.1.2 Exocytosis of neurotransmitter 
 
Communication between neurons takes place in a specialised structure 
called synapse, where axons and dendrites belonging to different neurons come in 
close proximity and exchange information in a unidirectional way (Purves 2012).  
In the mammalian central nervous system (CNS) the majority of neurons are 
connected by chemical synapses, in which neurotransmitter molecules stored in 
synaptic vesicles are released during a highly regulated process that starts when an 




action potential (AP) reaches the presynaptic terminal. The change in membrane 
potential causes the opening of the presynaptic voltage-gated Ca
2+
 channels 
(VGCCs), leading to the influx of Ca
2+
 into the cytosol. The elevation in the 
cytosolic Ca
2+
 concentration allows the fusion of the synaptic vesicles to the 
plasma membrane, so that neurotransmitters are released in the synaptic cleft 
where they can interact with the corresponding postsynaptic receptors, leading to 
the opening/closing of specific ions channels. In this way the signal is transmitted 
to the postsynaptic cells, and the result is the increased (in the case of excitatory 
neurotransmitters) or decreased (in the case of inhibitory neurotransmitters) 
probability that an AP will be generated (Purves 2012). 
Two classes of vesicles are found in neurons: small synaptic vesicles (SSVs) 
and large dense core vesicles (LDCVs). Classical neurotransmitters such as 
glutamate, acetylcholine, dopamine, gamma-aminobutyric acid (GABA) and 
serotonin are stored in SSVs, that are located mainly in the CNS, have a diameter 
of approximately 30 nm and appear as clear circles in electron microscopy (EM) 
images. Neuropeptides, amine and neurohormones are instead stored in LDCVs, 
that are mainly located in the peripheral nervous system (PNS), have a diameter 
ranging from 100 to 300 nm and look as having a dense core in EM images (Park 
and Kim 2009). 
These two classes of synaptic vesicles have different mechanisms of 
exocytosis: being mainly localised at the active zone, SSVs are released rapidly 
after a single AP and undergo a cycle of exocytosis/endocytosis and refilling of 
neurotransmitter. Neurotransmitters released from SSVs elicit fast electrical 
signals in the postsynaptic neurons by activating ion channels on their plasma 
membrane and thus mediate synaptic transmission. On the other hand, LDCVs are 
localised homogenously in the cytoplasm, and they are released only upon 
prolonged stimulation. Differently from SSVs, neurotransmitters stores in LDCVs 
do not produce fast synaptic transmission, but they modulate it by acting primarily 








1.1.3 Evoked and spontaneous exocytosis 
 
When we talk about exocytosis of neurotransmitter we usually think of the 
process initiated by an action potential, which, by depolarising the plasma 
membrane, allows the opening of VGCCs and the influx of Ca
2+
 into the cytosol. 
The increased cytosolic Ca
2+
 concentration then promotes fusion of vesicles with 
the plasma membrane and neurotransmitter release. This is known as evoked 
exocytosis. 
However, release of neurotransmitter also happens independently from an 
action potential. This is called spontaneous exocytosis, and was first described on 
the basis of postsynaptic recordings at the neuromuscular junction by Fatt and 
Katz (1952). Here they observed small postsynaptic depolarisations occurring 
continuously in the absence of any stimulation  (Fatt and Katz 1952). These 
events, constant in amplitude (about 0.5 mV), led to the formulation of the 
“quantal hypothesis”, stating that: (i) the quantum of neurotransmission at the 
basis of spontaneous miniature end-plate potentials (MEPPs) and evoked end-
plate potentials (EPPs) are the same; (ii) the release of each quantum is random, 
that is, independent from the release of other quanta; (iii) the evoked EPPs are the 
result of the synchronous release of several quanta  (Fatt and Katz 1952; del 
Castillo and Katz 1954).  
The constant amplitude of MEPPs is one of the most important features of 
this phenomenon. However, different factors can have an influence on it. First, the 
input resistance of the fibre, that defines the change in voltage associated to the 
injection of a current. An increased input resistance will generate a bigger 
membrane voltage change and vice versa  (Katz and Thesleff 1957; Harris and 
Ribchester 1979). Second, the resting membrane potential have an influence on 
the driving force (defined as the difference between resting potential and the 
reverse potential for the action of Ach on its receptor) of different ions; as a result, 
more negative membrane potentials generate bigger driving forces (and so 
stronger inward currents) and this translates in larger voltage responses; on the 
contrary, more positive membrane potentials will generate smaller voltage 
responses because the driving forces generated (and the corresponding inward 
currents) will be weaker  (McLachlan and Martin 1981).  




The dependency on Ca
2+
 is also true for spontaneous release: in fact, 
spontaneous exocytosis is sensitive to both intracellular and extracellular Ca
2+
 
concentrations. Intracellularly, the elevation of cytosolic Ca
2+
 due to release from 
intracellular Ca
2+
 stores (mediated by both inositol triphosphate (IP3) and 
ryanodine receptors), increases the rate of spontaneous exocytosis; in a similar 
way, elevations of extracellular Ca
2+
 concentration increase the frequency of 
neurotransmitter release, whilst reductions of extracellular Ca
2+
 concentration 
decrease it (Grassi et al. 1994; Li et al. 1998; Mozrzymas, Barberis and Cherubini 
1999; Giovannini et al. 2002; Awatramani, Price and Trussell 2005; Glitsch 
2008). 
Both evoked and spontaneous forms of neurotransmitter exocytosis have 
physiological roles. Evoked release is used by neurons to signal rapidly between 
one to another. Spontaneous release can regulate dendritic protein synthesis and 
expression of postsynaptic receptors. For example, spontaneous glutamate release 
regulates mRNA translation, enhancing it or inhibiting it according to the 
frequency of release (Sutton et al. 2004). Moreover, spontaneous glutamate 
release is essential to maintain dendritic spines by activating AMPA receptor 



















1.1.4 Mechanisms of exocytosis 
 
Synaptic vesicles undergo a series of steps before their content can be 
released. In the first step, called docking, the vesicles come in close proximity 
with where they are tethered to the plasma membrane; this is followed by a 
priming step, in which the vesicles are made competent for exocytosis. Finally, 
when an elevation in cytosolic Ca
2+
 concentration occurs, the membrane of the 
vesicles fuse with the plasma membrane, connecting the vesicle lumen to the 
extracellular space where the content of the vesicle can be released.  
The molecular machinery that governs the exocytic process consists of 
many interacting proteins. The main group of transmembrane proteins, 
collectively called “soluble N-ethylmaleimide-sensitive factor (NSF) attachment 
protein receptors” (SNAREs), drives vesicle fusion and includes synaptobrevin, 
also called VAMP2 (integral protein of SSVs), SNAP-25 and syntaxin-1 (located 
on the plasma membrane). There are also cytosolic proteins: Sec1-Munc18 like 
(SM) proteins, NSF and soluble NSF attachments proteins (SNAPs). Other 
important cytosolic molecules that modulate the process are synaptotagmin-1, 
Munc-13, Rab3 interacting molecule (RIM) and complexins  (Sudhof 2004; 
Sudhof and Rizo 2011; Südhof 2013) 
SNAREs are the initial components for the docking of the vesicles to the 
plasma membrane. VAMP2 and syntaxin-1 each contain a single SNARE motif 
(an extended coiled-coil stretch), while SNAP-25 contains two SNARE motifs. 
When these three proteins assemble, their four SNARE motifs come together 
pulling the vesicular and plasma membrane close to each other (Sollner et al. 
1993b; Sutton et al. 1998). At this stage, the two membranes still have different 
identities, and form a trans-SNARE complex. After the zippering of this complex 
in an amino-to-carboxy-terminal direction forces the two membranes to close 
proximity and fusion, VAMP2, syntaxin-1 and SNAP-25 are all localised on the 
plasma membrane, forming a cis-SNARE complex. 
SM protein Munc 18-1 is essential for the SNARE complex formation; however 
its role is still controversial and not completely understood. Munc 18-1 is known 
to bind to the closed conformation of syntaxin-1, preventing it from interacting 




with other SNAREs; when syntaxin-1 “opens” in preparation for the formation of 
the SNARE complex, Munc 18-1 remains attached to it, changing its binding 
mode to an interaction with the complex (Khvotchev et al. 2007). It was first 
proposed that Munc 18-1 acted by inhibiting the activation of syntaxin-1 (Yang et 
al. 2000; Wu et al. 2001); however, deletion of Munc 18-1 results in a complete 
loss of exocytosis (Verhage et al. 2000). It is proposed that Munc 18-1 is needed 
to guide syntaxin-1 to an appropriate SNARE complex formation, or to prevent a 
premature SNARE assembly (Jahn and Fasshauer 2012). 
Other proteins, RIM and Munc-13 are involved in the vesicle docking and 
priming steps and in recruiting Ca
2+
 channels next to the docked vesicles. RIM 
has several functions: it binds to Rab3 and Rab27 GTP-binding proteins on 
synaptic vesicles, therefore contributing to the docking; it binds to Ca
2+
 channels 
recruiting them to the active zone; finally, it binds to Munc-13, activating it. In 
turn, Munc-13 acts as a priming factor that promotes SNARE assembly by 
catalysing the conformational change of syntaxin-1 from closed to open (Südhof 
2013).  
Other molecules involved in priming are the complexins, which bind on the 
surface of the SNARE complex once it is already partially assembled. Complexins 
have both a stimulatory and an inhibitory function: they stabilise partially zipped 
SNARE complexes preparing them to be activated by synaptotagmin, and at the 
same time they block the progression of the zippering competing with VAMP2 
until Ca
2+
 enters the cell, when most likely synaptotagmin releases the cluster 
(Jahn and Fasshauer 2012). 
The principal Ca
2+
 sensor for the fusion mediated by SNARE appears to 
be synaptotagmin-1, an integral membrane protein located on the synaptic 
vesicles (Koh and Bellen 2003; Brose et al. 1992), whose cytoplasmic domain 
contains repeats of a region homologous to the C2 domains of the protein kinase 
C. Synaptotagmin-1 has two C2 domains, C2A and C2B, that can bind 3 and 2 
Ca
2+
 ions respectively (Ubach et al. 1998; Fernandez et al. 2001). 
In response to elevations in cytosolic Ca
2+
 concentration, synaptotagmin-1 
can bind to the plasma membrane lipids (Brose et al. 1992) and can also bind to 
phosphatidylinositol 4,5-biphosphate (PIP2) located within the inner leaflet of the 




plasma membrane (Schiavo et al. 1996; Hu et al. 2002). Most interestingly, 
synaptotagmin-1 also binds SNAREs syntaxin and SNAP-25 in a Ca
2+
 dependent 
manner (Sollner et al. 1993a; Schiavo et al. 1997; Chapman et al. 1995). 
Far from being simply a sensor for Ca
2+
, synaptotagmin-1 regulates 
synaptic vesicles exocytosis modulating various steps of the cycle: it interacts 
with SNAP-25 in a Ca
2+
 dependent manner promoting the docking of the vesicles 
to the plasma membrane (Chieregatti, Witkin and Baldini 2002); it contributes to 
the opening of the fusion pore through rearrangements that alter the distance and 
orientation of the synaptotagmin-1-SNAP-25 complex (Bai et al. 2004); finally, 
synaptotagmin-1 is also necessary for the endocytosis of SSVs once exocytosis is 





Figure 1.1. Schematic representation of the molecular machinery involved in 
vesicle exocytosis. On the top right, a synaptic vesicle is shown, being docked to 
the active zone (Südhof 2013). 
  




Once fusion has occurred, the SNARE complexes are disassembled by NSF, 
a member of the AAA
+
 (ATPases Associated with various cellular Activities plus) 
family. NSF acts by binding to the SNAPs and freeing VAMP2, thus allowing its 
recycling through endocytosis (Sollner et al. 1993a; Zhao et al. 2010). 
 
1.1.5 Full fusion and kiss and run 
 
The mode of fusion of synaptic vesicles to the plasma membrane during 
exocytosis has been long studied and two distinct mechanisms have been 
proposed in the early 1970s: full fusion of the vesicle and kiss and run. 
According to the first model, when a vesicle undergoes exocytosis its 
membrane fully collapses and fuses with the plasma membrane, becoming part of 
it. At a later stage, the vesicle is retrieved at a distal location and refilled with 




Figure 1.2. Full fusion model of vesicle exocytosis. The vesicle undergoing 
exocytosis fully fuses and becomes part of the plasma membrane.  
 
In the same years, Ceccarelli and collaborators noticed that upon 
prolonged stimulation at the neuromuscular junction the number of vesicles in the 
terminal remained constant for a long period of time, and only after several hours 
the release would stop, probably due to the lack of newly synthetized 
neurotransmitter. Using EM, they also visualised the omega membrane profile 
connecting the vesicle and the plasma membrane at the active zone. Therefore 
they came up with another model, known as “kiss and run”, according to which 
the vesicle only partially fuses with the plasma membrane, resulting in the 
opening of a small fusion pore. The neurotransmitter is quickly released and soon 




after the pore closes, maintaining the integrity of the synaptic vesicle (Ceccarelli, 
Hurlbut and Mauro 1972; Ceccarelli, Hurlbut and Mauro 1973). 
 
 
Figure 1.3. Kiss and run model of vesicle exocytosis. The vesicle membrane only 
partially fuses with the plasma membrane, generating an omega structure and a 
fusion pore. After the closure of the pore the vesicle is back at the active zone 
where it can be exocytosed again. 
 
Whilst the existence of full fusion has been widely accepted for a long 
time, the idea that kiss and run fusion can exist in neurons has been debated until 
recently. With time, evidence in favour of the existence of kiss and run fusion 
have been collected in endocrine cells, calyx of Held synapse, neuromuscular 
junction, goldfish retinal bipolar synapses (He and Wu 2007), cultured 
hippocampal synapses (Stevens and Williams 2000) and dopaminergic neurons 
(Wightman and Haynes 2004). 
With the accumulation of data suggesting that kiss and run fusion exists at 
synapses, the focus of the debate is now switching to whether this form of 
exocytosis is the major form of fusion.   
Regardless of the debate about what form of fusion is predominant, some 
works suggests that these two forms are both present at synapses and can coexist 
in the same terminal. The switch from one mechanism to the other could be a 
method to regulate synaptic strength and plasticity, as they would allow to release 
different quantities of neurotransmitter, different rates of release and also different 
times (Choi, Klingauf and Tsien 2000; Choi, Klingauf and Tsien 2003; He and 









1.2 α-Latrotoxin as a tool to study LPHN1-mediated exocytosis 
 
The black widow spider (genus Lactrodectus) is a venomous spider whose 
bite causes a variety of symptoms including difficult breathing, muscle cramps 
and spasms, high blood pressure, anxiety, nausea and restlessness.  Severe 
symptoms usually last for a couple of days and mild symptoms disappear after 
some weeks; death is rare in healthy adults, but is more common in children and 
elderly (Rauber 1983; Peterson 2006; Shackleford et al. 2015).  
Since the discovery in the 1930s that the active principles of the venom are 
proteins (D’Amour, 1936) acting on neurons (Sampayo 1944) and affecting 
neurotransmitter release  (Frontali et al. 1976; Duchen, Gomez and Queiroz 
1981), black widow spider venom (BWSV) became increasingly used as a 
scientific tool to uncover the mechanisms of neurotransmission. 
The principal toxic components of BWSV are called latrotoxins (LTX), and 
to date seven of them have been isolated. Five of them, called latroinsectotoxins α, 
β, γ, δ and ε, specifically target insects (Grishin 1998; Rohou, Nield and 
Ushkaryov 2007); one, α-latrocrustatoxin, specifically targets crustaceans (Elrick 
and Charlton 1999); another, α-latrotoxin (α-LTX), is vertebrate-specific, and it is 
one of the best characterised (Frontali et al. 1976). 
 
1.2.1 α-LTX as a secretogogue 
 
Due to its ability to cause massive release of neurotransmitters and 
hormones in all secretory cells that have regulated exocytosis, α-LTX has been 
widely used as a tool to study secretion.  
Starting from the 1970s, the effects of the toxin on secretion have been 
described in many neuronal and non-neuronal model systems such as frog NMJ, 
where α-LTX causes increased frequency of miniature end-plate potentials 
(MEPPs) and depletion of synaptic vesicles (Frontali et al. 1976); rat 
synaptosomes, where it causes a significant increase in the release of GABA 
(Grasso, Rufini and Senni 1978); mouse brain slices, where an increase in the 
frequency of exocytosis was described both for norepinephrine and for GABA 




(Tzeng and Siekevitz 1978; Tzeng, Cohen and Siekevitz 1978); in chromaffin 
cells, where the toxin causes an increased secretion of adrenaline and 
noradrenaline (Picotti, Bondiolotti and Meldolesi 1982); in pancreatic β-cells 
cultures, where it stimulates insulin exocytosis (Lang et al. 1998); in primary 
cultures of cerebellar granule cells, where α-LTX causes an increase in the release 
of amino acid transmitters (Grasso and Mercanti-Ciotti 1993); in hippocampal 
organotypic cultures, where the toxin increases the frequency of miniature 
excitatory postsynaptic currents (mEPSCs) (Capogna, Gahwiler and Thompson 
1996); in rat gonadotrophs, where it induces the release of luteinizing hormone 
(Tse and Tse 1999); and in neurohypophysis cells, where α-LTX causes the 
secretion of vasopressin and oxytocin (Hlubek, Tian and Stuenkel 2003). 
One of the most surprising properties of α-LTX-evoked exocytosis is that it 
can happen both in the presence and in the absence of extracellular Ca
2+
. The 
characteristics and modality of these two kinds of α-LTX-evoked secretion will be 
discussed in a further section (see 1.2.5). 
The secretogogue action of α-LTX is very potent. In fact, whilst Ca
2+
-
independent release needs the classic exocytic machinery to occur, Ca
2+
-
dependent release can still occur in mice lacking the SNARE proteins VAMP2 
and SNAP-25 and the active zone protein Munc-13 (Deak et al. 2009). It is 
possible, therefore, that in the presence of extracellular Ca
2+
 α-LTX uses an 
unknown pathway for exocytosis different from the classical one required instead 
in the absence of extracellular Ca
2+
 (Deak et al. 2009). 
 




1.2.2 α-LTX structure 
 
As described in several reviews (Ushkaryov 2002; Ushkaryov, Rohou and 
Sugita 2008; Silva, Suckling and Ushkaryov 2009), α-LTX is synthesized by free 
ribosomes in the cytosol of secretory epithelial cells in the black widow spider 
venom glands as an inactive precursor protein of 157 kDa. These cells then 
disintegrate, releasing the toxin, small molecules and proteases into the lumen of 
the venom gland. In order for the toxin to become active, the precursor has to be 
cleaved by a furin-like protease at two furin-like sites located in both N- and C-





Figure 1.4. Schematic representation of αLTX processing in the venom gland. The 
precursor of αLTX is a protein of 157 kDa. It is then cleaved at furin-like sites 
both at the N- and the C-termini to produce the mature αLTX, with a molecular 
mass of 131 kDa. 
 
The N-terminal part of α-LTX does not show significant homologies with 
other proteins. It consists of a large portion of α-helical structure and contains 
three conserved cysteines important for the structural stability and for the activity 
of the toxin (Kiyatkin et al. 1995). The C-terminal domain contains 22 ankyrin-
like repeats (ALRs), a structure found in a wide variety of proteins that mediates 
intra- and inter-molecular interactions (Sedgwick and Smerdon 1999).  




The three-dimensional (3D) structure of α-LTX was revealed by Orlova et 
al. (2000) using cryo-electron microscopy. It was shown that the monomeric α-
LTX consists of three domains: the wing at the N-terminal domain, mainly 
composed of α-helices; the body, comprising the first 17 ALRs; the head at the C-




Figure 1.5. αLTX primary and domain structure. Letters C denote conserved cysteines at 
the N-terminal domain; boxes correspond to ankirin-like repeats. The identified 3D 
structure domains are indicated below. 
 
However, the toxin does not exist as a monomer in nature, but as stable 
asymmetric dimers, in which two monomers are associated head-to-tail with the 
“horizontal” part of the body contacting the “vertical” part.  




 (Ashton et al. 
2000), the toxin is able to tetramerise into its active form. The tetramer, which 
resembles a bowl, has a C4 rotational symmetry, with the bottom formed by the 
horizontal parts of the bodies. The four heads form a central channel of about 3 
nm in diameter; at one point, the channel is restricted to 1 nm. The wings extend 
on the side of the body perpendicularly to the tetramer’s central symmetry axis 
(Orlova et al. 2000).  
 






Figure 1.6. 3D reconstructions of the α-LTX monomer, dimer and tetramer, 
viewed from the top and side (Ushkaryov, Rohou and Sugita 2008). 
 
 
1.2.3 Pore formation and receptor interactions 
 
α-LTX is an amphipathic molecule; its bottom, being hydrophobic, is able 
to insert into cellular membranes, while the hydrophilic upper part remains above 
them. The insertion of the toxin is complete, and the central hole crosses the 
membranes from side to side, forming a pore that makes them permeable (Orlova 
et al. 2000). 
The pore formed by α-LTX is pear-shaped, with a diameter of 2.5 nm at the 
bottom, 3.6 nm in the centre and 1 nm at the top. It is permeable to divalent and 
some monovalent cations (Volynski et al. 2000), and small molecules such as 
neurotransmitters and fluorescent dyes (Ashton et al. 2000; Davletov et al. 1998a), 
but not to trivalent cations, such as La
3+










Figure 1.7. Section of α-LTX pore crossing the membrane and allowing cations 
into the cytosol (Ushkaryov, Volynski and Ashton 2004). 
 
Although α-LTX is able to form pores in artificial lipidic bilayers 
(Finkelstein, Rubin and Tzeng 1976), biological membranes show resistance to 
the insertion of the toxin without the help of α-LTX receptors (Volynski et al. 
2000; Hlubek et al. 2000).  
Currently, three receptors are known to interact with α-LTX: neurexin Iα (NRX-
Iα), protein tyrosine phosphatase σ (PTP-σ) and latrophilin 1.  
NRX was the first α-LTX receptor to be isolated by affinity 
chromatography from bovine brain membranes (Petrenko et al. 1990). Six 
principal isoforms of NRX are expressed by three genes. These isoforms can be 
divided into two groups of three each, called α and β NRXs, with different domain 
structures. All of them consist of a single transmembrane region (TMR) and a 
short cytoplasmic tail; in α-NRXs, the N-terminal domain contains six laminin 
G/NRX/sex hormone-binding like (LNS) domains that, interspersed with 
epidermal growth factor-like (EGF-like) sequences, form three major repeats. In 
β-NRX, instead, the N-terminal is shorter and contains only one LNS domain and 
a unique N-terminal sequence (Ushkaryov et al. 1994; Ushkaryov et al. 1992). 
Of the six isoforms of NRX, only NRX-Iα binds α-LTX with high affinity, and 
this interaction is Ca
2+
-dependent (Petrenko et al. 1990; Davletov et al. 1995; 
Geppert et al. 1998). 




NRXs are localised mainly in the brain (Ushkaryov et al. 1992; Ullrich, 
Ushkaryov and Südhof 1995), with some level of expression also in pancreas and 
lungs, heart, liver and kidney (Occhi et al. 2002). 
PTP-σ is a receptor that, unlike NRX-Iα, is able to bind α-LTX also in the 
absence of Ca
2+
 (Krasnoperov et al. 2002). It is a member of the receptor-like 
PTPs family, and it consists of an extracellular ligand-binding domain, a single 
TMR, and a cytoplasmic phosphatase catalytic domain (Almo et al. 2007). 
Although the binding to α-LTX is lower than the one observed for the other two 
receptors, the interaction between PTP-σ and the toxin has been demonstrated to 
be specific (Krasnoperov et al. 2002).  
PTP-σ is mostly expressed in the brain, but it is also found in heart, kidney and 
placenta with lower expression (Pulido et al. 1995). 
Latrophilin 1 (LPHN1) is the major receptor for α-LTX, able to bind it in a 
Ca
2+
-independent manner. As this receptor is the main focus of the present work, 
its structure and function will be discussed in more detail in a following section 












Even before the isolation of the receptors that mediate α-LTX binding and 
function, it was clear that the toxin was able to trigger intracellular signalling; it 
was shown for example that binding of α-LTX led to the activation of 
phospholipase C (PLC), and to the subsequent production of IP3 and release of 
Ca
2+
 from intracellular Ca
2+
 stores (Vicentini and Meldolesi, 1984). However, the 
formation of the pore made the study of the receptors’ functions difficult. 
The situation was resolved with the fortuitous construction of a mutant α-
LTX containing a thrombin recognition site at the beginning of the ALR-
containing domain. This recombinant toxin was named LTX
N4C
, indicating the 
insertion of four amino acids between the N- and the C-termini (Ichtchenko et al. 
1998).  
This construct, having a defective folding, is still able to bind the receptors 
and to form dimers, but is unable to form tetramers and does not form membrane 











Figure 1.8. Structure of LTX
N4C
. (a) Representation of the domain structure of 
LTX
N4C
. The position of the insert is shown by an arrow. (b) Cryo-EM of native 
and mutant toxins showing that α-LTX, but not LTX
N4C
, is able to form tetramers 








1.2.5 Effects of α-LTX and LTX
N4C
 on exocytosis 
 
As described in a previous section (see Section 1.2.1) starting from the 
1970s data started to accumulate about the effects of α-LTX on neurotransmitter 
release in numerous neuronal systems such as the frog NMJ (Frontali et al. 1976), 
mouse cerebral cortex slices (Tzeng, Cohen and Siekevitz 1978), rat 
synaptosomes (Grasso, Rufini and Senni 1978), cerebellar granule cell cultures 
(Grasso and Mercanti-Ciotti 1993) and organotypic hippocampal cultures 
(Capogna, Gahwiler and Thompson 1996).  
The exocytosis caused by α-LTX is, however, different from the typical 
Ca
2+
-dependent exocytosis induced by action potentials; in fact, the toxin can 
induce exocytosis both in the presence and in the absence of extracellular Ca
2+
 
(Tzeng, Cohen and Siekevitz 1978; Ceccarelli, Grohovaz and Hurlbut 1979). 
The effects observed in the presence and absence of extracellular Ca
2+
 have 
different characteristics. First, in the presence of 1-2 mM Ca
2+
 a period of clonic 
release is initially observed, characterised by fast bursts of exocytosis, followed 
by a sustained tonic release that tends to decline and stop with time. In the 
absence of Ca
2+
, instead, the secretion is only tonic, with the frequency that 
slowly rises, reaches a peak and then gradually decreases (Ceccarelli, Grohovaz 
and Hurlbut 1979; Ceccarelli and Hurlbut 1980; Fesce et al. 1986; Lelyanova et 
al. 2009). 
Second, the total number of quanta released is roughly double in the 
presence of Ca
2+
 than in its absence. This is due to the role of Ca
2+
 in endocytosis, 
so that when Ca
2+
 is present vesicle recycling is still possible (Fesce et al. 1986). 
Third, Mg
2+
 is required for the Ca
2+
-independent action of the toxin (Misler 
and Hurlbut 1979), and Mg
2+ 
fully supports α-LTX tetramerisation and pore 
formation. This suggests that tonic Ca
2+
-independent exocytosis is caused by the 
pore that the toxin forms into the cellular membrane.  
Given the knowledge that α-LTX requires the binding to receptors and that 
Ca
2+
-independent exocytosis can be explained by the pore formation, it was 
necessary to find a tool to differentiate the role of receptors and pores. The 
appearance of LTX
N4C
 on the scene made this possibility an actuality. Unable to 




form pores and strictly requiring extracellular Ca
2+ 
for its activity (Ashton et al. 
2001), LTX
N4C
 permits the study of the Ca
2+
-dependent component of α-LTX 
effect alone, and also permits to delineate the role that the receptors have in this 
effect. 
The effect of LTX
N4C
 on nerve terminals has been described for the first 
time in CA3 pyramidal neurons (Capogna et al. 2003) and later in mouse NMJ 
(Lelyanova et al. 2009). It was shown that binding of LTX
N4C
 to a receptor 
(thought to be latrophilin 1, see next section for details), lead to the mobilization 
of Ca
2+
 from internal stores (Capogna et al. 2003); furthermore, it was 
demonstrated that LTX
N4C
 causes clonic secretion of neurotransmitter for several 
hours, without the appearance of the tonic secretion observed with native α-LTX 
and without cessation of the effect, probably due to the lack of membrane 
disruption usually caused by the native toxin pores (Lelyanova et al. 2009). This 
strongly suggests that the clonic release is the component mediated by the 









1.3 Latrophilin 1 
 
The major brain receptor for α-LTX is Latrophilin 1 (LPHN1), a presynaptic 
adhesion G protein-coupled receptor. It was isolated by two groups in 1996 from 
solubilised bovine brain using α-LTX affinity chromatography in the absence of 
Ca
2+
 (Davletov et al. 1996; Krasnoperov et al. 1996). Due to its high affinity for 
αLTX, it was named latrophilin by one group (Lelianova et al. 1997), whilst due 
to its ability to bind α-LTX in the absence of Ca
2+
 it was named CIRL (calcium-
independent receptor of α-latrotoxin) by the other group (Krasnoperov et al. 
1997). 
As discussed in a previous section (see paragraph 1.2.3), LPHN1 is not the 
only receptor for α-LTX; therefore, the rise in exocytosis frequency could be 
attributed to the activation of the other receptors, for example, NRX-Iα. To 
distinguish the effects on exocytosis caused by α-LTX are due to the activation of 
LPHN1 only, experiments were made under conditions known to prevent the 
binding of α-LTX to NRX-Iα. LPHN1 is able to bind α-LTX in all ionic 





, when replacing Ca
2+
, fully supports α-LTX-mediated effects on 
exocytosis, but does not allow the interaction of the toxin with NRX-Iα (Davletov 
et al. 1998b). Therefore, the effect on exocytosis observed in at least this 
condition is due to the activation of LPHN1 only (Volynski et al. 2003). 
 
1.3.1 G protein-coupled receptors: classification and signal transduction 
 
G protein-coupled receptors are a large family of membrane proteins with 
different structures and functions. The ligands targeting these receptors are very 
diverse, ranging from ions, to peptides, proteins, nucleotides, lipids, photons to 
odorants (http://www.guidetopharmacology.org/GRAC/ReceptorFamiliesForward 
?type=GPCR). 
Due to the diversity of this super-family, a classification is needed to group 
together proteins sharing common features and phylogenetic origin. Five main 
families have been identified (Fredriksson et al. 2003): 




• Secretin receptor family 
• Adhesion receptor family 
• Glutamate receptor family 
• Frizzled/Taste2 receptor family 
• Rhodopsin family 
 
The study of GPCRs is a prolific and intense field; many disorders, such as 
nephrogenic diabetes insipidus, colour blindness and hyperfunctioning thyroid 
adenoma, are due to abnormal GPCRs signalling and a great development in 
drugs targeting their functioning has risen (Karnik et al. 2003). 
All GPCRs share the same basic features: an extracellular N-terminus domain, 
seven transmembrane regions (TMRs) linked by three extracellular and three 
intracellular loops, and a cytosolic C-terminus domain. The major constant factor 






Figure 1.9. Schematic representation of a general heterotrimeric G protein-
coupled receptor, composed of an extracellular N-terminal ligand binding 
domain, 7 TMRs connected by 3 intracellular and 3 extracellular loops, and an 
intracellular C-terminal domain attached to an heterotrimeric G protein. When 
inactive, the α subunit of the G protein is associated with GDP. 




The seven stretches that form the TMRs are composed of 20-25 amino acids, 
forming α-helices of unequal length that cross the plasma membrane, organised in 
a barrel shape perpendicular to the membrane plane in a counter-clockwise 
manner from TMR I to TMR VII (when looking from the extracellular side). The 
TMRs are predominantly hydrophobic, but the strength of their hydrophobicity 
varies between them: TMR I, IV and VII, containing only one hydrophilic 
residue, are more hydrophobic than TMR II, III, V and VI, containing more 
neutral and ionic residues; this results in a different arrangement in the membrane, 
with the more hydrophobic TMRs exposed more to the lipidic bilayer (Ulloa-
Aguirre et al. 1999).  
Hydrogen bonds form between residues located in the same TMR and 
between residues belonging to different TMRs. These interactions exclude the 
possibility of a TMR pore in most GPCRs, and maintain the core tight in an 
inactive state (Ji, Grossmann and Ji 1998). 
Disulphide bridges between Cys residues, mainly located in the N-terminus 
and extracellular loops I and II, are important for the stability of the ternary 
structure and binding properties of the receptor (Dixon et al. 1987). At the C-
terminus, Cys residues can undergo palmitoylation, which creates a membrane 
anchor leading to the formation of a fourth intracellular loop. This process is vital 
for some GPCRs to maintain the functional coupling with G protein (O'Dowd et 
al. 1989; Qanbar and Bouvier 2003). 
When a ligand binds the receptor, a signal is generated and transmitted to the 
intracellular G protein through the TMR core.  
The specific binding site of the ligand is different depending on the class of 
GPCR involved and on the characteristics of the ligand. If the ligand is big, the 
correspondent GPCR usually exhibits a long N-terminus, where the binding site 
resides. For moderate size peptides, the binding site is usually located both in the 
N-terminus and extracellular loops; for small molecules, the ligand binding 
domain can be located in a pocket involving the middle and extracellular third of 
the TMs (such as for retinal chromophore), or in residues located in the first 
extracellular loop and several TMRs (such as for vasopressin) (Ulloa-Aguirre et 
al. 1999), or in the N-terminal domain alone (such as the metabotropic Glu and 




GABA receptors). Once the agonist has bound the receptor, conformational 
changes of the TMRs transduce the signal and the activation of G protein occurs. 
GPCRs are associated to heterotrimeric G proteins, composed of α, β and γ 
subunits. At least 28 G protein α subunits, 5 β subunits and 12 γ subunits have 
been identified, whose combinations are responsible for the diversity and 
specificity of the signalling. α subunits can be divided into four families according 
to their primary sequence similarities: Gs (Gs and Golf); Gi (Gtr, Gtc, Gg, G1-3, Go 
and Gz); Gq (Gq, G11, G14 and G15/16); G12 (G12 and G13) (Kristiansen 2004). The 
subunits β and γ form a tight complex dissociable only under denaturing 
conditions (Rens-Domiano and Hamm 1995). 
Upon binding of an agonist, the activated receptor goes through 
conformational changes that increase its affinity for the GDP-bound form of a 
heterotrimeric G protein. This triggers the exchange of the GDP (associated with 
the α subunit) with GTP, and the dissociation of the βγ complex. Both the α and 
βγ subunits can then interact with specific effectors to start the intracellular 
signalling typical of the specific G protein involved. The GTP is finally 
hydrolysed back to GDP by the intrinsic GTPase activity of the α subunit or by 
GTPase activating proteins (GAPs) and the complex α+βγ reassociates going back 
to the inactive state.  
The nature of the biological effects triggered by the activation of a receptor is 
very diverse, ranging from activation of ion channels, phospholipases and 




Latrophilins are part of the Adhesion GPCR (aGPCR) family composed of 
three isoforms: latrophilin 1, 2 and 3 (Hamann et al. 2015). Their genes, 
denominated lphn1, lphn2 and lphn3, are located respectively on chromosomes 
19, 1 and 4 in humans and on chromosomes 8, 3 and 5 in mice. All latrophilins 
can bind α-LTX, with the affinity decreasing form LPHN1 to LPHN3, which 
shows almost no binding at all (Silva and Ushkaryov 2010). 




Homologues forms of the three LPHNs are found in most chordates 
(Fredriksson and Schiöth 2005). LPHNs orthologues variants from distant 
vertebrates are more similar to each other than the homologues within one 
organism; this may indicate that the three LPHNs have different functions that 
have been strictly preserved in the evolutionary history of chordate animals (Silva 
and Ushkaryov 2010). The different pattern of expression of the three LPHN 
isoforms in various tissues further supports this explanation: whilst LPHN2 is 
ubiquitous, LPHN1 and 3 are expressed mainly in the brain (Ichtchenko et al. 
1999; Matsushita, Lelianova and Ushkaryov 1999). 
 
1.3.3 LPHN1 structure 
 
As a member of the aGPCR family, LPHN1 is a large protein (185 kDa) 
whose primary structure comprises a large extracellular N-terminal domain, seven 
TMRs connected by three extracellular and three intracellular loops, and a 
cytoplasmic C-terminal domain. It undergoes an intracellular post translational 
cleavage that produces two functional parts: the N-terminal fragment (NTF) and 
the C-terminal fragment (CTF).  
As described in Silva and Ushkaryov (2010) the NTF is a cell adhesion 
receptor-like domain of 120 kDa that begins with a hydrophobic signal peptide 
(SP). Following this, there is a 108 residues-long cysteine-rich region homologous 
to galactose-binding lectin (GBL); a 260 residues-long region homologous to 
olfactomedin; a 79 residues-long containing serines, theonines and prolines (STP); 
a 60 residues-long hormone-binding domain (characteristic of many adhesion 
GPCRs); a 180 residues-long Stalk region analogous to the one found in EMR3, 
another aGPCR. This region corresponds in LPH1 to the binding site for α-LTX; a 
57 residues-long containing four cysteines called GPCR proteolysis site (GPS) 
motif, containing the site of post translational cleavage that generates the NTF and 
the CTF. 
 





Figure 1.10. LPHN1 domain structure.  SP, signal peptide; GBL, galactose-
binding lectine; STP, Ser- Thr- and Pro-rich domain; HRM, hormone receptor 
motif; GPS, GPCR proteolysis site domain; 7 TMRs, seven transmembrane 
domains and correspondent loops; green arrow, cleavage site; red brackets, α-
LTX binding site. 
 
 
The CTF begins at the site of cleavage within the GPS motif, and it is 
composed of seven TMRs and a cytoplasmic tail, which is the least conserved 
domain among the latrophilin isoforms. The cytoplasmic tail contains five 
cysteine residues, three of which are positioned similarly to the ones in 
rhodopsin’s cytoplasmic tail, and may be palmitoylated (Lelianova et al. 1997). 
The extracellular loops 1 and 2 contain two cysteines that can form an 
intramolecular disulphide bridge.  
 




1.3.4 Interaction of LPHN1 fragments and intracellular signalling 
 
The cleavage occurring in the GPS motif that give rise to the NTF and the 
CTF takes place in the endoplasmic reticulum (ER) and it is required for the 
delivery of the receptor to the cell surface (Volynski et al. 2004). 
Once reached the cellular membrane, the two fragments behave 
independently as two distinct membrane proteins; the NTF, in fact, is not released 
into the medium, being attached to the membrane by a hydrophobic anchor, 
allowing it to stay on the membrane even without having any TMR (Volynski et 
al. 2004). 
The association of NTF and CTF plays a crucial role in the function of the 
receptor; in fact, binding of a ligand occur at the NTF, whilst the intracellular 
signalling cascade at the CTF. The two functional parts must therefore be able to 
interact in order to generate the physiological effect of the receptor. Indeed, it has 
been demonstrated that upon binding of LTX
N4C
 NTF and CTF associate, forming 
ternary complexes LTX-NTC-CTF on the plasma membrane (Volynski et al. 
2004). 
This association does not necessarily occur between the same cleaved 
receptor molecules, but can either happen between two different LPHN molecules 
or between the NTF/CTF of LPHN with the NTF/CTF of another aGPCR, due to 
the highly conserved GPS motif in this receptor family (Silva et al. 2009). 
As a GPCR, LPHN1 has been shown to interact with two types of Gα 
subunits: Gαo and Gαq/11 (Lelianova et al. 1997; Rahman et al. 1999). The 
coupling of these G proteins with LPHN1 is functional: in fact, their association is 
stronger when GDP is present and weaker when an excess of GTP is added 
(Rahman et al. 1999). Furthermore, it has been shown that the activation of 
LPHN1 by α-LTX causes a rise in the concentration of IP3 (Lelianova et al. 1997), 
whose production is triggered by the activation of PLC by a G protein. Indeed, the 
use of U73122, a drug that inhibits PLC activity, blocks the release of 
neurotransmitter caused by α-LTX in synaptosomes (Rahman et al. 1999). 
Elevation of IP3 leads to the release of Ca
2+
 from intracellular stores. Their 
role in LPHN1 activity has been investigated using thapsigargin (TG), a drug that 




by irreversibly blocking the sarco/endoplasmic reticulum Ca
2+
 ATPase (SERCA) 
pumps causes the depletion of the stores. Stores depletion indeed inhibits the α-
LTX-evoked release of neurotransmitter (Rahman et al. 1999). 
 
1.3.5 Endogenous ligands 
 
The first endogenous ligand of LPHN1 has been isolated by affinity 
chromatography and termed Lasso (LPHN1-associated synaptic surface organiser) 
(Silva et al. 2011).  
Lasso belongs to the family of teneurins, brain specific cell surface proteins 
that play an important role in the development of the central nervous system, 
being involved in axon guidance and synaptogenesis (Tucker et al. 2007; Young 
and Leamey 2009). Its primary structure consists of a single TMR; the 
extracellular domain has eight EGF repeats, of which two possess unpaired 
cysteines that permit covalent homodimerisation of the molecule. The teneurin C-
terminal associated peptide (TCAP) can be cleaved in vitro and possibly interact 
with LPHN1; when injected in the brain, TCAP affects behaviour linked to stress 
and anxiety (Wang et al. 2005). This would be in line with the implication of 
LPNH1 in attention deficit/hyperactivity disorder (ADHD), anxiety and 
schizophrenia. However no evidence of the TCAP cleavage exists in vivo so far 
(Silva et al. 2011).  
Lasso is a postsynaptic protein that strongly and specifically binds LPHN1 
on the presynaptic side, establishing a structural and functional interaction. Lasso 
is in fact able to activate LPHN1, initiating its signalling leading to an increase in 
the cytosolic Ca
2+












Figure 1.11. A. Domain structure of Lasso. Lasso is a 
monomeric protein with a single TMR; it can form 
homodimers by S-S bonds. 
It can be cleaved at the EGF-repeats, causing the 
release in the medium when the cleavage occurs on 
both monomers. 
B. Representation of the putative interaction between 
LPHN1 and Lasso at the synapses. LPHN1 
(presynaptic) GBL domain is thought to interact with 




More recently latrophilins, in particular LPHN3, has been found to interact with 
another molecule, fibronectin and leucine-rich transmembrane protein-3 (FLRT3) 
(O'Sullivan et al. 2012). This protein, whose levels of expression are high 
especially during the development of the nervous system (Robinson et al. 2004), 
acts as a repulsive cue in axon guidance and cell migration for neurons expressing 
the receptor Uncoordinated-5 (UNC-5) during embryonic development 
(Yamagishi et al. 2011), likely thanks to the ability of LPHN3, FLRT3 and UNC-
5 to form trimeric complexes that are also involved in cell adhesion (Lu et al. 
2015). In the adult nervous system, it can regulate neurite outgrow after 
peripherical nerve injury (Robinson et al. 2004). 
A B 




The interaction between the extracellular domains of LPHN3 and FLRT3, forms a 
trans-synaptic complex that is able to regulate the number of excitatory synapses 
both in vitro and in vivo (O'Sullivan et al. 2012). Moreover, the interaction 
between the olfactomedin domain of LPHN3 and the leucine rich repeat (LRR) 
domain of FLRT3 contributes to the development of glutamatergic synapses 
(Ranaivoson et al. 2015). 
 
 




1.4 Store-operated calcium entry 
 
In response to the activation of GPCRs, Ca
2+
 is released from the stores and 
goes into cytosol, helping to increase the cytosolic Ca
2+
 concentration which can 
affect multiple cellular activities, including modulation of exocytosis. In 
eukaryotic cells, the ER functions as intracellular calcium store. 
However, Ca
2+
 in the ER is needed for many cellular functions, such as 
correct protein folding and vesicle trafficking, and elevated Ca
2+
 concentration in 
its lumen is vital. In fact, depletion of Ca
2+
 from the ER for prolonged periods of 
time can lead to stress responses and apoptosis (Parekh and Putney 2005).  
A decrease in the ER Ca
2+
 concentration leads to the opening of store 
operated calcium channels (SOCCs) on the plasma membrane, and it is believed 
that a major role of these channels is to provide extracellular Ca
2+
 influx for the 
replenishment of the intracellular Ca
2+
 stores. After replenishment SOCCs close 
and Ca
2+
 entry stops (Putney 2007). The current underlying store-operated 




 current (ICRAC), with 
high Ca
2+
 selectivity and low single channel conductance. 
 
1.4.1 Main proteins involved in SOCE 
 
At least two classes of proteins are vital for the SOCE activation: stromal 
interaction molecules (STIMs) and Orai channels. 
STIMs are proteins with a single TMR that are located in the ER membrane 
and function as sensors of intraluminal ER Ca
2+
 concentration. Two STIM 
isoforms are expressed in vertebrates, STIM 1 and STIM 2. These two molecules 
have different tissue distributions, with STIM 1 being ubiquitously expressed and 
STIM 2 being mostly expressed in neuronal tissues (Stathopulos and Ikura 2013). 
The major contributor to the activation of SOCE is STIM 1, which reacts to 
depletion of ER intraluminal Ca
2+
 by changing conformation and translocating to 
portions of the ER in close proximity with the plasma membrane (PM), the so 
called ER-PM junctions (Salido, Sage and Rosado 2009). 
 






Figure 1.12. STIM 1 domain structure. SP, signal peptide; EFs, Ca
2+
-binding EF-
hand domains; SAM, sterile α motif; TMR, transmembrane region; CC1-3, 
cytosolic coiled-coil domains; P/S, Pro-Ser-rich region; Poly-K, poly-Lys rich 
domain 
 
In Figure 1.12 the domain structure of STIM 1 is represented. The most 
important domains for the function of STIM 1 are the EFs and SAM located in the 
ER lumen, and the CC1-3 cytosolic domains. At basal ER Ca
2+
 concentration, the 
EFs domains form a hydrophobic pocket in which the binding of Ca
2+
 occurs. The 
presence of Ca
2+
 keeps the EFs and the adjacent SAM domains in a stable 
monomeric conformation. Upon depletion of Ca
2+
, these domains destabilise and 
dimerization of EFs and SAM of two STIM 1 molecules is promoted. This leads 
to conformational changes that have repercussions on the cytosolic CC1-3 
regions, and to the redistribution of STIM 1 in the ER-PM junctions, where it 
activates CRAC channels on the PM (Stathopulos and Ikura 2013). 
As mentioned previously, two isoforms of STIM are expressed in vertebrates; it 
has been proposed that these two molecules have different functions, also dictated 
by their different affinities for Ca
2+
: higher for STIM 1, whose equilibrium 
dissociation constant (Kd) is ≈ 400 µM, and lower for STIM 2, whose Kd is ≈ 700 
µM. Thus, whilst STIM 1 gets activated by ER Ca
2+
 store depletion and plays a 
role in turning the SOCE ON and OFF, STIM 2 is in an activated state also in 
normal ER Ca
2+
 concentrations, playing a role in maintaining the basal 
intracellular Ca
2+
 concentration (Smyth et al. 2010; Stathopulos and Ikura 2013). 
Orai proteins form the Ca
2+
 selective pore of CRAC channels. Three Orai 
isoforms are expressed in mammalian cells (Orai 1-3), with similar functions and 
ability to generate SOCE when co-expressed with STIM 1. However, Orai 1 
seems to be the main isoform to mediate SOCE. 





Figure 1.13. Orai 1 structure. The N- and C-terminal domains are both located in 
the cytosol, the four TMRs (transmembrane domains) are connected by two 
extracellular and one intracellular loops. 
 
Orai 1 can bind calmodulin (CaM) in a Ca
2+
-dependent manner in a portion of the 
N-terminal domain rich in proline and arginine; the interaction with STIM 1, 
instead, involves a coiled-coil sequence at the C-terminal domain (Berna-Erro, 
Redondo and Rosado 2012; Prakriya 2013). 
Controversial evidence has been found on the involvement of transient receptor 
potential channels (TRPCs) in SOCE. In fact, to data that suggest an involvement 
of TRPCs, in particular TRPC 1, in SOCE, are counterposed results suggesting 
that TRPCs are more likely to function as receptor operated channels (ROCs).  
TRPCs are a family of non-selective Ca
2+
 permeable channels. Mammas express 
seven isoforms of TRPCs, that are widely expressed in all tissues. They have six 
TMRs with cytoplasmic N- and C-terminal domains. The C-terminal domain 
contains a TRP signature motif (EWKFAR), whose function is still unclear, and a 
calmodulin/IP3R-binding (CIRB) region, involved in the regulation of the channel 
activation (Salido, Sage and Rosado 2009; Smyth et al. 2010; Berna-Erro, 










 stores depletion and opening of SOCCs 
 
As mentioned previously, depletion of Ca
2+
 stores located in the ER leads to 
the activation of SOCCs and consequently the influx of Ca
2+
 ions into the cytosol; 
this mechanism is essential for the replenishment of the stores. 
The mechanisms by which the depletion is communicated from the ER to 
the PM is complex and involves many proteins such as STIM 1, Orai channels 
and TRPC 1; however, this mechanism is still not completely understood, and 
there are suggestions that other proteins, such as SERCA and the microtubule end 
binding protein (EB 1), and also lipids might play a role in it (Vaca 2010). 
STIM1 was previously described as a sensor for the ER Ca
2+
 concentration 
(Section 1.4.1). However, the role of this protein is much more complex due to its 
interactions with other proteins. It has been recently shown that STIM1 normally 
associates with EB 1 travelling continuously through the ER and functioning as a 
microtubule (MT) tracking protein with a role in ER remodeling (Grigoriev et al. 
2008). Only upon upon ER Ca
2+ 
depletion STIM1 dissociates form EB 1 and 
oligomerises at the ER-PM junctions, where first it associates with the SERCA 
pump (allowing the refilling of the stores in close proximity of the site of Ca
2+
 
entry), and then with Orais channels and/or TRPC1, initiating SOCE (Sampieri et 
al. 2009). TRPC 1 can also work as a ROC in association with IP3R (Vaca 2010). 
Once the refilling of the stores is complete, STIM1 dissociates from the SOCCs, 
then from the SERCA pump, and finally re-associates with EB 1 (Sampieri et al. 
2009). 
It appears that also lipids are important for SOCE: in fact, evidence suggests 
that both Orai and TRPC channels have to be localised in lipid rafts in order to 
exert their function as SOCCs (Pani and Singh 2009). Lipid rafts are sphingolipid 
and cholesterol-enriched domains on the PM that function as platforms for the 
grouping of signalling molecules, also allowing their interaction with channels 
and receptors. It appears that depletion of Ca
2+
 stores triggers the accumulation of 
SOCCs into lipid rafts, therefore facilitating the protein interactions needed to 
start the influx of calcium (Pani and Singh 2009).  
 





Figure 1.14. Components of SOCE. STIM 1 located at the ER is associated to EB 
1 when intraluminal Ca
2+
 concentration is high enough to allow its binding to 
Ca
2+
. Upon stores depletion STIM 1, unbound from Ca
2+
, travels to puncta close 
to the PM, where associates with SERCA pump and SOCCs initiating Ca
2+
 influx. 
TRPC can function as a ROC, associated to IP3R. Activated SOCCs are located in 
lipid rafts.  
 
Another protein that participates in SOCE as a modulator of Ca
2+
 influx is 
SARAF. This protein, localised on the ER membrane, shares structure similarities 
with STIM proteins; it has a single TMR, with a luminal regulatory domain and a 
cytosolic functional domain. The exact mechanism by which SARAF senses the 
elevation in ER Ca
2+
 concentration is not clear, however, it is hypothesised that, 
upon refilling of the stores, it promotes the disaggregation of STIM dimers, 
therefore, stopping Ca
2+
 influx from Orai/TRPC channels and preventing the over-
filling of the stores (Palty et al. 2012). 
 




1.4.3 SOCE in neurons 
 
The involvement of SOCE, and more broadly of Ca
2+
 released by 
presynaptic intracellular stores, in the modulation of spontaneous exocytosis is not 
well understood, and a limited number of studies have been carried out about this 
subject. Various studies from the 90’s suggest that spontaneous release, although 
dependent from the extracellular Ca
2+
 concentration (as previously discussed in 
Section 1.1.3), is not controlled by VGCCs, as the addition of Cd
2+
 (a non-specific 
VGCCs blocker) in the presence of tetrodotoxin (TTX) does not change its 
frequency (for a review see Bouron 2001). The modulation of spontaneous 
exocytosis by intracellular stores has been first described in cerebellar 
interneurons and in hippocampal pyramidal neurons (Llano et al. 2000; Emptage, 
Reid and Fine 2001); here the authors described calcium transients occurring in 
presynaptic terminals upon stimulations of the stores that were not dependent on 
VGCCs. These waves of Ca
2+
 influx, that in the basket cells are coupled to bursts 
of GABA release, are probably mediated by SOCCs, known to be activated in 
response to the decreased Ca
2+
 concentration in the stores.  
The function of the proteins involved in SOCE is not only limited to the 
refilling of the stores and to the possible regulation of spontaneous exocytosis: 
STIM 1 and Orai also participate in various signalling pathways (Majewski and 
Kuznicki 2015). 
For example, SOCE is involved in the nuclear factor of activated T cells 
(NFAT)-dependent gene expression, vital for the nervous system development 
and function. The NFAT signalling pathways is activated upon Ca
2+
 influx, 
usually mediated by L-type VGCCs and NMDA receptors. Recently it has been 
shown that also SOCE regulates the NFAT mediated gene expression; in fact, 
treatment of neural stem/progenitor cells with thapsigargin (TG) induced a SOCE 
response and, subsequently, the stimulation of NFAT mediated gene expression, 
which was affected by SOCE inhibitors 2-APB, SKF96365 and BTP-2 and was 
completely abolished in mice containing a loss of function mutation to Orai 
channles (Majewski and Kuznicki 2015). 




Another transcription factor regulated by SOCE is Sp4, whose activity is 
also regulated by Ca
2+
: hyperpolarisation causes Sp4 polyubiquitinisation and 
degradation in cerebellar neurons, while depolarisation causes its increase. 
Treatment with SOCE inhibitors 2-APB and SKF96365 prevented the 
polyubiquitination and degradation of Sp4 in hyperpolarised cells, and increased 
its abundance under depolarising conditions (Lalonde, Saia and Gill 2014). 
SOCE is also involved in guided axonal growth and regeneration, 
phenomena that are spatially and temporally regulated by Ca
2+
 signals. For 
example, TRPC channels are involved in BDNF-mediated growth cone guidance: 
inhibition of TRPC 3 channels impaired BDNF-induced Ca
2+
 elevation and 
growth cone turning (Li et al. 2005). Furthermore, growth cones responses to 
attractive guidance stimuli require the presence of STIM 1 and TRPC 1 (Shim, 
Zheng and Ming 2013). 
There is evidence that STIM 1 suppresses the depolarisation-induced 
activation of Cav1.2 (L-type) VGCCs, and alters its surface expression by 
internalisation, leading to a complete loss of function (Park, Shcheglovitov and 
Dolmetsch 2010). The authors suggested that STIM 1 inhibits Ca
2+
 entry through 
Cav1.2, whilst promoting its entry through Orai channels. Another research group, 
despite observing the same inactivation of VGCCs by STIM 1, also reported that 
this effect does not require activation of Orai channels (Wang et al. 2010). What 
they postulate is that Orai channels enhance the recruitment of STIM 1 near 
Cav1.2 VGCCs by trapping STIM 1 in the puncta.  
Together, all these results suggest that store depletion has a dual effect: on 
the one hand it activates SOCE; on the other it inhibits Ca
2+
 influx through -at 












1.5 Voltage-gated calcium channels 
 
Voltage gated calcium channels (VGCCs) are plasma membrane proteins 
that mediate Ca
2+
 influx in response to depolarisation of cells. They are widely 
expressed in many cell types, like neurons, muscle, cardiac and endocrine cells, 
and they initiate different cell events according to the cell type involved. In 
neurons, the opening of VGCC after an action potential is the trigger to initiate 
synaptic transmission (Dunlap, Luebke and Turner 1995).  
 
1.5.1 VGCCs structure 
 
VGCCs, purified for the first time from the skeletal muscle transverse 
tubules, are composed of four main subunits: α1, β, γ and α2δ.  
The α1 subunit is a protein of about 2000 residues organised in four 
repeated domains (I-IV), each of one is formed of six TMRs (S1-S6) with a 
membrane-associated loop between the TMRs S5 and S6. It is the pore forming 
subunit, and its expression alone is sufficient to have functional channels. The S4 
segment of each domain functions as the voltage sensor that promotes the channel 
activation: under the influence of the electric field, it rotates and initiates 
conformational changes that lead to the opening of the channel pore (Catterall 
2000). 
The β subunit is an intracellular protein with predicted α helices but no TMRs; the 
γ subunit is a glycoprotein with four TMRs; the α2δ subunit is a dimer connected 
to the plasma membrane by a TMR. This subunit, together with the β, helps to 
enhance the level of expression and to confer appropriate gating properties 
(Catterall 2011). 
 Differently from the VGCCs found in skeletal and cardiac muscles, the 
isolation of neuronal VGCCs revealed that these channels have all the subunits 
except the γ (Ahlijanian, Westenbroek and Catterall 1990; McEnery et al. 1991). 
 






Figure 1.15. VGCCs quaternary structure and subunit composition. VGCCs are 
formed of a α1 pore forming subunit that determines the characteristics of the 
current; an intracellular β subunit and an extracellular α2δ subunits that confer 
appropriate gating properties; a transmembrane γ subunit. Neuronal VGCCs 
have all the subunit except the γ (Hannon and Atchison 2013). 
 
1.5.2 Classes of VGCCs 
 
Different α1 subunits generate different types of Ca
2+
 current through the 
channels, with distinctive physiological and pharmacological properties. The 
subunits can be divided into three families: Cav1, Cav2 and Cav3.  
Cav1 (1 to 4) family generates L-type currents, so called because they are 
long lasting when Ba
2+
 is the current carrier; this type of current is activated at 
high voltages, has low voltage-dependent inactivation, large single channel 
conductance, and is regulated by cAMP-dependent protein phosphorylation 
pathways. It can be inhibited by Ca
2+
 antagonist drugs like benzothiazepines and 
dihydropyridines. This type of current can be found in skeletal and cardiac 
muscles, endocrine cells, neurons and retina. 
Cav2 (1 to 3) family generates different types of currents: Cav2.1 conducts 
P/Q-type currents, blocked by ω-agatoxin IVA; Cav2.2 conducts N-type currents, 




blocked by ω-conotoxin GVIA; Cav2.3 conducts R-type currents, blocked by the 
peptide SNX-482. These three types of currents are mostly found in neurons. 
Cav3 (1 to 3) family generates T-type currents, so called because of their 
transient opening; unlike L-type currents, this type activates at more negative 
membrane potentials, inactivates rapidly, deactivates slowly, and has a small 
single channel conductance. This type of current can be found in skeletal and 
cardiac muscles and in neurons (Catterall 2011). 
 
Table 1.1 Classes of VGCCs. 
 
Current type Pore-forming subunit Primary localisation 
L Cav1.1 Skeletal muscle 
L Cav1.2 Cardiac muscle, endocrine cells, 
neurons 
L Cav1.3 Endocrine cells, neurons 
L Cav1.4 Retina 
P/Q Cav2.1 Nerve terminals, dendrites 
N Cav2.2 Nerve terminals, dendrites 
R Cav2.3 Nerve terminals, dendrites, cell bodies 
T Cav3.1 Cardiac and skeletal muscles, neurons 
T Cav3.2 Cardiac muscle, neurons 
T Cav3.3 Neurons 
 
 
1.5.3 Cav2.1 channels 
 
As mentioned previously, Cav2.1 subfamily of Ca
2+
 channels conducts P/Q-
type currents. These channels are localised presynaptically in the central nervous 
system, where they are abundant especially in the cerebellum (Purkinje and 
granule cells), hippocampus, visual cortex, spinal cord and dorsal root ganglia 
(Mintz, Adams and Bean 1992). 




These channels are responsible (along with Cav2.2 channels) for fast release 
of neurotransmitters, such as GABA, glutamate and acetylcholine. They interact 
with synaptotagmin through a specific synaptic protein interaction site located in 
the intracellular loop connecting the domains II and III, and they can be regulated 
by G protein-coupled receptors, more specifically by the βγ subunit that shifts the 
activation of the channels to more positive membrane potentials (Catterall 2011). 
Several toxins act on P/Q Ca
2+
 channels, blocking them. Among them, ω-
agatoxin IVA and ω-agatoxin IVB from the American funnel web spider 
Agelenopsis aperta specifically block P/Q-type channels; ω-conotoxin MVIIC and 
ω-conotoxin CVIB from the marine cone snail block P/Q channels, along with N-
type channels; ω-grammotoxin from the tarantula spider Grammostola spatulata 
blocks both P/Q and N-type channels; ω-PnTx3-3 from the South American 
“armed” spider Phoneutrica nigriventer blocks P/Q, N and L-type channels 
(Nimmrich and Gross 2012). 
 




1.6 Aims and objectives 
 
This work aims to give new insight on the regulation of spontaneous 
exocytosis operated by G protein-coupled receptors, in particular LPHN1, using 
the mouse neuromuscular junction (NMJ) as a model system. 
As extensively discussed previously, LPHN1 is an adhesion G protein 
coupled receptor whose activation causes a massive increase in spontaneous 
neurotransmitter release (Capogna et al. 2003; Lelyanova et al. 2009); it has been 
shown that LPHN1 is functionally associated to Gαo and Gαq (Rahman et al. 
1999), and that its stimulation causes activation of PLC and elevation of 
intracellular IP3 (Ichtchenko et al. 1998).  
With this in mind, we hypothesize that LPHN1 has a role in regulating 
spontaneous exocytosis most likely by modulating the cytosolic [Ca
2+
] via the 
release of Ca
2+
 from intracellular stores and/or the opening of plasma membrane 
channels. This modulation should already give some effect when LPHN1 is at 
rest, but would be more prominent upon activation. At that point, we suggest that 
LPHN1 develops its effects by activating the Gαq protein intracellular pathway, 
which includes stimulation of PLC, subsequent production of IP3 and stimulation 
of IP3 receptors on the ER. This in turn causes the efflux of Ca
2+
 from intracellular 
Ca
2+
 stores and, consequently, the opening of store-operated Ca
2+
 channels 
(SOCCs) on the plasma membrane, whose activation causes a Ca
2+
 influx that 
further increases the cytosolic [Ca
2+
] allowing the refilling of the stores. 
Therefore, objectives of this work are: 
- To investigate the influence of LPHN1 on spontaneous exocytosis by 
studying LPHN1 KO mice; 
- To give evidences in favour of the hypothesis that LPHN1 is the receptor 
responsible for the elevation in exocytosis upon stimulation by LTX
N4C
; 
- To analyse the characteristics of LPHN1-mediated increase in spontaneous 
exocytosis; 
- To delineate the molecular mechanisms underpinning the effects observed 
upon LPHN1 activation, with particular attention to the Gαq signalling 
pathway and SOCCs. 
!









All chemicals were from Sigma-Aldrich (Sigma-Aldrich Company Ltd, Dorset, 
UK) unless otherwise stated. 
 
2.1.1 Bacterial strains 
 
Escherichia coli Rosetta-gami 2
TM
 strain competent cells were purchased from 
Novagen (Millipore UK Limited, Hertfordshire, UK); E. coli DH5α
TM
 strain 
competent cells were purchased from Invitrogen (Life Technologies Ltd, Paisley, 
UK). 
 
2.1.2 Bacteria culture media 
 
For bacterial cultures, media were prepared in distilled water and autoclaved at 
121°C. 2-XYT medium contained, per litre: 16 g Trypton, 10 g yeast extract and 5 
g NaCl (pH 7.5). 1.2-1.5% agar was added to the above medium to prepare agar 
plates. When needed, chloramphenicol (34 µg/ml), kanamycin (50 µg/ml), 
tetracycline (25 µg/ml) and/or ampicillin (100 µg/ml) were added. Antibiotics 
were purchased from Calbiochem (Millipore UK Limited, Hertfordshire, UK). 
SOC medium contained 0.5% yeast extract, 2% Trypton, 10 mM NaCl, 2.5 mM 
KCl, 10 mM MgCl2, 10 mM MgSO4, and 20 mM glucose.  
 




, Lasso and LPHN-42 plasmids were kindly donated by Vera Lelyanova. 










Figure 2.2. Plasmid for expression of LPHN1 on the basis of pcDNA3.1. 





Figure 2.3. Plasmid for expression of GST-Lasso. 
 
2.1.4 Cell lines 
 
Mouse neuroblastoma NB2a cells wild type (WT) and NB2a clones stably 
expressing LPHN-42 or LPHN-72 were from Professor Yuri Ushkaryov 
(University of Kent and Greenwich, Chatham Maritime, UK). 
 
2.1.5 Cell culture media 
 




and Trypsin-EDTA (0.25%, 
phenol red) were from Gibco (Life Technologies Ltd, Paisley, UK). Sterile water 
was from PAA (PAA Cell Culture Company, Cambridge, UK). Fetal bovine 
serum, Dulbecco’s PBS and G418 (200 µg/ml) were used. 
 






Lipofectamine 2000 transfection reagent was from Invitrogen (Life Technologies 
Ltd, Paisley, UK). Superfect
R
 transfection reagent was from Quiagen (QIAGEN 
Ltd., Manchester, UK). 
 
2.1.7 Mice  
 
1-2 days old C57BL/6J WT and LPHN1 knock out (KO) (AG148) newborn mice 
were used for hippocampal neurons primary cultures; 21-28 days old C57BL/6J 
WT and LPHN1 KO mice were used for electrophysiological experiments on 
neuromuscular junctions (NMJs).  
LPHN1 KO mice (AG148) were from Professor Yuri Ushkaryov (University of 
Kent and Greenwich, Chatham Maritime, UK); other mice were from Charles 
River (Charles Rivers Laboratories, Margate, UK). 
 




 (HA) and hibernate A
®
 minus calcium (HA – Ca
2+
 ) were purchased 
from BrainBits (BrainBits LLC, Springfield, US); Hank’s BSS without Ca
2+
  and 
Mg
2+
 and sterile water EP grade were from PPA (PPA Cell Culture Company, 




 supplement and GlutaMAX
TM
 were from 
Gibco (Life Technologies Ltd, Paisley, UK). Papain, laminin and poly-D-lysine 
were also used. 
 
2.1.9 Whole-cell patch clamp buffers 
 
External solution: 2 mM CaCl2, 3 mM CsCl, 11 mM glucose, 4.8 mM HEPES, 
160 mM NaCl. pH was adjusted to 7.2-7.5 with NaOH; glucose was added just 
before use and the solution was filter sterilised. Internal pipette solution: 150 mM 
CsCl, 10 mM EGTA, 5 mM HEPES, 10 mM NaCl, 4.5 mM ATP-Mg, 0.1 mM 
GTP. pH was adjusted to 7.2-7.5 with KOH.  








  buffer): 137 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 
10 mM HEPES, 5.6 mM glucose. Glucose was added just before use and the 
solution was filter sterilised. Buffer B (Ca
2+
 -free buffer): 137 mM NaCl, 5 mM 
KCl, 0.2 mM EGTA, 1 mM MgCl2, 10 mM HEPES, 5.6 mM glucose. Glucose 
was added just before use and the solution was filter sterilised. Variations to the 
buffers will be stated in the text as appropriate. Sharp electrodes manufactured 
from borosilicate glass (Harvard Biosciences, Inc., USA) were filled with a 5 M 
ammonium acetate solution. 
 
2.1.11 Pharmacological agents 
 
1-2-(4-methoxyphenyl)-2-[3-(4-methoxyphenil)propoxyethyl-1H-imidazole 
(SKF96365), 2-Aminoethyl diphenylborinate (2APB), BAPTA-AM, cadmium, 
gadolinium, nimodipine, prefluooctanoic acid (PFOA), ryanodine, tetrodotoxin, 
thapsigargin (TG), U73122 and U73343 were used. UBO-QIC was from the 
Institute of Pharmaceutical Biology, University of Bonn, Germany. ω-Agatoxin 
IVA, ω-conotoxin GVIA and ω-conotoxin MVIIC were from Alomone (Alomone 




Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
running buffer was prepared as a 10X (250 mM Tris, 2.5 M glycine, 10% SDS) 
and diluted to 1X when needed. 6X sample buffer was prepared with 0.375 M Tris 
(pH 6.8), 12% SDS, 60% glycerol, 0.6 M DTT and 0.06% bromophenol blue. 1X 
sample buffer was prepared with: 0.0625M Tris (pH 6.8), 2% SDS, 10% glycerol, 
0.1M DTT, 0.01% bromophenol blue. Coomassie Blue R dye contained 0.1 % 
Coomassie Brilliant Blue R-250, 50% methanol and 10 % glacial acetic acid. 
 
 




2.1.13 Western blotting 
 
Western blot transfer buffer, containing 25 mM Tris, 192 mM Glycine, 10% 




Antibodies used in immunofluorescence experiments are shown in Table 2.1.  
TBS-T buffer contained 137 mM NaCl, 2.7 mM KCl, 19 mM Tris, 0.1% triton-X. 
Blocking buffer contained TBS-T supplemented with 1% BSA. 
 
Table 2.1. Antibodies used for immunofluorescence experiments 
 
Antibody Species  Concentration Manufacturer 
Anti GST mouse 1:1000 Abcam 
Anti GST rabbit 1:1000 Abcam 
Anti V5 mouse 1:1000 AbdSerotec 
Anti LTX rabbit 1:2000 Obtained by 
immunisation 
of rabbits 
Anti LPHN1 rabbit 1:500 Obtained by 
immunisation 
of rabbits 
Anti mouse 680 nm donkey 1:1000 Li-Cor 
Anti mouse 800 nm donkey 1:1000 Li-Cor 
Anti rabbit 680 nm donkey 1:1000 Li-Cor 
Anti rabbit 800 nm donkey 1:1000 Li-Cor 
Anti rabbit-HRP conj. goat 1:5000 Santa Cruz 
Biotecnology 
 




2.1.15 Other materials 
 
Phosphate buffer saline (PBS) buffer contained 137 mM NaCl, 2.7 mM KCl, 10 
mM Na2HPO4, 1.8 mM KH2PO4. pH was adjusted to 7.4 using HCl. TE was 
prepared with 10 mM Tris-HCl and 1 mM EDTA (pH 8), and autoclaved at 
121°C. Glutathione-S-transferase (GST)-bind
TM
 kit for column affinity 
chromatography was purchased from Novagen (Millipore UK Limited, 


















2.2.1 Transformation of competent bacteria 
 
The heat shock method was used for transformation. Different amounts of DNA 
(from 1 to 10 ng) were added to 20 µl of cells, briefly mixed, and incubated for 30 
min on ice. Cells were then heated at 42°C in a water bath for 30 s, and re-placed 
on ice for 2 minutes. Subsequently, 80 µl of SOC medium was added to each 
tube, and the mixture was incubated for 1 h at 37°C, with shacking. 50 µl of the 
transformed cells were then plated on 2XYT-agar plates supplemented with 100 
µg/µl ampicillin, 34 µg/µl chloramphenicol, 25 µg/µl tetracycline (E. coli 
Rosetta-gami 2
TM
) or with 100 µg/µl ampicillin (E coli DH5α
TM
) and incubated 
overnight at 37°C, with vigorous shaking. 
 
2.2.2 Protein expression and extraction 
 
A single colony of bacteria was selected and cultured in 2 ml 2XYT containing 
100 µg/µl ampicillin, 34 µg/µl chloramphenicol, and 25 µg/µl tetracycline 
overnight shacking at 37°C. The next day the culture was diluted 1:50 with the 
fresh medium and left growing until the desired optical density was reached (0.25 
– 1). The culture was induced with 50 mM Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) and expression was carried out for 16 – 20 h at room temperature (RT). 
The culture was then centrifuged at 4°C at 5000 x g for 10 min. The pellet was 
then resuspended in 50 µl of ice cold PBS and sonicated 3 times for 30 s. The 
mixture was centrifuged again under the same conditions and the supernatant 
containing the soluble protein was collected. The pellet containing the insoluble 










2.2.3 Affinity chromatography 
 
The 10X GST bind/wash buffer provided in the kit (Novagen) was diluted to 1X 
with water. 10X elution buffer containing 100 mM reduced glutathione was 
prepared and aliquots were kept at -20°C. When needed, the elution buffer was 
diluted to 1X with dH2O. The column was prepared with 1.5 ml of GST bind 
resin consisting of an agarose matrix with attached reduced glutathione (GSH). 
Protease inhibitor cocktail for bacterial cells (Sigma-Aldrich) was added to the 
supernatant from the protein extraction procedure. The supernatant was then 
loaded into the column and incubated for 1 h, at 4°C, with end-over-end rotation.  
The extract was then passed through a plastic column supplied with a porous 
polythene filter, and fractions of the flow through were collected and stored for 
analysis. The column was then washed with 10 column volumes of GST wash 
buffer, and samples were taken for analysis. The bound protein was then eluted 
with 3 volumes of GST elution buffer, and the elution fractions were collected. 
 
2.2.4 LTX binding experiment 
 
Different concentrations of LTX were used (2 – 50 nM) in order to identify the 
best condition for binding. Cells expressing LPHN-42 or LPHN-71 were 
incubated with the toxin for 20 min in an Eppendorf tube. They were then 
centrifuged at 9000 rpm for 2 min at RT and the supernatant containing the 
unbound toxin was collected. Cells were then washed with PBS briefly (with a 10-
s centrifugation of individual tubes) and the supernatant was removed. After lysis 
for protein extraction (see Section 2.2.7), cells were centrifuged at 9000 rpm for 









2.2.5 Cell culture 
 
Cell cultures were performed under sterile conditions in a laminar air flow 
cabinet. Neuroblastoma NB2a cells WT were grown in DMEM medium 
containing GlutaMAX supplemented with 10% FBS. The same medium was used 
for NB2a cells stably transfected with LPHN-42 or LPHN-71 with the addition of 
G418 for selection of the cells containing the LPHN1 plasmids. Cells were plated 
in T75 flasks and grown at 37°C, 5% CO2.  
Passaging of the cells was performed after a confluence of 80-90 % was reached 
(normally, 2-3 times a week); for this, cells were washed with PBS, detached from 
the flask using Trypsin-EDTA for 1 min, and diluted with fresh complete DMEM 
at a ratio from 1:6 to 1:12 for further plating. 
 
2.2.6 Transient transfection 
 
The day before transfection, cells were counted using a haemocytometer and 
plated in 35-60 mm dishes (depending on the experiment) so that they would be 
80-90% confluent at the time of transfection.   
For transfection using Lipofectamine® 2000, the Lipofectamine® complex was 
prepared using serum-free medium, incubated at RT for 5 min, and then added to 
the DNA mixed with serum-free medium (4 µg DNA for transfections using a 35 
mm dish, 8 µg DNA for transfections using a 60 mm dish). After a further 
incubation of 20 min at RT the DNA-Lipofectamine complex was added to the 
cells and then incubated under usual conditions for 24-48 hours. 
For transfection using Superfect®: DNA and Superfect were diluted in serum-free 
medium and incubated for 5-10 minutes at RT to allow complex formation. The 
complex was then further diluted with serum-free medium, and transferred onto 
the cells after the growth medium in the plates was removed. After a 3-h 
incubation at 37°C, the transfection complex was removed from the plates and 
replaced with complete DMEM. The cells were then incubated under usual 
conditions for 24-48 hours. 
 




2.2.7 Protein extraction 
 
Plates with transfected cells were placed on ice, cells were washed with PBS 
containing 5 mM EDTA (to loosen cell attachment), scraped off the plates and 
transferred into 15 ml centrifuge tubes. Cells were then counted using a 
haemocytometer, centrifuged at 800 x g for 5 minutes at 4°C and diluted in PBS 
containing 1% Triton X-100 to a concentration of > 600,000 cells/100 µl. Cells 
were incubated on ice for 20 min, centrifuged, and the supernatant containing the 
solubilised proteins was collected. 
 
2.2.8 Chloroform/methanol precipitation 
 
One volume of methanol was added to the supernatant obtained from protein 
extraction and mixed well; 1 volume of chloroform was then added and mixed. 
The mixture was centrifuged at 10,000 rpm for 10 min, at RT. The supernatant 
was removed and discarded, the pellet containing proteins was left to air-dry for 




SDS-PAGE was carried out using a Bio-Rad apparatus. The concentration of the 
resolving gels was chosen according to the protein size, from 6 to 10%. The 
mixture (water, 30% polyacrylamide-Bis, Tris-HCl, pH 8.8, 10% SDS, 10% APS, 
TEMED) was poured into gel plates, overlaid with water and let polymerise 
overnight at 4°C. The 5% stacking gel mixture (dH2O, 30% polyacrylamide-Bis, 
Tris-HCl, pH 6.8, 10% SDS, 10% APS, TEMED) was poured on top of the 
resolving gel and let polymerise with a 10 or 15-wells comb. After 
polymerisation, the comb was removed and the wells washed with 1X SDS-PAGE 
running buffer. 
After addition of the sample buffer, samples were either boiled for 3 minutes at 
100°C or heated for 20 minutes at 50°C for samples containing LPHN1, briefly 
centrifuged and loaded into the wells.  




The gel was then placed into the gel tank filled with 1X running buffer; 
electrophoresis was carried out at a constant voltage of 120 V for ~ 90 minutes. 
The gel was then stained with Coomassie Blue R dye or used for western blot 
transfer. 
 
2.2.10 Western blotting 
 
After SDS gel electrophoresis, the proteins were transferred onto a polyvinylidene 
fluoride (PVDF) membrane at a constant current of 180 mA for 70 min using the 
wet method. The transfer tank (Sigma) was filled with 1X transfer buffer cooled 
down to 4°C using a water-circulating cooling incubator, with continuous stirring.  
Blotting paper and PVDF membrane were cut to fit the transfer cassette; the 
PVDF membrane was activated in methanol and pre-equilibrated with 1X transfer 
buffer.  
The cassette was assembled as follows: 1X sponge, 1X blotting paper, PVDF 
membrane, gel, 1X blotting paper, 1X sponge. Air bubbles were removed by 
carefully rolling a pipette over the surface. 
The blot cassette was placed in the transfer tank so that the gel was on the 




Figure 2.4. Western blot transfer cassette assembly. 






After the transfer was complete, the PVDF membrane was placed into a 50 ml 
centrifuge tube containing ~4 ml of blocking buffer and incubated on a rotator  
overnight. 
The following day, the blocking buffer was replaced with blocking buffer 
containing the primary antibody. After an incubation of 1 h, the membrane was 
washed (3 times for 5 min) with TBS-T, and then incubated with blocking buffer 
containing the secondary antibody for 1 hour. The membrane was then washed (3 
times for 5 min) and the blot was visualised using the Odyssey detection system.  
 
2.2.12 Neuronal cell cultures 
 
Hippocampi from 1-2 days old mice were dissected under a binocular microscope 
in aseptic conditions, placed into vials with HAB buffer (Hibernate A, 2% B27, 
0.5 mM GlutaMAX) and kept at 4°C until plating (no more than 10 days after 
dissection). 
Working under a sterile cell culture hood, cells were placed in dissociation buffer 
(HA – Ca
2+
  containing 2 mg/ml papain) and incubated 10 min at 37°C. The 
dissociation buffer was then removed and replaced with HAB buffer. The tissue 
was triturated using a silanised Pasteur pipette. The undispersed pieces were let to 
settle for 1 min, the supernatant containing the dispersed cells was transferred into 
a 15 ml tube and centrifuged at 700 rpm for 2 min. The pellet was resuspended in 
Neurobasal A medium supplemented with 2% B27 and 0.5 mM GlutaMAX, and 
the cells were plated on coverslips coated with 50 µg/ml poly-D-lysine and 10 
µg/ml laminin in a 24 wells plate (10,000 cells/well).  
Neurons were kept in an incubator at 37°C, 5% CO2 and half of the medium was 
changed every 3-4 days. The cultures were left growing for 14 – 21 days until 
used for electrophysiological recordings. 
 
 




2.2.13 Recordings of spontaneous postsynaptic currents in hippocampal 
neurons 
 
Experiments on central synapses were carried out on primary cultures of 
hippocampal pyramidal neurons, 21 days after plating.  
Coverslips with neurons were transferred into a perfusion chamber (Harvard 
Biosciences, Inc.) mounted on top of an inverted microscope and perfused at RT 
with external solution (see Section 2.1.9) at a flow rate of 1 ml/min. Borosilicate 
glass pipettes were pulled using a Flaming-Brown-type pipette puller (P97, Sutter, 
USA) to show a resistance of 3 – 7 MΩ, filled with the internal solution (see 
Section 2.1.9), and manipulated using a PatchStar motorised micromanipulator 
(Scientifica).  
The cells were observed on a computer screen using a C-mount colour video 
camera attached to the trinocular microscope head. The cell chosen for the patch 
was approached to obtain a cell-attached GΩ seal (resistance of the pipette of at 
least 1 GΩ). The recorded neurons were voltage-clamped at -70 mV, and a short 
suction was applied by mouth to break through the membrane to accomplish the 
whole cell patch.  
Excitatory postsynaptic currents (EPSC) and inhibitory postsynaptic currents 
(IPSC) were amplified (10 mV/pA), filtered (2.9 kHz), and digitised (5 kHz) 
using the recording equipment which consisted of a patch-clamp amplifier (Model 
2400, A-M Systems, Inc., USA), a two-channel 8-pole Bessel high-frequency 
filter/amplifier (LPF202A , Warner Instruments), a HumBug harmonic frequency 
quencher (Quest Scientific), and Digidata 1322A digital transformer (Axon 
Instruments). The data were acquired using pClamp software (Axon Instruments) 











2.2.14 Recordings of spontaneous postsynaptic potentials at the NMJs 
 
Experiments on NMJ were carried out on preparations of flexor digitorum brevis 
from the mouse hind paws (21-28 days old male mice, C57BL/6J). The mice were 
euthanized by cervical dislocation. The hind paws were removed and pinned to 
petri dishes coated with Silgard silicone polymer filled with Ca
2+
-containing 
buffer (see Section 2.1.10) using entomological pins; the muscle was removed and 
cleaned from the connective tissue under a dissection microscope. The 
preparations were then moved to the recording rig and observed using a C-mount 
video camera attached to a binocular microscope (SMZ-645, Nikon, Japan) and 
dark-field illumination. Presynaptic activity was evaluated by postsynaptic 
registration of miniature end plate potentials (MEPPs) using a sharp electrode (tip 
diameter < 0.5 µm, resistance 30 – 40 MΩ) prepared using a Sutter pipette puller 
(P97) and filled with a solution containing 5 M ammonium acetate. Electrodes 
were inserted into the muscle fibres using a PatchStar motorised 
micromanipulator (Scientifica) and the membrane potentials were recorded in the 
current clamp mode using Axoclamp 2B pre-amplifier (Axon Instruments), 
LPF202A amplifier with high frequency filter (Warner Instruments), Hum Bug 
harmonic frequency quencher (Quest Scientific), and Digidata 1322A digital 
transformer (Axon Instruments). 
Resting membrane potentials of recorded cells varied from -70 to -20 mV; only 
cells with membrane potentials between – 70 and -40 mV were considered for 
analysis. 
Preparations were bathed at room temperature in a static buffer containing 137 
mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES and 5.6 mM 
glucose, unless specified otherwise.  
Membrane potentials were acquired using Axoscope 10.2 software (Axon 
Instruments), the recorded traces were adjusted to baseline using Clampfit 
(pCLAMP 10 software) and analysed using MiniAnalysis 6.0 software 
(Synaptosoft). Frequency histograms of MEPPs were created in MiniAnalysis 
plotting the number of events per second. 




To test the effects of different pharmacological agents on the LTX
N4C
-induced 
increase in miniature end-plate potentials (MEPPs) the specified drugs were added 
to the NMJ preparations bathed in Ca
2+
 buffer (unless specified otherwise) for 15 
– 20 min prior to the addition of the toxin: PFOA (0.2, 1, 10, 50 and 100 µM), 
TTX (1 µM), UBO-QIC (1 µM), U73122 (10 µM), U73343 (10 µM), Gd
3+
 (1 
mM), nimodipine (10 µM), ω-Con MVIIC (1 µM), ω-Con GVIA (50 nM), ω-Aga 
IVA (200 nM). Recordings of MEPPs were taken immediately, after 10 min and 
just before the addition of LTX
N4C
 to evaluate possible changes in the basal 
frequency. BAPTA-AM was incubated for 40 min in Ca
2+
 -free buffer before the 
the toxin was added. Afetr the addition of 0.25 nM LTX
N4C
 the recordings 
continued for an average of 60 min. If the effect of LTX
N4C
 did not develop at the 
expected time (20 min after addition) the recordings continued for up to 90 min. 
In other experiments, drugs (100 µM PFOA, 1 µM UBO-QIC, 10 µM U73122, 10 
µM U73343, 50 µM 2APB, 100 µM ryanodine, 50 µM SKF96365, 100 µM 
YM58483, 10 µM TG, 10 µM nimodipine, 1 µ ω-Con MVIIC) were added 30 
min after LTX
N4C
 addition, i.e. when the toxin’s effect was already developed and 
recordings of increased activity from several cells were made.  
To test depolarisation-induced release, 20 mM KCl were used in containing a 
buffer containing 122 Mm NaCl, 0.2 mM EGTA, 1 mM MgCl2, 10 mM HEPES, 
5.6 mM Glucose, with or without 2 mM CaCl2. In the presence of 100 µM PFOA, 
the concentration of KCl used was 40 mM. 
 
2.2.15 Data analysis 
 
To ensure the presence of internal and external independent controls, recordings 
were collected from several fibres of the same preparation (n = 5 – 15) as well as 
from different paws (N = 2 – 3) for each experimental condition. 
The data were collected using MiniAnalysis 6.0 software (Synaptosoft) and 
validated using One-way ANOVA or non-parametric tests (Mann-Whitney U test) 
with significance set at P < 0.05 using GraphPad Prism 6.0. Graphs were created 
using GraphPad Prism 6.0; figures represent mean ± SEM unless otherwise 
specified. 




 CHAPTER 3 
RESULTS I. Expression of LTX
N4C




The expression of active αLTX and LTX
N4C 
is necessary in order to study the 
toxin-evocked effects due to the binding to LPHN1. Different methods have 
already been used to express LTX, using both baculovirus (Kiyatkin et al. 1995; 
Volynski et al. 1999) and bacterial (Dulubova et al. 1996) systems. However, both 
of these systems have been proven to be inadequate for the purpose. The 
baculovirus vectors used by Kiyatkin and collaborators (1995) proved to produce 
mostly insoluble and inactive αLTX; this problem was overcame by Volynski et 
al. (1999), who successfully optimised a method to express functional αLTX. 
However, several factors  such the high cost of the reagents needed, the long time 
needed for expression, the difficulty of the procedure and the low yield make this 
procedure not ideal. 
Bacterial expression, which partially overcomes the limitations mentioned 
above for the baculovirus system, has also been used to produce active αLTX 
(Dulubova et al. 1996); although being cheap, fast and  easy, this system did not 
solve the low yield problem, and the toxin produced was mostly insoluble due to 
incorrect protein folding. 
Here, I attempted to optimise a method for bacterial expression of LTX
N4C
 in 
order to overcome the problems encountered before. 
Expression of recombinant proteins using bacterial cells as a host is a widely 
used strategy due to its simplicity and speed, and the high yield of protein 
expressed. 
Different methods are available for bacterial transformation. In the present work, 
the method chosen was the heat shock, where bacterial cells are first incubated 
with the plasmid DNA at low temperature in the presence of divalent cation 
(Ca
2+
); this is followed by a sudden increase in temperature that causes the 
incorporation of the DNA plasmid into the bacterial cells. 




Despite the simplicity of the procedure and the high yield achieved with 
bacterial expression, problems can arise when expressing eukaryotic proteins in 
prokaryotic hosts, because (1) bacteria do not use some of the codons necessary 
for the translation of eukaryotic proteins and therefore lack the corresponding 
tRNAs; (2) bacteria lack the exocytotic secretory system and protein translation in 
bacteria occurs inside the cytosol, where the reductive environment and the lack 
of appropriate chaperones can prevent the proper post-translational modifications 
and folding of eukaryotic proteins; (3) in bacteria proteins destined for secretion 
are transported across the membrane by protein transport systems, which often fail 
to recognise eukaryotic proteins; (4) even if foreign proteins are transported 
through the inner membrane of the Gram negative bacteria, they may not readily 
escape from the bacterial periplasm and into the medium due to the relatively 
small size of the outer membrane pores.  
Different strategies can help overcome these problems and therefore improve the 
expression of the target protein (Khow and Suntrarachun 2012): 
- Modification of the bacteria strain so that the target protein finds a proper 
environment for its correct assembly; 
- Modification of the growth media, such as supplement of cofactors to help 
the correct protein folding; 
- Modification of the temperature in which the expression takes place, to 
slow down protein synthesis and therefore decrease protein aggregation 
and formation of inclusion bodies; 
- Co-expression of molecular chaperons to guide the folding of the 
recombinant protein in the appropriate way. 
In the present work I overcame some of these issues (codon preference and 
reducive cytosolic environment) by using a particular strain of E. coli, Rosetta-
Gami 2, which combines the features of Rosetta and Origami strains.  The Rosetta 
strain facilitates the expression of eukaryotic proteins because it contains the 
pRARE plasmid that supplies tRNAs for codons rarely used in E. coli (AUA, 
AGG, AGA, CUA, CCC and GGA). The Origami 2 strain contains mutations in 
the thioredoxin reductase (trxB) and glutathione reductase (gor) genes, which 




creates an oxidative environment and thus enhances disulphide bond formation in 
the cytoplasm, leading to the expression of correctly folded and active proteins. 
 LTX
N4C
 cDNA was previously subcloned in our laboratory into a GST-
fusion system. The gene of interest was inserted into a pGEX vector in-frame with 
the GST sequence, which therefore becomes fused to the protein of interest at the 
N-terminal. Expressing a recombinant protein as a GST-fusion protein gives some 
advantages: after translation, the GST protein rapidly folds into a stable and 
soluble protein; GST can be therefore used to guide the correct folding of the 
protein of interest, enhancing its expression and solubility. Furthermore, GST 
allows a simple and quick purification of the fusion protein by affinity 
chromatography using immobilised glutathione. 
The expression in the pGEX vector is controlled by a tac promoter, which can be 
induced by the lactose analogue isopropyl b-D thiogalactoside (IPTG); to control 
the expression of the insert more strictly, the vector also contains a lacI
q
 repressor 
that binds to the operator region of the taq promoter and prevents the expression 




Figure 3.1. Map of the pGEX GST-fusion vector 






3.2.1 Plasmid purification 
 
The plasmid encoding GST-LTX
N4C
 fusion protein had been previously prepared 
in our lab. 
 
 
Figure 3.2. Map of the GST-LTX
N4C
 plasmid used for bacterial expression. The 
toxin cDNA carried additional modifications: GST is attached at the N-terminal 
and V5 and Myc epitopes are attached at the C-terminal. These modifications 
allow the recognition of both the N- and C-termini of the recombinant fusion 




 plasmid was transformed into Rosetta-Gami 2 cells and the 
culture was grown in the presence of ampicillin, chloramphenicol, kanamycin and 
tetracyclin in order to maintain the pGEX_LTX
N4C
_V5-myc and the pRARE 
plasmids. 




To verify that the plasmid retained its structure and did not undergo any 
recombination in this bacterial strain, the plasmid was then isolated and analysed 
by restriction mapping and Agarose-gel electrophoresis (Figure 3.3). 
 
 
Figure 3.3. Restriction analysis of α-LTX
N4C
. Plasmid containing the GST-LTX
N4C
 
cDNA insert was cleaved with Xho I restriction enzyme. The reactions were 
analysed on a 1 % agarose gel at a constant voltage of 120V for 1 hour to yield 
the expected fragments. Lanes 1-3 contain plasmid preparations from three test 
cultures. Blue arrows indicate the position of the 6.22 kb and 2.36 kilobase-pair 
(Kbp) fragments as determined using the DNA size markers. The green arrow 
represents the position of the pRARE plasmid endogenously present in the 
Rosetta-Gami 2 cells. 
 
 
The plasmid isolated from the Rosetta-Gami-2 cells appeared to be cleaved 
into two fragments (6.22 kb and 2.36 Kbp), as expected from the map. However, 
the presence of the pRARE plasmid not only made it difficult to purify sufficient 
amounts of the pGEX_LTX
N4C
_V5-myc plasmid, but also precluded its detailed 
restriction mapping. Therefore, the plasmid DNA isolated from the Rosetta-Gami-
2 cells (and containing both plasmids) was re-transformed into XL-1 Blue 
bacterial cells for further analysis, amplified in the presence of ampicillin, but in 
the absence of chloramphenicol, kanamycin and tetracycline that are required for 
the survival of cells containing the pRARE plasmid. The plasmid DNA isolated 




from the recipient strain was then isolated and analysed by cleavage with 
restriction nucleases Xho I and Pst I, and their combination. As demonstrated by 
Figure 3.4, only the target plasmid was amplified in the recipient strain, and its 
restriction fragments fully corresponded to the theoretical map, indicating that the 
Rosetta-Gami cells did not alter the structure of pGEX_LTX
N4C
_V5-myc. Thus, it 






Figure 3.4. Restriction analysis of α-LTX
N4C
. Individual plasmid containing GST-
LTX
N4C
 cDNA insert were cleaved Xho I (lane 1), Pst I (lane 2) and the 
combination of Xho I and Pst I (lane 3) restriction enzymes. The reactions were 
analysed on a 1 % agarose gel at a constant voltage of 120V for 1 hour to yield 



















Several conditions were tested in order to optimise the expression of LTX
N4C
 
in the bacterial strain chosen. Because induction at different optical densities (OD) 
leads to different yields of expression (generally with the yield decreasing at 
increasing ODs), the cutures were grown up to different ODs (0.25, 0.50, 0.70 and 
1) to determine the optimal point of induction. After induction, the cultures were 
left expressing the protein at RT in order to slow both bacterial growth and protein 
expression; other cultures where treated in the same way but without induction by 
IPTG. Leaky expression was also optimised by growing bacteria at 37°C for 16 h 
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3.2.2.1 Leaky expression analysis 
 
To determine the presence and the extent of leaky expression of GST-
LTX
N4C
, I first carried out an experiment when a culture of Rosetta-Gami cells 
transformed with the pGEX-LTX
N4C
 plasmid was grown to 0.25 OD600 to achieve 
exponential growth and then allowed to grow at RT for 16 hours without 
induction. In parallel, a similar culture was grown under the same conditions, but 
was induced by adding IPTG at 0.25 OD600. In addition, a control culture of non-
transfected Rosetta-Gami cells was grown under the same regime, with or without 
IPTG induction. 
The expression of LTX
N4C
 was analysed by SDS-PAGE and Coomassie 
staining (Figure 3.5 A). As visible on the gel, a protein band of the size predicted 
for the GST-LTX
N4C
 fusion is present in the transformed cells, but not in the 
control (position of the protein pointed by the arrow). The protein is expressed in 
both conditions, both induced and non-induced. It is evident that the induction 
leads to a large overall increase of the expression (about 7.5 times more than non-
induced), but the majority of the protein produced is insoluble and precipitates in 
the pellet (with approximately 98.4 % of the protein produced in the pellet and 1.6 
% in soluble form, Figure 3.5 B and C). Although with the leaky expression the 
amount of recombinant toxin is much lower, the proportion of the soluble protein 
increases, while LTX
N4C
 content in the pellet decreases (with 89 % in the pellet 
and 11 % in the supernatant, Figure 3.5 B and C). 
Given the result of this experiment, suggesting that the greatest amount of 
functional protein is expressed without induction, this condition was always used 



























Figure 3.5. Analysis of the leaky expression of the GST-LTX
N4C
 fusion protein. A.  
Coomassie staining of GST-LTX
N4C
 expression. The position of the protein of 
interest is shown by the arrow. B. Comparison of total GST-LTX
N4C
 expression in 
induced and non induced cultures. Leaky expression is present, however the 
induced culture expresses approximately 7.5 times more protein than the non-
induced. C. Comparison of the amount of protein going in the pellet or in solution 
in the two conditions considered. Whilst only 1.6 % of the total fusion protein 
expressed is soluble in induced cultures, in non induced cultures approximately 











































3.2.2.2 Optimisation of induction 
 
One way to optimise the production of the soluble fusion protein is to find 
an optimal time for induction of expression. This is because the exponentially 
growing bacterial cells undergo changes to their physiological state, which affect 
the amount of chaperones available, the activity of transcription and translation 
and therefore may affect the cell’s ability to synthesise a properly folded protein. 
The expression of GST-LTX
N4C
 in cultures induced at different OD600 was 
analysed. Cultures were grown under usual conditions and separately induced at 
different OD600. They were then left for expression at RT for ≈ 16 hours. Control, 
non-induced cultures were grown at the exactly same growing conditions, but 
were not induced.  
The expression of GST-LTX
N4C
 was analysed using SDS-PAGE and 
Western blotting using an anti-GST antibody. As can be observed on the blot 
(Figure 3.6 A), a large quantity of soluble GST-LTX
N4C
 is expressed in the 
condition where the culture was induced at 0.5 OD600. The soluble fraction of 
expressed protein tends to decrease when the induction is made at a later stage, 
with the respective insoluble fraction increasing in the pellet. When not induced, 
the expression of LTX
N4C
 is overall lower, but most of the protein expressed is in 
a soluble form. No traces of LTX
N4C
 are detectable in the negative control. 
Given these observation, I concluded that the best condition of expression 
for LTX
N4C
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Figure 3.6. Optimisation of the time of induction of GST-LTX
N4C
 expression. A. 
Coomassie staining of the gel (top) and a respective Western blot (bottom) 
showing the amount of LTX
N4C
 expressed in the cultures induced at different 
OD600, in induced and non induced conditions.  Note that sample loading on the 
gel was proportionate to the volumes of the soluble and insoluble fractions, while 
10-fold lower amounts of cell pellets were loaded on the blot. B-C. Quantification 
of the expression of soluble LTX
N4C
 in induced cultures. In the induced conditions, 
with increasing OD600 at induction, the amount of fusion protein in the pellet 

















































Pellet  Supernatant  
Cont. Transfected α-LTX
N4C
 OD Cont. Transfected α-LTX
N4C
 OD 
- 0.25   0.5 0.7 1.0 - 0.25 0.5 0.7 1.0 




3.2.2.3 Optimisation of the leaky expression 
 
As previously shown, a high amount of soluble protein is expressed without 
induction. To explore the possibility of further enhancing the leaky expression, I 
experimented with time and temperature of growth to allow cultures to express 
LTX
N4C
 without induction. One culture was left expressing for 20 hours at RT, 
while another was left for 16 hours at 37°C.  
The expression of LTX
N4C
 was analysed using SDS-PAGE and Coomassie 
staining (Figure 3.7). As in the previous experiments, leaky expression produced a 
detectable amount of soluble protein and a relatively small amount of insoluble 
fusion protein in the pellet. Between the two different growing temperatures, 
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Figure 3.7. Optimisation of the leaky expression. A high amount of soluble protein 
is expressed without induction in both experimental conditions. The best condition 
to express LTX
N4C
 without induction seems to be at RT for 20 hours. 
 
 
A detectable amount of soluble GST-LTX
N4C
 protein was produced by 
leaky expression. However, the comparison between the expression after 
induction of an exponential culture at 0.5 OD600 (grown subsequently at 16°C) 
and the expression without induction after 20 h growth at RT, shows that a much 
larger amount of soluble fusion protein is produced when the culture is induced 





















































Figure 3.8. Comparison between the best conditions of expression without and 
with induction. The condition producing the larger amount of soluble LTX
N4C
 is 

































Purification of the expressed GST-LTX
N4C
 was performed using GSH-
column affinity chromatography and analysed by SDS-PAGE and western blot 
using an anti α-LTX antibody (Figure 3.9). A large amount of protein is visible in 
the load. After passing the load through the column a substantial amount of 
protein remained bound to the GST-bind resin, as in the flow through the quantity 
of LTX
N4C
 was visibly diminished. After extensive washes the column was eluted, 
and the majority of the purified protein is detectable in the third elution. Given the 
amount of protein that did not bind to the column, further affinity 
chromatographies of the flow through were performed in order to exhaust it. The 
presence of the protein in the washes suggests that the binding to the beads is not 
strong.  
Degradation of the protein is present. The upper band (≈160 kDa) represents 
the full size LTX
N4C
-GST construct; the lower (≈ 130 kDa) represent the full size 
LTX
N4C
 without the GST insert. Minor degradation is also detectable producing 





Figure 3.9. GSH-column affinity chromatography of LTX
N4C
. The purified protein  
presents signs of degradations. The protein is also visible in the flow through and 
in the washes. 
 
 








The functional activity of the purified LTX
N4C 
was tested using 
neuroblastoma NB2a cells expressing LPHN1. Wild type NB2a cells were used as 
a negative control. Different concentrations of GST-LTX
N4C
 were added to 
establish the best condition for binding.  Binding was analysed by SDS-PAGE 
and Western blot using an anti V5 antibody (Figure 3.10). 
The N-terminal fragment of LPHN1 stained with the anti-V5 antibody was only 
visible in transfected cells. However, the binding of the toxin was detectable also 
in the negative control, suggesting some non-specific binding. It is notable that at 
2, 5 and 20 nM GST-LTX
N4C
, the LPHN1-expressing cells bind a higher amount 
of fusion protein than the control cells. However, at 50 nM GST-LTX
N4C
, LPHN1 
N-terminus seems to be strongly affected by the bound toxin, which is no longer 
detectable. This may be caused by the detrimental effect of the very high 
concentration of LTX
N4C
 that may overstimulate latrophilin, causing cell death, 
which leads to membrane disruption with consequent loss of bound protein and/or 






 biological activity. Bound LTX
N4C 
is present to also in 
untransfected cells, suggesting that the a large proportion of binding is non-
specific. However, with the exception of 50 nM fusion protein, LTX
N4C
 binds the 
LPHN1-expressing cells better.  






Having chosen to express LTX
N4C
 in a bacterial system, I tried to overcome 
the problems associated with the incorrect protein folding by using the Rosetta-
Gami 2 E. coli strain. The optimisation procedure included the induction of fusion 
protein expression at different stages of culture growth and subsequent incubation 
at different temperatures. It has been found that a very high proportion of soluble 
GST-LTX
N4C
 is expressed when the culture is induced at 0.5 OD and then grown 
at 16°C. The induction under these specific conditions also produces better yield 
of the fusion protein compared to its leaky expression without induction. 
However, the yield of soluble protein is much lower at optical densities of 0.25 
and 0.7, which creates only a very narrow window of culture density at which the 
successful expression can be expected.  
The GST-LTX
N4C
 fusion protein can be relatively easily and inexpensively 
purified using GSH-column affinity chromatography, although this process is also 
rather inefficient, with a large proportion of fusion protein appearing in the flow-
through fractions and only a small amount being eluted from the column. The 
fusion protein has a relatively low biological activity as tested by its binding to the 
toxin receptor LPHN1.  
When expression of GST-LTX
N4C
 was repeated using the same conditions 
as described above, very little soluble protein was produced, and its purification 
was unsuccessful. This suggests that the selected conditions are not robust for 
reliable production of GST-LTX
N4C
. 
Given the large amounts of GST-LTX
N4C
 that can be produced in a 
preparative bacterial culture, the losses described above could still make bacterial 
expression worthwhile. However, the biological activity of the bacterially 
produced protein remains uncertain, and requires more research. In addition, 
further optimisation of expression and the use of cooling incubators are required.  
For these reasons, we conclude that the expression of LTX
N4C
 in a 
bacterial system is not optimal. Alternative methods for its expression could be 
using yeast or baculovirus systems. 






 used in the experiments described further on in this work was 
expressed in a baculovirus system. 
 
 






RESULTS II. Spontaneous exocytosis: control by LPHN1 




4.1  Introduction 
 
As extensively discussed in the first chapter (see Chapter 1, Sections 1.2 and 
1.3), Latrophilin-1 (LPHN1) is a presynaptic G-protein-coupled receptor whose 
function has been investigated using α-latrotoxin, a component of Black Widow 
spider venom, in its native (α-LTX) and mutant (LTX
N4C
) forms. The native α-
LTX is a tetramer that binds presynaptic receptors and inserts itself into the 
cellular membrane, forming pores permeable to divalent cations. In contrast, 
LTX
N4C 
is unable to form pores, but still binds the same receptors, and it can be 
used to study the functions of the receptors alone (Ushkaryov, Volynski and 
Ashton 2004). When bound to LPHN1, both α-LTX and LTX
N4C
 cause a dramatic 
increase in the frequency of neurotransmitter release, suggesting a role of this 
receptor in the regulation of exocytosis (Capogna et al. 2003; Lelyanova et al. 
2009).  
There are two endogenous ligands of LPHN1: Lasso/teneurin-2 (Silva et al. 
2011) and FLRT3 (Boucard et al. 2014). As argued in Discussion (Section 4.3), 
only Lasso, but not FLRT3, binds to neuronally-expressed LPHN1. However, in 
any case the role of these interactions in LPHN1 signalling is unclear, and 
therefore I used the exogenous agonist of LPHN1, LTX
N4C
.  
Here, I investigated the role of LPHN1 in spontaneous release of 
neurotransmitter at neuromuscular junction (NMJ) and in central synapses, by 
comparing the frequency of spontaneous (miniature) synaptic events in wild type 
(WT) and LPHN1 knockout (KO) mice. Furthermore, the effects that LTX
N4C
 
exerts on exocytosis in NMJ were analysed using different bathing buffers. 
  





4.2  Results 
 
4.2.1 Basal frequency of exocytosis at the mouse NMJ 
 
Given the known role of extracellular Ca
2+
 in LTX-induced exocytosis, I first 
determined the basal rate of neurotransmitter release by recording MEPPs in a 
buffer containing 2 mM Ca
2+
 or no added Ca
2+
, without any other experimental 
manipulation. Recordings were collected from several fibres of the same paw as 





-containing buffer, spontaneous release of neurotransmitter had a 
frequency of 0.36 ± 0.03Hz (approximately 1 vesicle released every 3 seconds) 





Figure 4.1. Examples of representative individual traces of MEPPs recorded at 








 form the extracellular buffer caused a decrease in the 
neurotransmitter release of about 3.5 fold, with a frequency of 0.10 ± 0.01 Hz 
(approximately 1 vesicle released every 10 seconds) (Figures 4.2 and 4.3). The 
MEPPs amplitude did not change between the two experimental conditions (0.82 
± 0.11 mV in Ca
2+
 vs. 0.87 ± 0.17 mV in Ca
2+
-free buffer).  















Figure 4.3. A. Average frequencies of MEPPs in the presence and absence of 
Ca
2+
e (2 mM). B. Average amplitude of MEPPs with and without the presence of 2 
mM Ca
2+
e. The difference between the conditions is not statistically significant (n 
= 23 individual cells with Ca
2+
 and 12 without Ca
2+
; ***, P < 0.001, Mann – 









4.2.2 Basal frequency of exocytosis at the NMJ as a function of LPHN1 
expression 
 
To investigate the involvement of LPHN1 in the spontaneous release of 







) mice. Recordings were made both in Ca
2+
-containing and in Ca
2+
-free 
buffers to determine the Ca
2+
 dependence of the process on all genetic 
backgrounds. 
Results show a progressive increase of neurotransmitter release with the 
decreasing dose of the LPHN1 gene: in Ca
2+
-containing buffer, the average 





mice I determined an increase in the frequency that went up to an average of 0.56 
± 0.14 Hz; finally, in LPHN1
-/-
 mice the frequency reached an average of 1.68 ± 
0.44 Hz (Figure 4.4 A). 
The MEPPs average amplitudes are not significantly different between the 
experimental conditions (0.82 ± 0.11 mV in WT; 0.79 ± 0.31 mV in Het; 0.85 ± 
0.24 mV in KO, Figure 4.4 B).  
Removal of Ca
2+
 from the extracellular buffer caused a decrease in the frequency 







 was still present. The average frequency of exocytosis 
was 0.10 ± 0.01 Hz in 
+/+
 mice; in 
+/-
 mice the average frequency rose to an 
average of 0.24 ± 0.13 Hz; finally, in 
-/- 
mice the average frequency of release 
went up to 0.61 ± 0.19 Hz (Figure 4.4 A). 
The MEPPs average amplitudes were not significantly different between the 
experimental conditions (0.87 ± 0.17 mV in LPHN1
+/+
; 0.86 ± 0.22 mV in 
+/-
; 0.81 
± 0.19 mV in 
-/-
, Figure 4.4 B). 
 
















Recordings were done in the presence and absence of 2 mM Ca
2+
e. The 





 and 28 
-/- 







 and 29 
-/-
 individual cells in Ca
2+
-free buffer. **, 
P < 0.01, One-way ANOVA). The difference in the average amplitudes 














 hippocampal neuronal 
cultures 
 
Hippocampi from 1-2 days old mice were dissected and plated on coverslips 
following the protocol described in Chapter 2, Section 2.2.12. The cultures were 
then grown for several days/weeks and compared in terms of cells’ viability and 
physiological parameters.  




 cultures did not significantly differ in the 
number of cells per field of view (
+/+
: 434 ± 37.56 cells/field of view, n = 7; 
-/-
: 
430 ± 35.2 cells/field of view, n = 7, see Figure 4.5 C). 





grew in very different ways, with the 
+/+ 
neurons being healthy, dense and 
connected, while the 
-/- 
cultures were very sparse and with few connections, with 
many neurons dead (Figure 4.6 A and B). 




 neurons was determined by 
recording miniature excitatory and inhibitory postsynaptic currents using the 
whole-cell voltage clamp approach (see Chapter 2, Section 2.2.13 for details). 
LPHN1
+/+
 neurons showed a significantly higher average frequency of EPSCs and 
IPSCs than LPHN1
-/-
 neurons (0.21 ± 0.05 Hz in LPHN1
+/+ 
neurons vs. 0.10 ± 
0.02 Hz in 
-/-
 neurons, see Figure 4.7 A). 
The average amplitudes were not statistically different in the two conditions 
considered (1.28 ± 0.04 nA in LPHN1
+/+
 and 1.39 ± 0.07 nA in 
-/-
 neurons, see 




























 Figure 4.5. Primary cultures of LPHN1 WT (A) and KO (B) pyramidal neurons 
on day 1 of culture. Cells were plated with an average of 10-25 x 10
3
 cells per 











      A                                                          B 
 
 
Figure 4.6. Primary cultures of WT (A) and LPHN1 KO (B) pyramidal neurons 















 pyramidal neurons primary cultures. The difference between 
the conditions is not statistically significant (n = 25 and 26 cells for WT and KO 




25 µm  25 µm  





The analysis of the ESPCs and ISPCs separately shows that upward-going 




 cultures. In 
both cases, however, the frequency was higher in LPHN1
+/+
 neurons (Figures 4.8, 
4.9 and 4.10).    
 
 
Figure 4.8. ESPCs and ISPCs analysis. In both cultures, the majority of the 
postsynaptic currents recorded were upward-going inhibitory currents (87% 





Continued on the next page 
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Figure 4.9. Individual traces of IPSCs (A, C) and EPSCs (B, D) recorded in WT 
(A, B) and KO (C, D) pyramidal neuron primary cultures. Note the presence of an 
IPSC in D. 
 
 




hippocampal primary cultures (n = 25 LPHN1
+/+
 cells and 26 
-/-
 cells. **, 









The amount of recorded spontaneous synaptic activity in dissociated neuronal 
cultures may depend on the number of synaptic connections made by adjacent 
neurons onto the recorded cell. Given that LPHN1 KO mice spontaneously 
released 4.7 times more acetylcholine at the NMJs (Section 4.2.2 above) and 3 
times more glutamate and GABA at central synapses (A. Ashton, Y. Ushkaryov; 
unpublished data) than WT animals did, the results described in this Section 
indicate that synaptic connectivity in the 14 days-old hippocampal cultures from 
KO mice was at least 6 times poorer than in such cultures from WT animals.   
 
  





4.2.4 Stimulation of spontaneous exocytosis by LTX
N4C
 at the NMJ 
 
In order to investigate the effects of the activation of LPHN1 on spontaneous 
neurotransmitter release recordings of MEPPs were performed on neuromuscular 
preparations stimulated using LTX
N4C
. 
The response to the toxin was examined in the absence and in the presence of 
extracellular Ca
2+




 is known to bind 
to LPHN1, and therefore it should be able to activate the machinery that brings 
about an increase in neurotransmitter release. However, under this condition, 
LTX
N4C
 was not able to elicit this effect, and the frequency of exocytosis showed 
only a small non-significant increase (0.19 ± 0.05 Hz).  
Upon the addition of 2 mM Ca
2+
, the effect of the toxin immediately started, and 
the frequency of neurotransmitter release increased up to 160 times compared to 
the basal frequency without extracellular Ca
2+
 (15.50 ± 7.07 Hz). 





 to exert its effects on exocytosis. However, these effects do not 
develop immediately after the toxin is added to preparations in a buffer containing 
2 mM Ca
2+
. In this case, a delay of about 17 ± 2.5 minutes (n = 5) is always 
observed, likely due to the fact that LPHN1 needs time to activate the intracellular 
pathways involved in its activity. After this time, the cells start to fire with the 
increased frequency described above (Figure 4.12). 
The average amplitude of MEPPs before and after the addition of LTX
N4C
 was not 
significantly different (0.82 ± 0.11 mV in Ca
2+





















Figure 4.11 A. The frequency of MEPPs in Ca
2+
-free buffer, after the addition of 
LTX
N4C




 was only able to induce 
and increase in the frequency of exocytosis when Ca
2+
e was present. B. Average 
frequency of MEPPs in Ca
2+





= 5 cells in Ca
2+
-free buffer, 5 cells after the addition of LTX
N4C
, and 4 cells after 
further addition of 2 mM Ca
2+



























































Figure 4.12. Frequency of MEPPs in the presence of 2 mM Ca
2+
e and after the 
addition of LTX
N4C
. The effects of LPHN1 stimulation do not develop immediately 
after the addition of LTX
N4C




























4.2.5 Bursts analysis 
 





-containing buffer was that it was not uniform. The terminals went 
through bursts of increased exocytosis, in which the frequency could reach close 
to 100 Hz, and periods of moderate activity, where the rate of release was 
significantly lower than that observed in the bursts, but about 2.5 times higher 
than the basal frequency (Figure 4.13). The averaged frequency of 
neurotransmitter release was 47.37 ± 4.09 Hz during bursts and 0.75 ± 0.10 Hz 
during the interburst intervals (Figure 4.14 A). 
The MEPPs amplitude during bursts and interburst intervals was not significantly 
different (0.69 ± 0.01 Hz during bursts and 0.65 ± 0.02 Hz during interburst 
intervals, Figure 4.14 B). 
When compared to the frequencies that appear in 2 mM Ca
2+
 only (ranging from 0 
to 1 Hz), when LTX
N4C
 is added we have three groups of frequencies: a group, 
similar to the one observed in Ca
2+
-containing buffer, representing interburst 
intervals; and a group, whose frequency ranges from 10 to 100 Hz (representing 
the bursts); and a third group, whose frequencies range from 1 to 3 Hz, that I 
termed undefined bursting activity to indicate that in such instances it was not 





















   
 
 
Figure 4.13. Individual traces of MEPPs recorded at the mouse NMJ after the 
addition of 0.25 nM LTX
N4C
. The frequency of spontaneous neurotransmitter 
release dramatically increased compared to the frequency in Ca
2+
 only. 




 is the appearance of bursts of 
release (underlined in red) that can reach frequencies of 100 Hz, interspersed 
with periods of moderate activity where the frequency goes back closer to control. 
B. A magnified section of a MEPPs recording in a burst. C. A magnified section of 
















Figure 4.14. Average frequency of MEPPs during bursts and interburst intervals. 
B. Average amplitude of MEPPs in bursts and interburst intervals. The difference 
between the conditions is not statistically significant (n = 14 bursts, 13 interburst 




Figure 4.15. Distribution of frequencies in Ca
2+





, the majority of events are concentrated between 0 and 1 Hz. 
After the addition of LTX
N4C
, instead, due to the bursting behaviour I have three 
groups of frequencies: one corresponding to the interburst periods (0 – 0.75 Hz), 
one to corresponding to the bursts (10 – 100 Hz), and one corresponding to 






























Figure 4.16. Representation of the frequency (A) and duration (B) of the bursts 









4.2.6 Influx of extracellular Ca
2+ 
is crucial for the effects of LPHN1  
 
I showed in my previous experiments that extracellular Ca
2+
 is needed to cause the 
increase in exocytosis due to the activation of LPHN1 after addition of LTX
N4C
. 
However, from these experiments it was not possible to determine if the 
extracellular Ca
2+
 was simply needed outside the cell, for example to enhance the 
binding of the toxin to the receptor, or if Ca
2+
 needed to enter into the nerve 
terminals in order to cause these effects.  
To address this issue, I performed experiments using BAPTA-AM, a Ca
2+
 chelator 
able to penetrate inside cells and bind two Ca
2+
 ions. 
When 500 µM BAPTA-AM was incubated with the muscle preparations, the 
frequency of exocytosis underwent a small decrease (from 0.10 ± 0.01 Hz to 0.07 
± 0.04 Hz). 
Under this conditions, 0.25 nM LTX
N4C
 was not able to elicit a significant 
increase in exocytosis even after the addition of Ca
2+
 (0.12 ± 0.04 Hz and 0.22 ± 
0.04 Hz before and after the addition of Ca
2+
, respectively,), suggesting that the 
influx of Ca
2+
 and consequent elevation in cytosolic Ca
2+
 concentration is needed 
to see the effects of LPHN1 activation (Figures 4.17 and 4.18).  
  














Figure 4.17. A. Representation of the protocol used in the experiments using 





buffer treated with BAPTA-AM and after Ca
2+
 was added to the buffer (C). The 
addition of LTX
N4C











Figure 4.18. Average frequency of MEPPs induced by LTX
N4C
 in terminals filled 
with BAPTA-AM. Ca
2+
 influx is needed to elicit the increase in exocytosis typical 
of the activation of LPHN1, as chelation of intracellular Ca
2+
 fully inhibits 
exocytosis even when the cation is added to the extracellular buffer. A control 
treated with LTX
N4C
 but not with BAPTA-AM is shown (n = 5 cells in Ca
2+
-free 
buffer, 8 cells in Ca
2+
-free buffer after the addition of BAPTA-AM, 4 cells after 
subsequent addition of LTX
N4C
 and 12 cells after addition of 2 mM Ca
2+
. 7 cells 
have been used for the control with LTX
N4C
; ***, P < 0.001, Mann – Whitney U 
test). 
  





4.2.7 Stimulation of spontaneous exocytosis using GST-Lasso 
 
Lasso is the main endogenous ligand known for LPHN1. To investigate the 
effects that this protein could have in exocytosis, current clamp experiments were 
carried out following the same procedure used with LTX
N4C
. 
Recombinant fragment of Lasso fused to glutathione-S-transferase (GST), GST-
Lasso, was purified from Escherichia coli by affinity chromatography using a 
glutathione column (for details see Chapter 2, Section 2.2.3), and dialysed in a 
buffer containing 2 mM Ca
2+
.  
Upon addition of 100 nM GST-Lasso, the frequency of exocytosis was increased 
by about 3 times only in one of the experiments, whilst in the other cases the 
frequency decreased about 2 times; overall, it was not possible to observe a 
significant change in the rate of neurotransmitter release (0.45 ± 0.3 Hz, Figure 
4.20 A). 
The average amplitudes are not statistically different in the two conditions 
considered (0.79 ± 0.02 in buffer A vs. 0.89 ± 0.07 mV after the addition of GST-




Figure 4.19. Individual traces of MEPPs in Ca
2+
-containing buffer after the 
addition of GST-Lasso. This stimulation was not able to significantly change the 
rate of spontaneous exocytosis. 






Figure 4.20. A. Average frequency of MEPPs in Ca
2+
-containing buffer before 
and after the addition of 100 nM GST-Lasso. The difference is not statistically 
significant. B. Average amplitude of MEPPs before and after the addition of GST-
Lasso in Ca
2+
-containing buffer. The difference is not statistically significant (n = 
19 cells in Ca
2+









4.2.8 The effects of LTX
N4C










-containing buffer causes a 160-fold increase in 
exocytosis, characterised by bursting behaviour. Previous data suggest that this 
effect is not due to pore formation and must be mediated by a receptor (Volynski 
et al. 2003). However, LPHN1 is not the only receptor that binds LTX
N4C
; 
neurexin Iα (NRX-Iα) and PTP-σ also bind to LTX
N4C
, although NRX requires 
Ca
2+
 for the binding (see Chapter 1, Section 1.2.3).  
A way to ascertain that the effects on exocytosis observed upon addition of 
LTX
N4C
 can be ascribed to the activation of LPHN1 only is to replace the Ca
2+
 in 




. In fact, in the presence of these divalent 
cations LTX
N4C
 binds well to LPHN1, but the binding to NRX-Iα is not possible 
(Davletov et al. 1998).  
The neuromuscular preparations were incubated in buffers containing 2 mM Ba
2+
 
or 2 mM Sr
2+
 and MEPPs were recorded in order to measure the basal frequency 
of exocytosis in the presence of these cations. Compared to the basal frequency of 
exocytosis in Ca
2+
 buffer (0.36 ± 0.03 Hz), the average frequency in these 
conditions was not significantly different (0.34 ± 0.29 Hz and 0.58 ± 0.20 Hz 
respectively). 
Upon the addition of 0.25 nM LTX
N4C
, the frequency of exocytosis increased 
significantly, and cells showed the bursting behaviour typical of the activation of 
LPHN1; bursts reached an average frequency of 41.05 ± 3.02 Hz in Ba
2+
-
containing buffer and 37.45 ± 17.94 Hz in Sr
2+
-containing buffer (Figures 4.21 
and 4.22 respectively). Interburst intervals had a frequency of 0.88 ± 0.19 Hz in 
Ba
2+
-containing buffer and 0.84 ± 0.16 Hz in Sr
2+
-containing buffer (Figures 4.21 











, both in unstimulated NMJs (0.82 ± 0.11 mV in 
Ca
2+
, 0.90 ± 0.06 mV in Ba
2+
 and 1.01 ± 0.04 mV in Sr
2+
) and in NMJs treated 
with LTX
N4C
 (0.69 ± 0.01 mV in Ca
2+
, 0.93 ± 0.02 mV in Ba
2+
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Figure 4.21. Individual traces of MEPPs in Ba
2+
 buffer after the addition of 
LTX
N4C
. A burst (A) and an interburst interval (B) are shown. C. Average 




 buffer without Ca
2+
, and after the 
addition of LTX
N4C
 (N = 2, n = 11 cells recorded in Ca
2+
 buffer, 16 cells in Ba
2+
 
buffer, and 70 cells after the addition of LTX
N4C
; ***, P < 0.001, Mann – Whitney 
U test).  
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Figure 4.22. Individual traces of MEPPs in Sr
2+
 buffer after the addition of 
LTX
N4C
. A burst (A) and an interburst interval (B) are shown. C. Average 




 buffer without Ca
2+
, and after the 
addition of LTX
N4C
 (N = 2, n = 8 cells recorded in Ca
2+ 
buffer, 5 cells in 2 mM 
Sr
2+
, and 45 cells after the addition of LTX
N4C









These results indicate that LTX
N4C
 does not require neurexins to stimulate 
exocytosis and suggest that LPHN1 plays a crucial role in toxin’s effect. 
However, in the absence of Ca
2+
 the toxin can still interact with PTPσ 
(Krasnoperov et al. 2002), and although the toxin triggers a signalling cascade 
inconsistent with the stimulation of PTPσ (activation of Gαq, PLC and release of 
intracellular Ca
2+
), some involvement of PTPσ in the massive exocytosis observed 
here could not be excluded.  
 
  











To exclude the possibility that the effects on exocytosis described here are caused 
by the binding of LTX
N4C
 to either NRX or PTPσ, LPHN1
-/-
 mice were used. 
LTX
N4C
 (0.1 nM) was added to the NMJ preparations in Ca
2+
-containing buffer, 
and the frequency of MEPPs was recorded. As a confirmation of the results 
described earlier in this chapter (Section 4.2.2) the basal frequency of exocytosis 
in LPHN1
-/-
 was significantly higher than in LPHN1
+/+
 preparations (1.7 ± 0.3 




 preparations did not significantly change 
the frequency of exocytosis (1.8 ± 0.5 Hz). The same concentration of LTX
N4C
 
was instead sufficient to cause an increase of exocytosis in 
+/+
 preparations, which 
went from a basal frequency of 0.37 ± 0.2 Hz to a frequency of 4.9 ± 0.8 Hz after 
the addition of LTX
N4C
 (Figures 4.23 and 4.24 A).  
As expected, no bursts were found in the absence of LTX
N4C




preparations; upon addition of 0.1 nM LTX
N4C
, the bursts increased to 14/h 
in LPHN1
+/+
 and 0.7/h in 
-/-
 cells (Figure 4.24 B).  





 and strongly suggest that the effects of LTX
N4C
 on exocytosis are 
mediated by the activation of LPHN1 rather than the other two toxin receptors 
(NRX and PTPσ). 
 
!





 (A) and 
-/-
 (B) NMJ preparations. 
 

















buffer (n = 19 LPHN1
+/+
 and 3 
-/-









 buffer (n = 3 
LPHN1
+/+
 and 3 
-/-
; **, P < 0.01, Mann – Whitney U test). 
 
  










LPHN1 is composed of two functional parts, the extracellular N-terminal 
fragment (NTF) and the intramembrane C-terminal fragment (CTF), that need to 
interact in order to induce intracellular cascade that produce the effects on 
exocytosis described throughout this chapter.  
Perfluorooctanoic acid (PFOA) is a weak detergent that can be used to solubilise 
multi-subunit protein without dissociating them into individual subunits. PFOA 
was used to study the interaction of the NTF and CTF of LPHN1 in rat brain 
synaptosomes by comparing its ability to solubilise the fragments with that of 
Thesit (Lubrol). While Thesit solubilised both fragments in parallel, by obviously 
disrupting the membrane (see Figure 4.25 A), PFOA solubilised the NTF and CTF 
differentially. In fact, at RT exposure of synaptosomes to increasing 
concentrations of PFOA caused the complete solubilisation of the NTF at 0.5% 
(12 mM) PFOA, together with a small amount of the CTF, and of both the NTF 
and CTF at much higher concentrations (>1%, 24 mM) (see Figure 4.25 B). The 
differential solubilisation was even more prominent at 4° C: in this case, while the 
NTF was removed from the membrane at PFOA concentration of 0.5%, the CTF 
did not get solubilised at any of the PFOA concentrations tested (see Figure 4.25 
C) (Rahman, Ushkaryov, data not published). 
An important conclusion could be made on the basis of these findings: although 
PFOA is a weak detergent and does not readily solubilise the cell membrane, it 
still breaks up the association between the NTF and CTF. The interaction of the 
two LPHN1 fragment is vital for the receptor to transduce its signal inside the 
cell, where the G protein initiates the intracellular cascade that in turn leads to the 
increase in exocytosis described. It is therefore possible that, if PFOA were able 
to dissociate NTF and CTF without disrupting the membrane and solubilising the 
NTF, the activation of LPHN1 by LTX
N4C
 would not have the usual outcomes on 
exocytosis. In fact, PFOA at concentrations below 300 µM is not toxic to cultured 
cells (Choi et al. 2013) and thus should not damage the plasma membrane, but 
could inhibit the NTF-CTF interaction.  








Figure 4.25. Solubilisation of LPHN1 NTF and CTF from rat brain synaptosomes 
by different concentrations of Thesit and PFOA. A. Thesit removes both fragments 
from the membrane equally (4 °C); both NTF and CTF start to go in solution at 
0.05% and are completely solubilised at 0.5% Thesit. PFOA differentially 
solubilises NTF and CTF at RT (B) and at 4 °C (C). At both temperatures the NTF 
goes in solution at 0.5% PFOA; the CTF is solubilised at 1% PFOA at RT, but 
never at 0° C.  
 
 
To test this hypothesis, the preparations were incubated with different 
concentrations of PFOA (0.2 – 100 µM) and LPHN1 was stimulated with LTX
N4C
 
in order to investigate the possible changes in its activity. 
A non-significant rise in the frequency of neurotransmitter release was observed 
after the addition of PFOA at all concentrations tested (0.69 ± 0.38 Hz). This rise 
in frequency, similar to the one observed in LPHN1
+/- 
















suggest that LPHN1 was already deregulated to some extent by PFOA, and that 
this deregulation is causing an increase in neurotransmitter release. The lack of 
statistical significance might be due to type II statistical error, which could be 
overcome by increasing the number of recordings in these conditions.   
After the addition of PFOA, the LTX
N4C
-induced rate of exocytosis was affected 
in a PFOA concentration-dependent manner. At increasing concentrations of 
PFOA the number of cells responding with bursting behaviour to LPHN1 
stimulation by LTX
N4C
 decreased significantly, and the time for the toxin to 
develop its effects greatly increased. AT 100 µM PFOA the toxin was unable to 
cause any effect. (see Table 4.1 and Figure 4.26). 
 
Table 4.1. Percentage of cells bursting, time to burst (min) and overall frequency 


















0 89 17 15.50 2 38 
0.2 82 23 13.72 2 28 
1 40 24.5 7.66 2 25 
10 21.5 21 1.87 2 27 
50 12.5 59.5 1.56 2 32 
100 0 ∞ 0.84 3 44 
 
 
In all conditions where the cells responded to LTX
N4C
 bursting behaviour was 
present, and the average frequency of exocytosis inside the burst did not 
significantly differ from the control condition (Ca
2+
 buffer without the presence of 
PFOA), suggesting that although the activity of LPHN1 was impaired by the 
presence of PFOA, when the signalling was able to start to produce its effects the 
mechanism was fully functional and only its triggering was affected.  







Figure 4.26. The percentage of cells bursting after the addition of LTX
N4C
 (A) and 
the time elapsed from the addition of the toxin and the observed effect (B) were 
plotted against the concentration of PFOA. 
 
Exocytosis during bursts of activity showed a small, non-significant decrease with 
increasing PFOA concentration (Figure 4.27 A). However, because the number of 
cells responding to the stimulation of LPHN1 constantly fell with the increase in 
PFOA concentration, the overall frequency of neurotransmitter release 

























































Figure 4.27. A. Average frequency of MEPPs during bursts at different 
concentrations of PFOA. The difference between the conditions is not statistically 
significant (n = 33 bursts in Ca
2+
 buffer, 22 in 0.2 µM PFOA, 11 in 1 µM PFOA, 
6 in 10 µM PFOA and 4 in 50 µM PFOA). B. Overall average frequency of 
exocytosis after the addition of LTX
N4C 
at different concentrations of PFOA (n = 
38 cells in Ca
2+
 buffer, 28 in 0.2 µM PFOA, 25 in 1 µM PFOA, 27 in 10 µM 
































In a reverse experiment, 100 µM PFOA added after the increase of exocytosis 
caused by the activation of LPHN1 had already started was able to stop this effect 
almost completely. In fact, the overall frequency of exocytosis dropped from 
15.50 ± 7.07 Hz observed after the addition of LTX
N4C
 in control conditions to 
1.12 ± 0.52 Hz in the presence of 100 µM PFOA. The inhibition in the effects of 
LPHN1 activations happened in approximately 2 minutes. Of the 16 cells 
recorded, only 3 were still reacting to the toxin, one of them showing bursting 
behaviour (22 Hz during the burst) and the other two having an overall increased 
frequency of 2 and 6 Hz (Figure 4.28).  
The presence of PFOA in the extracellular buffer did not cause any significant 
changes in the average MEPPs amplitude compared to the control in Ca
2+
 buffer 
(0.82 ± 0.11 mV in Ca
2+
, 0.98 ± 0.05 mV in the presence of PFOA), nor did the 
subsequent addition of LTX
N4C
 (0.75 ± 0.03 mV in 0.2 µM PFOA, 0.76 ± 0.06 
mV in 1 µM PFOA, 1.05 ± 0.04 mV in 10 µM PFOA, 1.06 ± 0.01 mV in 50 µM 




Figure 4.28. Average frequency of MEPPs in Ca
2+
 buffer and after the addition of 
LTX
N4C
 and 100 µM PFOA. PFOA significantly inhibits the effects on exocytosis 
caused by the activation of LPHN1 (n = 19 cells recorded after the addition of 
LTX
N4C





































Figure 4.29. Single traces of MEPPs during bursts after the addition of LTX
N4C
 in 
0.2 (A), 1 (B), 10 (C), and 50 (D) µM PFOA. The frequency of MEPPs inside the 
burst does not change between these conditions. No bursts develop in 100 µM 












To exclude the possibility that PFOA prevented the binding of the toxin to the 
receptor and therefore reduced or fully blocked LPHN1 activation by LTX
N4C
, a 
binding experiment was performed under the same conditions used in the 
experiments described earlier. LPHN1-expressing neuroblastoma (Nb2a) cells 
were incubated with 5 nM αLTX in the presence of several PFOA concentrations 
(0.2, 50 and 100 µM). Nb2a cells not expressing LPHN1 were used as a control. 
Following incubation with the toxin, the amount of bound and unbound LTX
N4C
 
was determined by Western blotting (see Chapter 2, Section 2.2.4 for details). 
As shown in Figure 4.30, the concentrations of PFOA I used in the experiments 
on NMJ did not prevent the binding of LTX to LPHN1. This interaction was 
specific, as demonstrated by in a control experiment with WT neuroblastoma cells 




Figure 4.30. Western blot analysis of unbound (U) and bound (B) samples of 
αLTX to LPHN1 expressing cells. In LPHN1 expressing cells, αLTX band is 
visible only in the pellets containing the cells. By contrast, in WT cells most αLTX 
is present in the supernatant. As the purpose of this experiment was not to 
compare the amount of binding of the toxin to LPHN1 in the presence of different 










Interestingly, PFOA also affected depolarisation-induced exocytosis. One way to 
study spontaneous, asynchronous exocytosis is to increase the extracellular KCl 
concentration to depolarise cells. In our control experiments the NMJ preparations 
were initially incubated in Ca
2+
-free buffer; subsequently 20 mM KCl and 2 mM 
Ca
2+
 were added to the buffer (as shown at the top of panel A in Fig. 4.31), and 
MEPPs were recorded in order to evaluate the changes in the frequency of 
exocytosis. No significant changes in exocytosis were detectable when KCl was 
added in the absence of Ca
2+
 (0.10 ± 0.01 Hz in Ca
2+
-free buffer vs. 0.11 ± 0.05 
Hz after the addition of 20 mM KCl); addition of Ca
2+
 caused a gradual but fast 
increase of neurotransmitter release (time from the addition to start, 22 ± 8 
seconds) that reached an average of 16.13 ± 5.34 Hz, and then slowly decreased 
and fully seized in approximately 40 minutes (Figure 4.31). In both conditions 
(with/without extracellular Ca
2+
) the resting membrane potential of the muscle 
fibres became more positive upon addition of KCl. 
To investigate whether PFOA affects only LPHN1-mediated exocytosis or 
depolarisation-induced exocytosis as well, KCl was used to depolarise the 
membrane in the presence of different concentrations of PFOA. The 
concentrations used were 10 µM PFOA (the concentration at which LPHN1-
mediated exocytosis showed strong impairment) and 100 µM PFOA (the 
concentration at which LPHN1-mediated exocytosis was completely blocked). 
The presence of 10 µM PFOA to the buffer did not bring about any significant 
changes either in the frequency of exocytosis (11.63 ± 1.23 Hz, Figure 4.32, A) or 
to the time necessary to elicit the increase of exocytosis (67.5 ± 53 seconds, 
Figure 4.32, B). 
With 100 µM PFOA, instead, the addition of 20 mM KCl was not able to cause 
any increase in the frequency of exocytosis (0.33 ± 0.28 Hz). To have an effect, it 
was necessary to increase the concentration of KCl to 40 mM (Figure 4.32 A), and 
also in this case the effect developed about 7 minutes after the addition of KCl 
(420 ± 60 seconds, Figure 4.32, B). At that point, no significant differences were 
observed in the frequency of exocytosis (17.56 ± 3.08 Hz). 








Figure 4.31. Changes in the frequency of MEPPs after the sequential addition of 
20 mM KCl and 2 mM Ca
2+
. Recordings were made on multiple individual fibres 
as indicated by the breaks in the otherwise continuous data. Addition of KCl 
slightly depolarised the muscle fibres, causing an increased resting membrane 
potential. B. Average frequency of MEPPs in Ca
2+
-free buffer, and after the 
sequential addition of 20 mM KCl and 2 mM Ca
2+ 
(n = 10 cells recorded in Ca
2+
-
free buffer, 21 cells after addition of KCl, and 38 cells after subsequent addition 
of Ca
2+
; ***, P < 0.001, Mann – Whitney U test). 
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Figure 4.32. A. Average frequency of MEPPs after the addition of 20 mM KCl in 
the presence of different concentrations of PFOA. To elicit a response in the 
presence of 100 µM PFOA it was necessary to double the amount of KCl used (n 
= 55 cells recorded in the presence of 20 mM KCl in Ca
2+
 buffer, 33 in 10 µM 
PFOA, 11 cells in 100 µM PFOA; 9 cells were recorded in the presence of 40 mM 
KCl in 100 µM PFOA; ***, P < 0.001, One-way ANOVA). The resting membrane 
potential was slightly increased after the addition of KCl. B. Time from the 
addition of KCl to the start of increased exocytosis. With 100 µM PFOA and 40 
mM KCl, the difference is statistically significant (n = 2 experiments using 20 mM 
KCl in 10 µM PFOA and 2 experiments using 40 mM KCl in 100 µM PFOA; **, 
P < 0.01, Mann – Whitney U test). 
!
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4.2.11 TTX-sensitive voltage-gated sodium channels and membrane 
depolarisation are not required for LPHN1-mediated increase in 
exocytosis 
 
Due to some similarities in the behaviour of LTX
N4C
 and KCl-induced exocytosis 
and based on earlier reports that LTX
N4C
 can inhibit voltage-gated potassium 
channels (Lang et al. 1998; Lajus et al. 2006), there remained a possibility that 
LTX
N4C
 acted by depolarising the membrane. To investigate whether voltage-
gated Na
+
 channels and cell depolarisation are involved in the activity of LPHN1, 
I used tetrodotoxin (TTX). Produced by endosymbiotic bacteria and found 
principally in fish belonging to the Tetraodontiformis family, this potent 
neurotoxin is able to block voltage-gated Na
+ 
channels, by binding to and closing 
their pore domain, and thus inhibit the formation of action potentials. 
NMJ preparations were bathed in Ca
2+
-containing buffer (2 mM) and 1 µM TTX 
was added; no significant changes in the frequency of exocytosis were detectable 
between this two conditions (0.36 ± 0.03 Hz in Ca
2+
 buffer vs. 0.57 ± 0.17 Hz 
after the addition of TTX). Subsequent addition of 0.25 nM LTX
N4C
 was able to 
elicit an increase in exocytosis, in all features comparable with the increase 
obtained in control conditions, showing bursting behaviour. The overall frequency 
of exocytosis was 18.78 ± 4.52 Hz, and the frequency during the burst was of 
33.48 ± 4.42 Hz (Figures 4.33 and 4.34 A). 
The presence of TTX in the buffer did not significantly change the average 
amplitude of MEPPs (0.81 ± 0.07 mV), neither did the addition of LTX
N4C
 (1.04 ± 












Figure 4.33. Single trace of a MEPPs recording showing a burst in the presence 




Figure 4.34. A. Average frequency of MEPPs in Ca
2+
-containing buffer and after 
the addition of TTX and LTX
N4C
. 1 µM TTX does not inhibit the increase in 
exocytosis caused by the activation of LPHN1 by LTX
N4C
. B. Average amplitude of 
MEPPs in Ca
2+
 buffer and after the addition of TTX and LTX
N4C
. The difference 
between the conditions is not statistically significant (n = 6 cells in Ca
2+
 buffer, 5 
cells after addition of TTX and 12 cells after addition of LTX
N4C
; ***, P < 0.001, 











The purpose of the experiments described in this chapter was to analyse 
spontaneous neurotransmitter release and the role that LPHN1 plays in this 
process. To do so, the basal frequency of exocytosis was studied in LPHN1 WT, 
Het and KO mice, using as a model system either the neuromuscular junction 
(NMJ) and primary cultures of pyramidal neurons. 
The NMJ is a well establish model system to study the physiological 
mechanisms of synaptic transmission. Its structure has been extensively studied 
since the early 20
th
 century, using gold or silver staining techniques and visualised 
with light microscopes. Later on in the 1950s, electron microscopy studies 
showed the high density of synaptic vesicles in the presynaptic terminals and the 
folding of the postsynaptic membranes at motor endplates associated with the 
postsynaptic densities  (De Robertis 1958; Heuser 1989; Ribchester 2009) . 
Studies at the frog NMJ demonstrated that muscular contraction happens in 
response to electrical stimulation of the innervating neuron and that acetylcholine 
(ACh) is the neurotransmitter used in these synapses. Moreover, NMJ studies 
gave strong support to one of the central neurobiological dogmas, that is that 
neurotransmitters are released from presynaptic vesicles by Ca
2+
-dependent 
exocytosis, followed by endocytosis and refilling of the vesicles with ACh  (del 
Castillo and Katz 1956; Ceccarelli and Hurlbut 1980a; Ceccarelli and Hurlbut 
1980b; Heuser 1989; Ribchester 2009) . 
To study neurotransmitter release at the NMJ I used sharp electrodes and 
the current clamp approach. This is an intracellular recording technique used to 
record spontaneous MEPPs. This approach, developed in the 1950s by Bernard 
Katz on the frog NMJ (Fatt and Katz 1952), consists in applying an electrical 
current to a cell using a microelectrode, and recording the fluctuations in the 
membrane voltage of that cell through an amplifier. In this method (such as in the 
voltage clamp method, used in the experiment in central synapses and discussed 
later), the changes in the postsynaptic membrane potential are recorded to 
evaluate the presynaptic release of vesicles filled with neurotransmitter.  





 As well as in the peripheral nervous system (PNS), I examined 
neurotransmitter release also in the central nervous system using as a model the 
pyramidal neurons of the hippocampus. 
In central neurons, excitatory responses are mediated by glutamate acting on 
AMPA and NMDA receptors (Hestrin et al. 1990), while inhibitory responses are 
mediated by GABA acting on GABAA and GABAB receptors (Isaacson, Solis and 
Nicoll 1993).  
  To study neurotransmitter release at central synapses I used the whole-cell 
voltage clamp approach. In this technique, the membrane potential is held to a 
desired voltage, and by doing so it is possible to measure the flow of current 
through the membrane of cells and thus directly detect the opening of ion 
channels (Cole 1949). 
 At the mouse NMJ, the basal rate of spontaneous exocytosis in Ca
2+
-
containing buffer is of about 1 vesicle every 3 seconds. Removal of Ca
2+
 from the 
extracellular buffer causes a significant decrease in the rate of neurotransmitter 
release, that drops to 1 vesicle released approximately every 10 seconds.  
This result supports the observation that spontaneous asynchronous release is 




]e) (Glitsch 2008; 
Ermolyuk et al. 2013), whilst it seem to contradict other findings according to 
which [Ca
2+
]e would only weakly influence this kind of exocytosis, especially at 
the NMJ (Smith et al. 2012; Ramirez and Kavalali 2011). 
Things change when the basal frequency of release is analysed in LPHN1 Het and 
KO mice. At the NMJ, the frequency of exocytosis consistently increases going 
from LPHN1 WT, Het and KO: as I already mentioned, in LPHN1 WT mice 1 
vesicle is released every 3 seconds when Ca
2+
 is present in the extracellular 
buffer; in Het mice the rate goes up with 1 vesicle released every 2 seconds and in 
KO mice there is a further increase to 2 vesicles every 1.2 seconds. 
When Ca
2+ 
is removed from the extracellular buffer, I find the same tendency of 
increased exocytosis between the three genetic backgrounds. In LPHN1 WT mice, 
the rate of spontaneous release is of 1 vesicle released every 10 seconds; in Het 
mice the rate goes up to 1 vesicle released every 4 seconds, and in KO mice it 
goes further up to 1 vesicle released every 1.6 seconds.  





These results strongly support the hypothesis that LPHN1 has a role in the 
control and regulation of spontaneous exocytosis. The involvement of LPHN1 in 
this process was already previously demonstrated by the fact that its activation by 
α-LTX or LTX
N4C
 leads to a dramatic increase in the frequency of 
neurotransmitter release both at the mouse NMJ and in central synapses (Davletov 
et al. 1998; Capogna et al. 2003; Lelyanova et al. 2009). However, our 
experiments conducted using LPHN1 KO models show that LPHN1 controls 
exocytosis not only upon its activation, but also in resting conditions, when 
LPHN1 seems to have a role in restricting Ca
2+
 influx and thus reducing the rate 
of spontaneous neurotransmitter release. 
 Other suggestions about the physiological role of LPHN1 come from the 
experiments conducted on cultured pyramidal neurons. Initially designed to 
investigate spontaneous exocytosis in the same way as in the NMJ, results in 
central synapses showed an inverse trend, with the frequency of release observed 
in LPHN1 KO neurons being lower than that in WT neurons. However, LPHN1 
WT cultures had a significantly higher cell density and, consequently, a larger 
number of synaptic connections than LPHN1 KO cultures. This played an 
important role in the recorded synaptic activity and, therefore, further experiments 
using equal-density cultures (or pairs of cultured neurons forming monosynaptic 
connections) should be conducted. Nonetheless, these results suggest that LPHN1 
may be important for neuronal survival and connectivity (a view supported by 
Boucard et al. 2014).  
Another thing to notice is that the majority of PSCs recorded in both WT and KO 
neurons were inhibitory in nature. This suggests that the connections present in 
the cultures were mostly due to interneurons connected to the pyramidal cells, 
rather than being the pyramidal cells communicating between them. This suggests 
a bigger role of LPHN1 in the survival of pyramidal neurons compared to 
interneurons.  
 Experiments were conducted on mouse NMJ in order to investigate the 
effects that the stimulation of LPHN1 using LTX
N4C
 has on the release of 
neurotransmitter. The results collected confirm previous studies that showed how 
the activation of LPHN1 led to an increase in exocytosis (Capogna et al. 2003; 





Lelyanova et al. 2009). However, due to the difficulties in maintaining a good seal 




 was never completely 
removed in that work (Capogna et al., 2003). In the present work, LTX
N4C
 was 
added to the preparations in the presence or in the total absence of extracellular 
Ca
2+
. Being still able to bind LPHN1 in the absence of extracellular Ca
2+
  
(Davletov et al. 1996b) , LTX
N4C
 should be able to activate the receptor and start 
the intracellular signalling also in this condition. However, when Ca
2+
 is not 
present in the extracellular buffer, no increase in exocytosis is observed. The 
effect starts as soon as Ca
2+
 is added to the buffer (within 1 minute), leading to an 





 is added directly in Ca
2+
-containing buffer, 
however, its effects do not develop immediately, but always after a delay of about 
17 minutes. This suggests that LPHN1 needs time to activate the molecular 
pathways that lead to the increased exocytosis. 
 An interesting characteristic of the LTX
N4C
-evoked neurotransmitter 
release is that it goes through waves of increased activity (bursts of exocytosis) 
interspersed with periods of moderate activity, where the frequency is only 
slightly higher than that observed in resting conditions. Depending on LTX
N4C
 
concentration, the frequency of MEPPs in these bursts can reach 100 to 200 Hz, 
while the bursts are quite irregular both in pattern and in length, ranging from a 
few seconds to a couple of minutes. The interburst intervals have an average 
MEPPs frequency closer to control conditions and their length can also vary from 
10 seconds to several minutes. This behaviour suggests that LPHN1 causes waves 
of increased intracellular Ca
2+
 concentration, which in turn lead to waves of 
increased exocytosis. Whether the Ca
2+
 responsible for this elevation comes from 
intracellular Ca
2+
 stores or from the opening of some Ca
2+
 channels on the plasma 




 seems to be crucial for the effects of LPHN1 activation 
by LTX
N4C
 to start manifesting. At least two possibilities could explain this 
dependency: either (1) Ca
2+
 is needed outside the cells, for example, to enhance 
the binding of LTX
N4C
 to LPHN1 and/or LPHN1 activation, or (2) Ca
2+
 needs to 





enter the nerve terminals and thus increase neurotransmitter release. The Ca
2+
-
independency of the binding of LTX
N4C
 to LPHN1 has been demonstrated 
previously  (Davletov et al. 1996a) . Furthermore, our experiments using 
intracellular Ca
2+
 chelator BAPTA-AM strongly suggest that the mutant LTX
N4C
 





 is chelated within the cytosol. This suggests that 
specifically cytosolic Ca
2+
 is required for LTX
N4C
-stimulated LPHN1 to trigger 
exocytosis.  
So far, two endogenous ligands for LPHN1 have been described (Silva et 
al. 2011; O’Sullivan et al. 2012). The first was isolated by affinity 
chromatography of solubilised rat brain on the N-terminal domain of LPHN1 and 
termed Lasso. It is a postsynaptic protein belonging to the Teneurin family, but its 
function and the role of its interaction with LPHN1 are still unclear (Silva et al. 
2011). The second, FLRT3, a protein with roles in axon guidance and cell 
migration for Uncoordinated-5-expressing neurons during the development of the 
CNS, was identified by low-stringency immunoprecipitation with the N-terminus 
of LPHN3, whose structure is only partially homologous to that of LPHN1 
(O’Sullivan et al. 2012).  
The interaction of both Lasso (teneurin-2) and FLRT3 with LPHN1 in 
low-stringency conditions were subsequently confirmed by cell-expression 
experiments (Boucard et al. 2014). However, the FLRT3 did not bind LPHN1 in 
affinity chromatography (Silva et al. 2011). This can be explained by the use of 
LPHN1 constructs expressing in different cell lines: Silva et al. (2011) used 
neuroblastoma NB2a cells, while all other authors used HEK293 cells.  
Our laboratory has studied the ability of different cell lines to produce 
native LPHN1 and determined that the protein expressed in neurons or neuron-
like cells, such as NB2a differs in its secondary structure from LPHN1 expressed 
in non-neuronal cells, such as HEK293 and CHO. Moreover, only the 
neuronal/NB2a-expressed LPHN1 retains the ability to bind αLTX and mediate its 
effect (Y. Ushkaryov, personal communication). This promiscuity of LPHN1 
interactions, dependent on the site of LPHN1 synthesis, may be a rather 
significant observation from the point of view of the role that LPHN1 plays in the 





brain as opposed to other tissues, where it is expressed in small amounts 
(Ichtchenko et al. 1999; Matsushita, Lelianova and Ushkaryov 1999). However, 
importantly for our findings, all LPHN1 used this project was produced in NB2a 
cells or in native neurons and therefore was most likely linked to Lasso. 
Experiments were therefore conducted using a recombinant fragment of 
Lasso which had been shown to induce presynaptic Ca
2+
 signals in central 
synapses (Silva et al. 2011). In the instance of mouse NMJs, however, no 
significant changes in the frequency of exocytosis were observed (Figure 4.20). 
This observation may indicate that LPHN1-Lasso interaction does not directly 
regulate exocytosis, or at least not under the conditions tested in this work. Lasso 
is a member of the teneurin family, a class of proteins involved in neuronal 
development, axon guidance and synaptogenesis (Tucker et al. 2007; Young and 
Leamey 2009). This could suggest that LPHN1-Lasso interaction is involved in 
the synapses formation and survival. Such a conclusion is consistent with the 
LPHN1 KO cultures demonstrating poor synaptic connectivity and neuronal 
survival rate compared to WT ones. 
My experiments also, for the first time, have addressed the possibility that 
LTX
N4C
 effects could be mediated not only by LPHN1, but also by other receptors 
able to bind LTX
N4C
, mainly NRX Iα. Exploiting the ability of LPHN1 to bind 
LTX
N4C 





NRX Iα interaction (Petrenko et al. 1990; Davletov et al. 1995; Geppert et al. 
1998), the replacement of Ca
2+





4.21 and 4.22) confirms that LTX
N4C
 does not require NRX Iα (or any other 
neurexins, which all need Ca
2+
, Geppert et al. 1998). Even more importantly, the 
use of NMJ preparations from mice lacking LPHN1 strongly support the 
hypothesis that LPHN1 is the only receptor that mediates the effect of LTX
N4C
 
(Figure 4.24).  
Another suggestion that LPHN1 is responsible for mediating the effects on 
exocytosis observed upon addition of LTX
N4C
 comes from our experiments using 
PFOA. When synaptosomes are incubated with PFOA, the NTF and CTF of 
LPHN1 are differentially solubilised; this can suggest that PFOA is able to 
prevent the interaction between the two LPHN1 fragments, with potential 





repercussions for the LPHN1-mediated signalling and exocytosis. Indeed, at any 
PFOA concentration higher than 0.2 µM LPHN1-mediated exocytosis was 
impaired in a concentration-dependent manner and completely blocked by 100 
µM PFOA (Figure 4.26), a concentration that does not disrupt LTX
N4C
-LPHN1 
interaction (Figure 4.30) nor causes any cytotoxic effects (Choi et al. 2013). Thus, 
the interaction between NTF, which binds LTX
N4C
, and CTF, which mediates 
intracellular signalling, is essential for LTX
N4C
-induced exocytosis.  
Very interestingly, at higher concentrations, PFOA also retards the 
depolarisation-induced neurotransmitter release and requires higher concentration 
of KCl to stimulate exocytosis (Figure 4.32). This result suggests that the 
dissociation of NTF and CTF of LPHN1 impairs the ability of presynaptic 
terminals to respond to depolarisation. This observation is comparable to the one 
obtained when hippocampal neuronal cultures were treated with a soluble form of 
LPHN1 (Ushkaryov, data not published). When the soluble ectodomain of 
LPHN1 was added to the cultures at an early stage of synapse development, the 
interaction between endogenous LPHN1 and its postsynaptic ligand (most likely 
Lasso) was perturbed, leading to the loss of LPHN1 from presynaptic nerve 
terminals. As a result, the synapses formed in this culture were largely insensitive 
to moderate depolarisation. This synaptic inactivity could be overcome by a 
stronger or longer-lasting depolarisation. The conclusion from that work is that 
LPHN1 contributes to the ability of presynaptic terminals to respond to 
depolarisation by enabling Ca
2+
 influx. This may be due to a decreased activity of 
VGCCs or their inappropriate localisation in the active zone. In this case, the loss 
of presynaptic LPHN1 could be compared to the dissociation (and inhibition) of 
LPHN1 by PFOA, which also leads to synaptic insensitivity to depolarisation. 
Both experiments suggest that LPHN1 plays a central role in Ca
2+
 maintenance at 
the presynaptic terminal.  
 Taken together, these results confirm the involvement of LPHN1 in the 
regulation of exocytosis, and show that the activation of this receptor by LTX
N4C
 
causes waves of exocytosis, which most likely follow the waves of increased 
intracellular Ca
2+ 
concentration. However, the molecular mechanisms underlying 
the effects of LPHN1 signalling remain unclear. The purpose of the next chapters 





is to investigate which intracellular pathways are induced on LPHN1 activation 
and the source of the Ca
2+
 responsible for the intracellular oscillations that lead to 
the bursting exocytosis. 











As discussed in Chapter 4, LPHN1 is involved in the control of spontaneous 
exocytosis: LPHN1 KO and, to a lower degree, Het mice show deregulations in 
the rate of spontaneous neurotransmitter release at the NMJ. Experiments on 
central synapses also suggest a role of LPHN1 in neuronal survival and 
connectivity. 
 My results from experiments using LTX
N4C
 confirm previous studies that 
showed how the activation of LPHN1 leads to a dramatic increase in the rate of 
exocytosis (Capogna et al. 2003; Lelyanova et al. 2009); I showed that in order for 
this increase to happen extracellular Ca
2+
 is needed. In fact, in Ca
2+
-free buffer the 
frequency of exocytosis does not significantly change compared to the baseline.  
 Although the effects of the activation of LPHN1 have now been confirmed 
in the current project, little has been known about the molecular mechanisms that 
cause them. In this chapter I explore the intracellular pathways involved in this 
activation. 
First, I investigated what Gα protein subunit is activated by LPHN1; I then 
interfered with the intracellular molecular components of the pathway activated 
by the G protein in order to ascertain whether these are responsible for the effects 
observed when LPHN1 is activated.  
  





5.2 Results  
 
5.2.1 Gαq is involved in the activity of LPHN1 
 
Previous studies showed that LPHN1 is coupled to G proteins; in particular, 
affinity chromatography of solubilised rat brain membranes using an αLTX 
column showed that Gαo and Gαq/11 are associated with LPHN1, which was 
isolated on the toxin column (Rahman et al. 1999). 
To ascertain that the effects observed when LPHN1 is activated are mediated by 
one of these G proteins, I performed LTX
N4C
-induced stimulation of the mouse 
NMJ in the presence of an inhibitor specific for the Gαq/11. This molecule, called 
UBO-QIC, is an analogue of YM254890; extracted from the plant Ardisia 
crenatasims. UBO-QIC is an acyclic depsipeptide that inhibits the Gαq/11 
signalling by directly binding to this G protein and inhibiting the release of GDP 
(Bernard et al. 2014). 
When added in Ca
2+
-containing buffer (2 mM) at the beginning of the recordings, 
UBO-QIC prevented the LPHN1-mediated activity by interfering with its 
molecular signalling pathway. In fact, when 0.25 nM LTX
N4C
 was added after 1 
µM UBO-QIC, the toxin was not able to produce the typical effects I described in 
the previous chapter (see Chapter 4, Sections 4.2.4 and 4.2.5). The MEPPs 
frequencies were 0.33 ± 0.08 Hz in Ca
2+
 buffer with UBO-QIC, 2.28 ± 1.99 Hz in 
Ca
2+
 buffer with UBO-QIC and LTX
N4C 
(Figure 5.2 A, B, C). 
No differences in the average amplitude were present between the experimental 
conditions considered (0.82 ± 0.11 mV in Ca
2+
 buffer, 0.81 ± 0.06 mV in the 















Figure 5.1. Single traces of MEPPs recordings in Ca
2+
 buffer after the addition of 
UBO-QIC (A) and LTX
N4C
 (B). The addition of LTXN4C does not cause increased 






























Figure 5.2. A. Frequency plot of a recording of MEPPs in Ca
2+
 buffer (2 mM), 
after the addition of UBO-QIC and LTX
N4C
. The presence of UBO-QIC in the 
buffer prevents the activation of Gαq/11 protein and the effects usually observed 
upon addition of LTX
N4C
 do not develop. B. Average frequency of MEPPs in Ca
2+
 
buffer, after the addition of UBO-QIC and of LTX
N4C
. The difference between the 
conditions is not statistically significant. C. Scatter plot of the data summarised in 
B. Each point represents the frequency of a single fibre recorded under the given 
condition. Note that about 30% of the recorded cells still respond to the toxin with 
increased frequency. D. Average amplitude of MEPPs in Ca
2+
 buffer, after the 
addition of UBO-QIC and LTX
N4C
. The difference between the conditions is not 
statistically significant (N = 3, n = 20 cells recorded in Ca
2+
, 24 after the addition 
of UBO-QIC and 36 after addition of LTX
N4C
). 





















































In a reverse experiment, when added after 0.25 nM LTX
N4C
 and when the effects 
of the activation of LPHN1 were already manifested, UBO-QIC (1 µM) was able 
to significantly reduce the frequency of exocytosis (15.50 ± 7.07 Hz LTX
N4C
 vs 
2.76 ± 1.35 Hz LTX
N4C
 and UBO-QIC, Figure 5.4 A and B). The fall in the 
frequency of neurotransmitter release is observed after approximately 6 minutes 
from the addition of UBO-QIC. 
The differences in the average amplitudes between the experimental conditions 
were not significant (0.82 ± 0.11 mV in Ca
2+
 buffer, 1.14 ± 0.02 mV after the 
addition of LTX
N4C





Figure 5.3. Single traces of MEPPs recordings in Ca
2+
 buffer after the addition of 
LTX
N4C
 (A) and UBO-QIC (B). UBO-QIC is able to stop the increased exocytosis 












Figure 5.4. A. Frequency plot of a recording of MEPPs in Ca
2+
-containing buffer 
(2 mM) where UBO-QIC was added once LTX
N4C 
already started to exert its 
effect. UBO-QIC is able to significantly reduce the frequency of exocytosis due to 
the activation of LPHN1. B. Average frequency of MEPPs in Ca
2+
 buffer, after the 
addition of LTX
N4C
 and subsequent addition of UBO-QIC. C. Average amplitude 
of MEEPs in Ca
2+
 buffer and after the addition of LTX
N4C
 and UBO-QIC. The 
difference between the conditions is not statistically significant (N = 3, n = 19 
cells recorded in Ca
2+
 buffer, 36 after the addition of LTX
N4C
, and 29 after the 
addition of UBO-QIC; **, P <0.010, Mann – Whitney U test). 
 


















































5.2.2 PLC is needed for LPHN1 activity 
 
After determining that Gαq/11 was responsible for LPHN1 activity, it was 
important to further investigate the molecular pathway involved in the effects 
observed upon LPHN1 activation. PLC is a known downstream intracellular 
target of activated Gαq/11. The involvement of PLC in αLTX Ca
2+
-dependent 
release and the ability of PLC inhibitors to attenuate LTX
N4C
 effects on exocytosis 
were already described in model systems such as synaptosomes and cultured 
pyramidal neurons (Davletov et al. 1998; Rahman et al. 1999; Capogna et al. 
2003). Here, I interfered with PLC in NMJ preparations using its well-known 
inhibitor, U73122. This compound has a double action that in turn leads to 
decreased intracellular Ca
2+
 concentration: it both inhibits the coupling of PLC 
with the G protein and prevent the hydrolysis of PIP2 to IP3 (Bleasdale et al. 
1990; Smith et al. 1990; Bleasdale and Fisher 1993). The inactive analogue of 
U73122, U73343 was used as a control. 
When added in Ca
2+
-containing buffer at the beginning of the recordings, 10 µM 
U73122 inhibited the effects of LPHN1 activation. In fact, when 0.25 nM LTX
N4C
 
was subsequently added, the toxin was not able to fully produce its effects (0.34 ± 
0.12 Hz Ca
2+
 buffer with U73122 vs. 2.39 ± 1.81 Hz Ca
2+
 buffer with U73122 and 
LTX
N4C
 Figure 5.6 A and B). 
The differences in the average amplitudes between the conditions studied were 
not statistically significant (0.82 ± 0.11 mV in Ca
2+
 buffer, 0.77 ± 0.06 mV in the 
presence of U73122, and 0.96 ± 0.06 mV after the addition of LTX
N4C
, Figure 5.6 
C). 









Figure 5.5. Single traces for MEPPs recordings in Ca
2+
 buffer in the presence of 
U73122 (A) and after the addition of LTX
N4C
 (B). Stimulation of LPHN1 by 
LTXN4C is not able to produce the typical increase in spontaneous exocytosis 















Figure 5.6. A. Frequency plot of a MEPPs recording in Ca
2+
 buffer (2 mM), after 
the addition of U73122 and of LTX
N4C
. The presence of U73122 in the buffer 
successfully inhibits the activation of LPHN1. B. Average frequency of MEPPs in 
buffer A, after the addition of U73122 and subsequent addition of LTX
N4C
. The 
difference between the conditions is not statistically different. C. Average 
amplitude of MEPPs in Ca
2+
 buffer, and after the sequential addition of U73122 
and LTX
N4C
. The difference is npt statistically significant (N = 2, n = 9 cells 
recorded in Ca
2+





















































The blockade of LPHN1 effects was also observed when PLC is inhibited after 
LPHN1 already started to act. In fact, adding U73122 after LTX
N4C
 already 
started to exert its effects led to a significant decrease in the MEPPs frequency 
(22.85 ± 3.87 Hz in Ca
2+
 buffer with LTX
N4C





 and U73122, Figure 5.8 A and B). The decrease in neurotransmitter 
release was observed after approximately 20 minutes from the addition of 
U73122. 
The average amplitudes did not significantly change between the experimental 
conditions considered (0.82 ± 0.11 mV in Ca
2+
 buffer, 0.80 ± 0.03 mV after the 
addition of LTX
N4C





Figure 5.7. Single traces of MEPPs recordings in Ca
2+ 
buffer after the addition of 
LTX
N4C
 (A) and subsequent addition of U73122 (B). U73122 is able to abolish the 
effects of LPHN1 activation. 
A 
B 



















Figure 5.8. A. Frequency plot of a MEPPs recording in Ca
2+
 buffer (2 mM), after 
the addition of LTX
N4C
 and of U73122. U73122 successfully reduces the increase 
in exocytosis caused by LTX
N4C
. B. Average MEPPs frequency in Ca
2+
 buffer, 
after the addition of LTX
N4C
 and subsequent addition of U73122. C. Average 
amplitude of MEPPs in Ca
2+
 buffer, and after the sequential addition of LTX
N4C
 
and U73122. The difference between the conditions is not statistically significant  
(N = 2, n = 13 cells recorded in Ca
2+
 buffer, 19 after the addition of LTX
N4C
, and 
38 after the addition of U73122; **, P < 0.010, Mann – Whitney U test).  
 

































U73343 was used in the same kind of experiments, as a negative control and to 
make sure that the PLC inhibitor U73122 did not have off-target activities. In this 
case, LPHN1 was able to fully activate and develop the usual effects when 
U73343 (10 µM) was added either before or after LTX
N4C





Figure 5.9. A. Average frequency of MEPPs in Ca
2+
 buffer (2 mM) and after the 
sequential addition of U73343 and LTX
N4C 
(N = 1, n = 6 cells recorded in Ca
2+
 
buffer, 6 after addition of U73343,and 12 after addition of LTX
N4C
; ***, P < 
0.001, Mann – Whitney U test ) . B. Average frequency of MEPPs in Ca
2+
 buffer 
(2 mM) and after the sequential addition of LTX
N4C
 and U73343. The difference 
between the conditions is not statistically significant (N = 1, n = 5 cells recorded 
in Ca
2+
 buffer, 10 afetr addition of LTX
N4C
, and 9 after addition of U73343, Mann 
– Whitney U test). 
  





5.2.3 Role of intracellular Ca
2+
 stores in the activity of LPHN1 
 
The experiments described in the previous sections confirm that the molecular 
pathway involving Gαq/11 protein and the subsequent activation of PLC is 
necessary for the LPHN1-mediated effect. The final target of the molecular 
pathway investigated here is the intracellular Ca
2+
 stores: PLC leads to the 
production of IP3 (and DAG) from PIP2, and IP3 in turn activates IP3 receptors 
(IP3R) on the endoplasmic reticulum (ER); this causes the release of Ca
2+
 from the 
intracellular Ca
2+




In previous works, LTX
N4C
 was shown to cause hydrolysis of PIP2 (and 
consequent production of IP3) in synaptosomes (Ichtchenko et al. 1998), and the 
block of IP3 receptors caused inhibition of the effects on exocytosis operated by 
LTX
N4C
 in cultured hippocampal neurons (Capogna et al. 2003). To verify that 
intracellular Ca
2+
 stores are involved in My model system, the NMJ, I used 2-
Aminoethoxydiphenyl borate (2APB), a blocker of IP3R (IC50 = 42 µM).  
When added after the addition of 0.25 nM LTX
N4C
, i.e. after the effects due to the 
activation of LPHN1 were already fully developed, 50 µM 2APB was able to 





 vs 0.18 ± 0.13 Hz in Ca
2+
 buffer with LTX
N4C
 and 2APB, 
Figure 5.11 A and B). The decrease in neurotransmitter release was observed after 
approximately 20 minutes from the addition of 2APB. 
The average amplitude between the conditions considered was not significantly 
different (0.82 ± 0.11 mV in Ca
2+
 buffer, 0.91 ± 0.01 mV after the addition of 
LTX
N4C


















Figure 5.10. Single traces of MEPPs recordings in Ca
2+
 buffer after the addition 
of LTX
N4C
 (A) and 2APB (B). Addition of 2APB fully stops the effects due to the 


































Figure 5.11. A. Frequency plot of a MEPPs recording in the presence of 2 mM 
Ca
2+
, after the addition of LTX
N4C
 and of 2APB. 2APB is able to significantly 
reduce the elevation in exocytosis caused by LTX
N4C
. B. Average frequency of 
MEPPs in Ca
2+
 buffer, after the addition of LTX
N4C
 and subsequent addition of 
2APB. C. Average amplitude of MEPPs in Ca
2+
 buffer and after the sequential 
addition of LTX
N4C
 and 2APB. The difference is not statistically significant (N = 
2, n = 6 cells recorded in Ca
2+
 buffer, 13 after addition of LTX
N4C
 and 11 after the 
addition of 2APB; ***, P < 0.001, Mann – Whitney U test). 
 


















































However, 2APB also blocks TRPC channels. In research, this compound is used 
to manipulate intracellular release of calcium ions and modify TRPC channel 
activity (it stimulates SOCE at low concentration and inhibits it at higher 
concentrations), although its lack of specific effects calls for caution when 
interpreting the results under certain circumstances (Maruyama et al. 1997; 
Bootman et al. 2002). 
Therefore, to confirm the crucial role of the intracellular Ca
2+
 stores in the 
downstream signalling medated by LPHN1, I used a very specific blocker of the 
Ca
2+
 ATPase involved in the refilling of intracellular Ca
2+
 stores, thapsigargin 
(TG). This drug elevates the cytosolic Ca
2+
 concentration by stimulating the 
release of Ca
2+
 from IP3- and ryanodine sensitive stores, and at the same time 
blocking the sarco/endoplasmic reticulum Ca
2+
 ATPase (SERCA) pump, causing 
the depletion of the stores (Thastrup et al. 1990; Lytton, Westlin and Hanley 
1991; Treiman, Caspersen and Christensen 1998).  
TG alone caused a large increase in spontaneous neurotransmitter release when 
added to the NMJ preparartions (as described in Chapetr 6, section 6.2.2); in Ca
2+
-
free buffer, this increase ceases once the elevation in intracellular Ca
2+
 subsides.  
When added after the peak in exocytosis caused by TG in Ca
2+
-free buffer had 
subsided, LPHN1 activation by LTX
N4C
 was unsuccessful to elicit the increase in 
exocytosis typically observed, also after the addition of 2 mM Ca
2+
 to the 
extracellular buffer (0.10 ± 0.01 Hz in Ca
2+
-free buffer, 8.85 ± 1.28 Hz after the 
addition of TG, 0.16 ± 0.09 Hz after the addition of LTX
N4C
 and 0.02 ± 0.01 Hz 
after the addition of Ca
2+
, Figure 5.13). This result strongly supports the 
hypothesis that intracellular stores are crucial for LPHN1-mediated increase in 

















Figure 5.12. Individual traces of MEPPs recordings in Ca
2+
-free buffer after the 
addition of TG (A), and after the addition of LTX
N4C
 (B) and 2 mM Ca
2+
 (C) once 
the effects of TG had ceased. In the presence of LTX
N4C
, the addition of Ca
2+
 after 
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Figure 5.13. Average frequency of MEPPs in Ca
2+
-free buffer and after the 
sequential addition of TG, LTX
N4C
, and 2 mM Ca
2+
(N = 2, n = 5 cells recorded, in 
Ca
2+
-free buffer, 5 after the addition of TG, 5 after the addition of LTX
N4C
 and 9 
after the addition of Ca
2+
; ***, P < 0.001, Mann – Whitney U test). 
 
 
Furthermore, to ascertain whether IP3 sensitive stores are the only ones involved 




The neuromuscular preparations were treated with 100 µM ryanodine and 
subsequently LTX
N4C
 was added in order to see if the effects of the activation of 
LPHN1 were still able to develop. The presence in the buffer of ryanodine did not 
prevent the development of the effects of LTX
N4C
, and cells showed increased 
exocytosis and bursting behaviour. However, under these conditions the overall 
increase was slightly less than in Ca
2+
 buffer alone (9.45 ± 2.59 Hz in the presence 
of ryanodine vs. 15.50 ± 7.07 Hz in Ca
2+
 buffer, Figure 5.14). The average 
frequency during the bursts was of 25.80 ± 2.13 Hz, a value that is not 
significantly different from the one observed in Ca
2+
 without the addition of the 
drug.   
 
!






Figure 5.14. Comparison between the average frequency of MEPPs in Ca
2+
-
containing buffer (2 mM) after the addition of LTX
N4C
, and in Ca
2+
-containing 
buffer with ryanodine after the addition of LTX
N4C
 (N = 1, n = 7 cells recorded in 
Ca
2+
 buffer, 5 cells after the addition of LTX
N4C
, and 11 cells after the addition of 
LTX
N4C
 in the presence of ryanodine; **, P < 0.010, Mann – Whitney U test). 
  







The purpose of the experiments described in this chapter was to delineate 
the intracellular molecular pathway that LPHN1 activates in order to develop its 
effects.  
As discussed previously, LPHN1 is a G protein coupled receptor, most 
likely associated with Gαo and Gαq/11 proteins (Rahman et al. 1999).  
Gαo is the most abundant G protein in the CNS and in the PNS, where it plays a 
major role in neuronal development and axonal regeneration, being associated 
with GAP-43 protein and representing about 10% of the proteins present in 
growth cones. The association of Gαo with Alzheimer’s amyloid-β (A4) precursor 
protein (APP) suggests a role for this protein in the pathogenesis of Alzheimer’s 
disease. It also has a role in visual signal transduction and olfactory reception (for 
a review see Kasahara and Ui, 2011).   
The GPCRs that are associated with Gαo are mostly neurotransmitter receptors, 
such as muscarinic ACh receptors (M2 subtype), dopamine D2 receptors, α2A 
adrenergic receptors, and GABAA receptors. The target molecule for this G 
protein is adenylate cyclase: activation of Gαo inhibits its activity, therefore 
reducing the production of cAMP. Furthermore, Gαo is known to inhibit 
neurotransmitter release by inhibiting the action potential-evoked opening of P/Q 
and N-type Ca
2+
 channels (for a review see Kasahara and Ui, 2011). 
By contrast, activation of Gαq/11 leads to an increase in cytosolic [Ca
2+
] by 
activating PLC, which in turn hydrolyses PIP2 which releases IP3 and DAG. IP3 
will then activate IP3R on the ER leading to the release of Ca
2+
 from intracellular 
Ca
2+
 stores, whilst DAG activates protein kinase C (PKC).  
Similarly to Gαo, GPCRs associated with Gαq/11 are neurotransmitter receptors, 
such as muscarinic Ach receptors (M1, M3 and M5), and serotonin 5-HT2 
receptors.  
Because the activation of LPHN1 causes an increase in neurotransmitter release, I 
tested the functional involvement of Gαq/11 in this effect. To do so, I used a 
selective inhibitor of Gαq/11, UBO-QIC, which inhibits the Gαq/11 signalling by 





directly binding to this G protein and inhibiting the exchange of GDP with GTP 
(Bernard et al. 2014).  
My experiments support the hypothesis that Gαq/11 is the G protein 
involved in the increase of neurotransmitter release observed upon activation of 
LPHN1. The evidence for this is that inhibition of this G protein prevented the 
increase in MEPPs due to LPHN1 activation when added before LTX
N4C
 (see 
Figure 5.2), and significantly reduces the frequency of exocytosis when added 
after the effects of LPHN1 activation were already present (see Figure 5.4).  
To further evaluate whether the molecular pathway initiated by LPHN1 
activation involves Gαq/11, I conducted further experiments using drugs interfering 
with the downstream molecular elements of the Gαq/11 pathway. Previous studies 
already showed an involvement of these molecules in the effects on exocytosis 
caused by both αLTX and LTX
N4C 
in different model systems. First, PLC, an 
enzyme found in the cytoplasm that acts by cleaving phospholipids (in this case 
PIP2) at the phosphate group, was shown to completely inhibit αLTX Ca
2+
-
dependent exocytosis in synaptosomes (Davletov et al. 1998; Rahman et al. 1999), 
and to significantly reduce LTX
N4C
 effects in cultured hippocampal neurons 
(Capogna et al. 2003).  
Second, PIP2 hydrolysis and consequent production of IP3 was shown to 
be involved in the effects of LTX
N4C
 in synaptosomes (Ichtchenko et al. 1998), 
and the block of IP3R was demonstrated to significantly reduce the effects of the 
mutant toxin on exocytosis in hippocampal neurons (Capogna et al. 2003). 
In the present experiments using NMJ preparations, the effect of LPHN1 
activation was blocked by U73122, a well-known inhibitor of PLC, whose effects 
contribute to the decrease of cytosolic [Ca
2+
] by inhibiting the coupling between 
Gαq/11 and PLC, while at the same time preventing the hydrolysis of PIP2. These 
experiments further suggest the involvement of PLC in the downstream effects of 
LPHN1 and, therefore, support the hypothesis that this is the pathway used by this 
receptor. Indeed, U73122 inhibits the development of the LTX
N4C
 effects via the 
activation of LPHN1 when added before (Figure 5.6) or after (Figure 5.8) 
LTX
N4C
. This effect was specifically caused by the PLC inhibition (see Figure 
5.9). 





Finally, I have confirmed the involvement of the IP3-sensitive intracellular 
calcium stores as a final target of the downstream molecular pathway of LPHN1. 
Thus, blocking IP3R with 2APB blocked the effect of LTX
N4C
 via LPHN1. 
Although caution is needed when using 2APB due to its relatively poor 
specificity, at least some of the effects observed can still be attributed to the 
blockade of IP3R. First, 2APB-induced inhibition of the effects of LPHN1 
stimulation is in line with the rest of the experiments revealing the downstream 
mechanism of this receptor. Second, the depletion of the calcium stores using TG 
also blocks the LTX
N4C
 actions. 
2 APB was more effective than UBO-QIC and U73122 in reducing the 
frequency of neurotransmitter release. This can be due to the fact that TRPC 
channels, that open in response to intracellular Ca
2+
 store depletion, are also 
blocked by 2APB, causing a further drop in the cytosolic [Ca
2+
]. This mechanism 
is further discussed in the next Chapter (Chapter 6). However, at least part of the 
effect of 2APB can be attributed to the blockade of IP3R, because the effect of this 
drug did not develop immediately, which would be expected if it blocked influx of 
extracellular Ca
2+
 via a channel.  
Interestingly, although IP3-sensitive stores appear to be most important for 
the action of LTX
N4C
, the ryanodine experiments demonstrate the possible 
additional involvement of Ryanodine sensitive stores in the effects of LPHN1 
activation.  However, the contribution of the ryanodine-sensitive stores is 
relatively small, causing only a slight decrease in the frequency of 
neurotransmitter release (see Figure 5.14) and failing to inhibit the bursting 
behaviour typical of the activation of LPHN1. 
Taken together, the results of these experiments support the involvement 
of Gαq/11 protein and of its intracellular signalling pathway in the effects that 
develop in response to the activation of LPHN1. The subsequent activation of 
PLC, hydrolysis of PIP2 in IP3 and consequent opening of IP3R are essential for 
the increase in spontaneous exocytosis observed after addition of LTX
N4C
. The 
resulting mobilisation of Ca
2+
 from the IP3-sensitive intracellular Ca
2+
 stores 
appear therefore to be a crucial element for LPHN1 to be able to fully develop its 
effects (Figure 5.15).  







Figure 5.15. Schematic representation of the intracellular pathway activated by 
LPHN1. Upon binding of LTX
N4C
, LPHN1 activates Gαq protein, which in turns 
activates PLC on the plasma membrane (arrow 1). PLC then promotes the 
cleavage of PIP2 in DAG and IP3 (arrow 2); whilst the first activates PKC, the 
latter binds to IP3Rs on the ER, causing the release of Ca
2+
 from intracellular 
Ca
2+
 stores into the cytosol (arrow 3). The elevation in cytosolic Ca
2+
 
concentration in turn starts the machinery that ultimately leads to increased 
exocytosis of neurotransmitter. 
 
 
One important aspect of these findings is that cytosolic Ca
2+
 plays a 
critical role in the effect of LTX
N4C
-induced activation of LPHN1. Thus, My 
experiments using BAPTA-AM (see Chapter 4, Section 4.2.6) directly indicate 
that chelation of cytosolic Ca
2+
 completely blocks LTX
N4C
 effects. However, the 
increase in cytosolic Ca
2+
 concentration caused by LPHN1 signalling leading to 
Ca
2+
 release from intracellular stores does not seem to be in itself sufficient to 
increase exocytosis.. In fact, as we discussed in Chapter 4, LTX
N4C
 does not cause 










 influx is needed in order to observe the increase in exocytosis 
typical of the activation of LPHN1. This aspect needs further investigation, and 
the next chapters of this work will address this issue. 
 










I reported in the previous chapter that the intracellular molecular pathway 
activated by LPHN1 involves Gαq/11 protein, PLC, and IP3R that ultimately causes 
an increase in intracellular [Ca
2+
] due to the efflux of Ca
2+ 
from the intracellular 
Ca
2+
 stores located at the ER (see Chapter 5). 
 However, the rise in intracellular [Ca
2+
] caused by this mechanism is not 
sufficient to elicit the increase in the frequency of neurotransmitter release typical 
of the activation of LPHN1, as the addition of LTX
N4C
 in the absence of 
extracellular Ca
2+
 does not cause any significant change in the rate of exocytosis.  
Furthermore, I demonstrated that extracellular Ca
2+
 is needed to enter the 
cells in order to allow the effects of the activation of LPHN1 to develop (see 
Chapter 4, section 4.2.6). 
In this chapter I investigated the nature of the channels involved in this 
mechanism. Based on the crucial involvement of the intracellular calcium stores 
in the effect of LTX
N4C
, I hypothesised that the toxin-evoked signal, via activation 
of LPHN1 and depletion of the stores stimulates the process called store-operated 
calcium entry (SOCE). The channels involved in SOCE, the store-operated Ca
2+
 
channels (SOCCs), are a class of channels present at the plasma membrane that 
become activated in response to the decrease in [Ca
2+
] in the intracellular Ca
2+
 
stores (Putney 2007). The exact nature of these channels is still being investigated, 
but evidences suggest that SOCCs include Orai channels (Orai 1 – 3) and TRPC 
channels (TRPC 1 – 7). The opening of SOCCs is regulated by STIM protein 
(STIM 1 – 2), an ER Ca
2+
 sensor that detects a decrease in the stored [Ca
2+
] and 
causes the opening of Orais and TRPCs (for a review see Chapter 1, Section 
1.4.1). 
  







6.2.1 SOCE is involved in the activity of LPHN1 
 
To test the involvement of SOCCs in the increase in exocytosis caused by the 





Gadolinium is a trivalent cation known to act as a blocker of many cation 
channels including TRPCs. More specifically, Gd
3+
 is known to inhibit Ca
2+
 entry 
through TRPC 1, TRPC 2, TRPC3, TRPC 6 and TRPC 7, whilst it has an opposite 
effect on TRPC4 and TRPC 5, which can be stimulated by Gd
3+
 and in general by 
trivalent cations (Schaefer et al. 2000). 





 (1 mM) was subsequently added to the preparations and MEPPs 
were recorded in order to test its effects on the basal frequency of 
neurotransmitter release. No significant changes were detected in the frequency of 
exocytosis with the addition of Gd
3+
 alone (0.42 ± 0.13). Upon addition of 
LTX
N4C
 no significant changes were recorded in the frequency of MEPPs; out of 
16 cells recorded only one cell showed a slight increase in exocytosis to 3.21 Hz, 
suggesting that the block of SOCE induced by Gd
3+
 was not complete in all cells. 
However, the overall frequency of exocytosis did not significantly differ from the 
frequency recorded in the other conditions (0.28 ± 0.15 Hz, Figure 6.2 A and B). 
The average amplitude did not show any significant difference between the 
conditions tested (0.82 ± 0.11 mV in Ca
2+
 buffer, 0.87 ± 0.18 mV in the presence 
of Gd
3+
 and 1.12 ± 0.04 after the addition of LTX
N4C













Figure 6.1. Single traces of MEPPs recordings in the presence of Gd
3+ 
(A) and 
after the addition of LTX
N4C
 (B). Addition of LTX
N4C
 in the presence of Gd
3+
 does 




































Figure 6.2. A. Frequency plot of a MEPPs recording in the presence of 2 mM 
Ca
2+






 inhibits the development of 
LPHN1-mediated ACh release. B. Average frequency of MEPPs in Ca
2+
 buffer, 
after the addition of Gd
3+
 and subsequent addition of LTX
N4C
. The difference 
between the conditions is not statistically significant. C. Average amplitude of 
MEPPs in Ca
2+




. The difference 
is not statistically significant (N = 2, n = 7 cells recorded in Ca
2+
 buffer, 9 cells 
with Gd
3+




































































































As discussed in a previous section (see Chapter 5, Section 5.2.3), this compound 
has the double effect of blocking IP3R and TRPC channels (Bootman et al. 2002). 
In addition, low concentrations of 2APB may even stimulate Ca
2+
 influx via 
SOCCs. However, I used a high concentration of 2APB. Therefore, the effects 
observed when using 2APB in my experiments can be at least partially attributed 
to its inhibitory action on SOCCs, in particular TRPC 3, TRPC 6 and TRPC 7 
(Lievremont, Bird and Putney 2005). 
Addition of 50 µM 2APB to the preparations after the LPHN1-mediated effects 
had already started caused a significant decrease in the frequency of 
neurotransmitter release (13.93 ± 5.08 Hz Ca
2+
 buffer with LTX
N4C
 vs 0.18 ± 0.13 
Hz Ca
2+
 buffer with LTX
N4C
 and 2APB, Figure 6.4 A and B). This decrease in 
observed after approximately 20 minutes from the addition of 2APB. 
The average amplitude between the conditions considered was not significantly 
different (0.82 ± 0.11 mV in Ca
2+
 buffer, 0.91 ± 0.01 mV after the addition of 
LTX
N4C


















Figure 6.3. Single traces of MEPPs recordings in Ca
2+
 buffer after the addition of 
LTX
N4C
 (A) and 2APB (B). 2APB is able to stop the elevation in exocytosis that 
















Figure 6.4. A. Frequency plot of a MEPPs recording in the presence of 2 mM 
Ca
2+
, after the addition of LTX
N4C
 and subsequent addition of 2APB. 2APB 
significantly reduced the elevation in exocytosis caused by LTX
N4C
. B. Averaged 
frequency of MEPPs in Ca
2+
 buffer, after the addition of LTX
N4C
 and 2APB. C. 
Average amplitude of MEPPs in Ca
2+
 buffer and after the sequential addition of 
LTX
N4C
 and 2 APB. The difference between the conditions is not statistically 
significant (N = 2, n = 6 cells recorded in Ca
2+
 buffer, 13 cells after addition of 
LTX
N4C
, and 11 cells after addition of 2APB; ***, P < 0.001, Mann – Whitney U 
test). 
 








































































































hydrochloride (SKF96365) is an imidazole compound that inhibits SOCE by 
blocking TRPCs channels and by interfering with the STIM – Orai 1 association 
after Ca
2+
 store depletion (Varnai, Hunyady and Balla 2009). Furthermore, 
SKF96365 blocks T-type VGCCs (Singh et al. 2010) and K
+
 channels (Schwarz, 
Droogmans and Nilius 1994).  
SKF96365 (50 µM) was added to the neuromuscular preparations after the effects 
of LPHN1 had already started to manifest upon the addition of 0.25 nM LTX
N4C
. 
The decrease in exocytosis started after approximately 1 minute from the drug 
addition, with some cells becoming quiet and others still under the effects of 
toxin, although with a lower frequency. The block of exocytosis was complete, 
with no cells reacting to LTX
N4C
, after approximately 10 minutes from the 
addition of SKF96365. On average the frequency of exocytosis dropped from 
20.26 ± 6.12 Hz to 1.46 ± 0.67 Hz (Figure 6.6 A and B). 
The average amplitude was not significantly different between the conditions 
considered (0.82 ± 0.11 mV in Ca
2+
 buffer, 0.96 ± 0.04 mV after the addition of 
LTX
N4C
, and 1.14 ± 0.02 mV after the addition of SKF96365, Figure 6.6 C). 









Figure 6.5. Single traces of MEPPs recordings in Ca
2+
 buffer after the addition of 
LTX
N4C
 (A) and of SKF96365 (B). Addition of SKF96365 is able to fully stop the 

























Figure 6.6. A. Frequency plot of a MEPPs recording in the presence of 2 mM 
Ca
2+
, and after the addition of LTX
N4C
 and SKF96365. SKF96365 successfully 
inhibits the increase in exocytosis caused by LPHN1 activation. B. Average 
frequency of MEPPs in buffer A, and after the addition of LTX
N4C
 and SKF96365. 
C. Average amplitude of MEPPs in Ca
2+
 buffer and after sequential addition of 
LTX
N4C
 and SKF96365. The difference is not statistically significant (N = 1, n = 5 
cells recorded in Ca
2+
 buffer, 7 cells after addition of LTX
N4C
 and 17 cells after 
addition of SKF96365; ***, P < 0.001, Mann – Whitney U test). 




































































































This compound, a pyrazole derivate, is a potent inhibitor of SOCE, as it has been 
shown to block TG-induced Ca
2+
 influx (Ishikawa et al. 2003; Zitt et al. 2004).  
YM58483 (100 µM) was added once the activation of LPHN1 already manifested 
its effects upon the addition of 0.25 nM LTX
N4C
. The cells recorded continued to 
burst for approximately 15 minutes after the addition of YM58483, but with a 
lower overall frequency; the spontaneous activity subsequently stopped almost 
completely. The calculated averaged frequency of exocytosis after addition of 
YM58483 was 2.92 ± 1.62 Hz (Figure 6.8 A and B). 
The average amplitude of MEPPs did not significantly change between the 
experimental conditions considered (0.82 ± 0.11 mV in Ca
2+
 buffer, 1.01 ± 0.01 
mV after the addition of LTX
N4C
, and 0.74 ± 0.02 mV after the addition of 





Figure 6.7. Single traces of MEPPs recordings in Ca
2+
 buffer after the addition of 
LTX
N4C
 (A) and of YM58483 (B). YM58483 is able to inhibit the effects due to 

























































Figure 6.8. A. Frequency plot of a MEPPs recording in buffer containing 2 mM 
Ca
2+
, and after the addition of LTX
N4C
, and YM58483. YM58483 significantly 
reduced the frequency of exocytosis caused by LPHN1 activation by LTX
N4C
. B. 
Average frequency of MEPPs in Ca
2+
 buffer, and after the addition of LTX
N4C
, 
and YM58483. C. Average amplitude of MEPPs in Ca
2+
 buffer, and after the 
sequential addition of LTX
N4C
 and YM58483. The difference between the 
conditions is not statistically significant (N = 1, n = 6 cells recorded in Ca
2+
 
buffer, 15 cells after addition of LTX
N4C
, and 11 after addition of YM58483; **, P 
< 0.010, Mann – Whitney U test). 








































































To summarise, all the drugs used directed to block or inhibit different components 
of the SOCE successfully acted against the activation of LPHN1 and, although not 
completely, they were effective in decreasing significantly the frequency of 





Figure 6.9. Summary of the average frequency of MEPPs upon addition of drugs 
directed to inhibit or block components of the SOCE (Gd
3+
, 2APB, SKF96365, 
and YM58483). The values of MEPPs frequency in each condition were compared 
to the effects of LTX
N4C
 using the Mann – Whitney U test (**, P < 0.01; ***, P < 
0.001). The graph shows the results of four independent series of experiments, 
where the effects of LTX
N4C
 under treatment conditions were compared to their 
own negative and positive control values, recorded on the same preparations 
prior to the treatments. The graph does not attempt to compare each treatment to 
an average control value, but only serves to illustrate the scale of effects of 
different treatments (note, however, that the control values are remarkably similar 
in all experiments). For these reasons, no correction for multiple pairwise 


























































6.2.2 Depletion of intracellular Ca
2+
 stores using thapsigargin 
 
As I determined in the experiments described in the previous sections of this 
chapter, the activation of LPHN1 ultimately leads to the influx of Ca
2+
, which 
presumably occurred due to the opening of SOCCs in response to the depletion of 
the intracellular Ca
2+
 stores. To confirm the critical role of the intracellular Ca
2+
 
stores in the LPHN1 signalling pathway, I used thapsigargin (TG), an inhibitor of 
the sarco/endoplasmic reticulum Ca
2+ 
ATPase (SERCA) pump. Extracted from the 
plant Thapsia garganica, this compound raises the cytoplasmic Ca
2+
 
concentration by stimulating the release of Ca
2+
 from IP3 and GTP-sensitive 
intracellular stores, and at the same time irreversibly blocking the refilling of 
these stores by the SERCA pump (Thastrup et al. 1990; Lytton, Westlin and 
Hanley 1991; Treiman, Caspersen and Christensen 1998). 
In a Ca
2+
-containing buffer (2 mM), the effects caused by the elevation of 
intracellular [Ca
2+
] caused by TG were remarkably similar to the effects of 
LPHN1 activation by LTX
N4C
. However, as the Gαq – PLC – IP3 pathway was not 
stimulated by TG, its effects were apparently due to the opening of SOCCs. This 
suggested that the burst-like release of ACh caused by LTX
N4C
 is indeed 
associated with the activity of SOCCs.  
Upon the addition of 10 µM TG, the frequency of neurotransmitter release had a ~ 
35 fold increase compared to the basal frequency of release in Ca
2+
 buffer (0.36 ± 
0.03 Hz in Ca
2+ 
buffer vs 12.12 ± 2.56 Hz after the addition of TG). This increase 
occurred within 1 minute from the addition of the drug, and it could continue for a 
long time (> 1 hour) without attenuation (Figure 6.11 A and B).  
Addition of TG caused a significant increase in the average amplitude of MEPPs 
(0.82 ± 0.11 mV in Ca
2+
 buffer, 2.5 ± 0.02 mV after the addition of TG, Figure 
6.11 C). 







Figure 6.10. Single traces of MEPPs recorded in Ca
2+
 buffer after the addition of 
10 µM TG. This drug caused a 35 fold increase in neurotransmitter release, that 
lasted > 1 hour without attenuation. 
 
 
















































Figure 6.11. A. Frequency plot of a MEPPs recording in 2 mM Ca
2+
 and after the 
addition of TG. B. Average frequency of MEPPs in Ca
2+
 buffer and after the 
addition of TG. C. Average amplitude of MEPPs in Ca
2+
 buffer and after the 
addition of TG (N = 3, n = 25 cells in Ca
2+
 buffer, 27 cells after addition of TG; 






-free buffer, the addition of TG caused a temporary increase in 
neurotransmitter release that ceased after ~ 10 minutes. The features of this 
increase were not significantly different from that observed in the presence of 
extracellular Ca
2+
 (11.25 ± 4.98 Hz in Ca
2+
-free buffer vs 12.12 ± 2.56 Hz in Ca
2+
 
buffer). After the cessation of exocytosis, if Ca
2+
 was added to the extracellular 
buffer, the frequency of exocytosis went back up to the previous levels (13.49 ± 
1.19 Hz), and again continued for a long time (Figure 6.13 A and B).  
Also in this case the average amplitude of MEPPs in TG (both in the presence and 
in the absence of Ca
2+
) was significantly higher than the amplitude in Ca
2+
 buffer; 
the amplitude with and without Ca
2+
 in the presence of TG was not statistically 
significant (2.08 ± 0.03 mV and 2.17 ± 0.03 mV respectively, Figure 6.13 D). 
























































Figure 6.12. Single traces of a MEPPs recording in Ca
2+
-free buffer after the 
addition of TG. The elevation in frequency of exocytosis in the absence of Ca 
2+
 in 
the extracellular buffer is the same as in the presence of Ca
2+
. In this case, 
however, the elevation stops after about 10 minutes. 
 
 
























Figure 6.13. A. Frequency plot of a MEPPs recording in Ca
2+
-free buffer, after 
the addition of TG and subsequent addition of 2 mM Ca
2+
. B. Average frequency 
of MEPPs in a Ca
2+
-free buffer, after the addition of TG and subsequent addition 
of 2 mM Ca
2+
. C. Comparison between the average frequency of MEPPs induced 
by 10 µM TG in the presence and in the absence of extracellular Ca
2+
. The 
difference is not statistically significant. D. Average amplitude of MEPPs caused 
by TG in the presence and in the absence of extracellular buffer. The difference is 
not statistically significant (N = 2, n = 15 cells recorded after the addition of TG 
in Ca
2+
buffer, and 18 cells in Ca
2+
 free buffer). 
 
 













































































Interestingly, when TG (10 µM) was added in Ca
2+
-containing buffer after 
LTX
N4C
 (0.25 nM), and after the effects of LPHN1 activation had already 
developed, the exocytosis stopped completely within seconds of the addition of 






Figure 6.14. Single traces of MEPPs in Ca
2+
 buffer after the addition of LTX
N4C 
(A) and after the addition of TG (B). TG is able to stop LPHN1-mediated increase 






















Figure 6.15. A. Frequency plot of a MEPPs recording in the presence of 2 mM 
Ca
2+
, and after the sequential addition of LTX
N4C
 and TG. Addition of TG, after 
LTX
N4C
 had triggered an increase in exocytosis, caused a sudden cessation of 
neurotransmitter release. B. Average frequency of MEPPs in Ca
2+
 buffer, after 
the addition of LTX
N4C
 and TG (N = 3, n = 12 cells recorded in Ca
2+
 buffer, 15 
cells after the addition of LTX
N4C
, and 17 cells after the addition of TG; ***, P < 













































































In a specular experiment, when LTX
N4C
 (0.25 nM) was added in Ca
2+
-free buffer 
after the peak of exocytosis caused by TG (10 µM) has ceased, I did not observe 
any increment in the frequency of neurotransmitter release, not even when 2 mM 
Ca
2+





-free buffer + TG, and 0.02 ± 0.01 Hz after the 
addition of Ca
2+
, Figure 6.17). This data suggested that intact intracellular Ca
2+
 
stores were critical for the toxin-induced influx of extracellular Ca
2+
 and likely 






Figure 6.16. Single traces of MEPPs recording in Ca
2+
-free buffer after the 
addition of TG (A), and after the addition of LTX
N4C
 (B) and Ca
2+
 (C) once the 
effects of TG has ceased. The effects of LTX
N4C 
are not able to develop in the 


























Figure 6.17. Frequency plot of a MEPPs recording in Ca
2+
-free buffer, and after 
the addition of TG, LTX
N4C
, and 2 mM Ca
2+
. When added once the peak of 
exocytosis caused by TG ceased, LTX
N4C
 was not able to increase the frequency of 
exocytosis even if 2 mM Ca
2+
 was added. B. Average frequency of MEPPs in 
Ca
2+




 (N = 2, n = 5 cells 
recorded in Ca
2+
-free buffer, 5 cells after addition of TG, 5 cells after the addition 
of LTX
N4C
, and 9 after the addition of 2 mM Ca
2+
; ***, P < 0.001, Mann – 























































































As I discussed in a previous chapter (see Chapter 4, Section 4.2.8), experiments 
using LTX
N4C
 to stimulate LPHN1 were conducted replacing the Ca
2+
 in the 




.  These experiments, as well as 
demonstrating that LTX
N4C
 acts via LPHN1 rather than NRX, also help to support 
the hypothesis that the release of Ca
2+
 from the stores followed by opening of 
SOCCs and subsequent Ca
2+
 entry in nerve terminals is the mechanism by which 
LPHN1 works. Here, I specifically investigated the role of divalent cations (other 
than Ca
2+
) in mediating the stimulation of Ca
2+
 release from the intracellular 





are both permeable to TRPC channels and are able to generate ICRAC 
(Yeromin et al. 2004; Parekh and Putney 2005; Bakowski and Parekh 2007; Ma et 
al. 2008; Salido, Sage and Rosado 2009; Moreno and Vaca 2011). Furthermore, 
they can stimulate Ca
2+
 release from intracellular stores, increasing the 
intracellular [Ca
2+
] and stimulating neurotransmitter release (Gregoire, Loirand 
and Pacaud 1993; Przywara et al. 1993; Verhage et al. 1995; Spencer and Berlin 
1997). 
Neuromuscular preparations incubated in a buffer where Ca
2+
 was substituted 
with 2 mM Ba
2+
, were able to respond to the activation of LPHN1 in a manner 
very similar to that observed in the presence of Ca
2+
. The overall average 
frequency of exocytosis reached an average of 9.71 ± 1.35 Hz, and the cells 
showed the bursting behaviour typical of the activation of LPHN1. The frequency 
in the bursts reached an average of 41.05 ± 3.02 Hz, and during interburst 
intervals an average of 0.88 ± 0.19 Hz (Figure 6.19 A and B). However, the time 
elapsed from the addition of LTX
N4C
 to the appearance of the bursts was slightly 
increased (it took on average 41 ± 4.04 min) compared to the delay observed in 
Ca
2+
 buffer (17 ± 2.5 min, Figure 6.22).  
The MEPPs average amplitude did not show any significant change between the 
conditions considered an in respect to the control amplitude in Ca
2+
 buffer (0.82 ± 





0.11 mV in Ca
2+
 buffer, 0.92 ± 0.03 mV in Ba
2+ 
buffer, and 0.91 ± 0.02 mV in 
Ba
2+
 buffer after the addition of LTX
N4C





Figure 6.18. Single traces of MEPPs recordings in Ba
2+
 buffer (A) and after the 
addition of LTX
N4C



















Figure 6.19. A. Average frequency of MEPPs in Ba
2+
 buffer before and after the 
addition of LTX
N4C
. B. Average amplitude of MEPPs in Ba
2+
 buffer before and 
after the addition of LTX
N4C
. The difference is not statistically significant (N = 2, 
n = 16 cells recorded in Ba
2+
 buffer and 70 cells recorded after addition of 
LTX
N4C
. ***, P<0.001, Mann – Whitney U test). 
 
 
In a similar way, preparations incubated in a buffer where Ca
2+
 was replaced by 2 
mM Sr
2+
 responded to the activation of LPHN1 by 0.25 nM LTX
N4C
 with 
increased exocytosis, that overall reached a frequency of 6.51 ± 2.27 Hz. The cells 
showed bursting behaviour, with an average frequency of 37.45 ± 17.94 Hz during 
bursts and 0.84 ± 0.16 Hz during interburst intervals (Figure 6.21 A and B). In 
this case, it was necessary to wait 92 minutes to see the effects of the activation of 
LPHN1 on exocytosis (Figure 6.22). 
The MEPPs average amplitude was not significantly different between the 
conditions considered and compared to the control amplitude in Ca
2+ 
buffer (0.82 
± 0.11 mV in Ca
2+
 buffer, 0.85 ± 0.08 mV in Sr
2+
 buffer, and 0.78 ± 0.03 mV after 
the addition of LTX
N4C



























































Figure 6.20. Single traces of MEPPs in Sr
2+
 buffer (A) and after the addition of 
LTX
N4C





 in the extracellular buffer. 
 
!  
Figure 6.21. A. Average frequency of MEPPs in Sr
2+
 buffer before and after the 
addition of LTX
N4C





-containing buffer. The difference is not statistically significant 
(N = 2, n = 5 cells recorded in 2 mM Sr
2+
, 45 cells recorded after the addition of 
LTX
N4C



















































































Figure 6.22. Time elapsed between the addition of LTX
N4C
 and the start of its 






 buffer. The time LPHN1 
















The experiments described in this chapter were designed to investigate the 
involvement of store-operated Ca
2+
 entry (SOCE) downstream of activation of 
LPHN1. As I previously discussed, the intracellular pathway activated by LPHN1 
leads to the increase in cytosolic [Ca
2+





 from IP3-sensitive Ca
2+
 stores and ultimately the influx of Ca
2+
 
through SOCCs.  
It has been well described in the literature how the depletion of 
intracellular Ca
2+
 stores causes the opening of SOCCs located at the plasma 
membrane (PM): STIM, a transmembrane protein located at the ER, functions as a 
Ca
2+
 sensor detecting the fall in ER [Ca
2+
]; it then forms dimers and translocates 
into puncta in close proximity to the PM, where it contacts Orais and TRPC 
channels, causing their opening and consequent influx of Ca
2+
 that can then refill 
the stores. At this point, SARAF detects the elevation of ER [Ca
2+
] and promotes 
the disaggregation of STIM dimers, preventing the overfilling of the stores by 
inhibiting SOCE (for a review see Chapter 1, Section 1.4.2). 
Considering this mechanism, the next step of my investigation was 
directed to test the involvement of these channels in the activity of LPHN1. 
Several blockers of the SOCE molecular components were used in current clamp 
experiments where LPHN1 was activated using LTX
N4C
, and the changes in 
exocytosis caused by these drugs were analysed. 
All drugs used (Gd
3+
, 2APB, SKF96365, and YM58483) significantly 
inhibited (or fully blocked) the increase in exocytosis caused by the activation of 
LPHN1 (see Figure 6.9). Of these drugs, 2APB was the most effective in stopping 
the effects of LPHN1, likely due to the fact that this drug does not only act on 
SOCCs, but also on IP3R; these effects combined resulted in an overall lower 
cytosolic [Ca
2+
] and, as a consequence, in a greater inhibition of exocytosis.  
The experiments conducted using TG prove the ability of the intracellular 
Ca
2+
 stores to induce massive spontaneous exocytosis. As I showed (see Figure 
6.11), the effects of TG alone (when used in a buffer containing Ca
2+
) are very 
similar to the effects observed with the stimulation of LPHN1 by LTX
N4C
. 





However, as we can expect, the bursting behaviour is not present in this case as 
TG, blocking the SERCA pumps, prevents the refilling of the stores and therefore 
periodical inactivation of SOCCs. Things take a different direction when TG is 
used in a Ca
2+
 free buffer: in this case, the increase in exocytosis is only 
temporary and ceases after a short time; at that point, addition of Ca
2+
 to the 
extracellular buffer causes the exocytosis to increase again, due to the influx of 
Ca
2+
 from the SOCCs that have been activated upon store depletion (see Figure 
6.13).  
The TG experiments also demonstrated the central role of stores in the 
opening of SOCCs downstream of LTX
N4C
-induced activation of LPHN1. When 
TG depletes the stores in a Ca
2+
-free buffer, then LTX
N4C
 is unable to act, even in 
the presence of extracellular Ca
2+
 (see Figure 6.17). This was unexpected, taking 
into consideration that in the absence of LTX
N4C
, the addition of Ca
2+
 to TG-
treated preparation increases the release of neurotransmitter again.  
Even more interesting is what happens when TG is added after LTX
N4C
. In 
this case, TG causes the sudden and complete cessation of neurotransmitter 
release (see Figure 6.15) within 3-5 s.  
This result is quite difficult to explain unless we hypothesise a non-
canonical effect of TG. In the literature, TG is always described as a drug that 
very specifically targets the SERCA pump in the intracellular Ca
2+
 stores 
(Thastrup et al. 1990; Lytton, Westlin and Hanley 1991; Treiman, Caspersen and 
Christensen 1998). However, as the effect of TG (when added after the toxin) 
develops almost instantaneously, it cannot be due to the inhibition of SERCA. 
Indeed, (1) the drug cannot penetrate into the cell so quickly (in less than 5 s), and 
(2) even if it did, the blockade of SERCA would increase cytosolic Ca
2+
 due to its 
leakage from the stores, leading to an increase rather than a decrease in 
spontaneous exocytosis. Thus, my findings suggest that TG also has another effect 
on the cells. One possible way to explain these results is that TG may act as a 
blocker of a crucial Ca
2+
 channel used by LPHN1 to develop and maintain its 
effects.  
These considerations and also the fact that LTX
N4C
 does not cause an 
increase in exocytosis in the absence of extracellular Ca
2+
, but TG does, made us 





review the theory according to which Ca
2+
 release from the stores is the only 
mechanism of LTX
N4C
 action via LPHN1. In fact, it seems clear that LPHN1-
mediated stimulation of IP3R is insufficient to stimulate the release of Ca
2+
 from 
the stores and the subsequent depletion and opening of SOCCs. It is clear now 
that at least at the beginning of LPHN1 activation, the influx of Ca
2+
 from 
extracellular space is necessary to start the mechanism delineated so far. The fast 
inhibition of the toxin’s effect by TG also points at such a possibility. 




 showed that an influx of 
not only Ca
2+
, but also other divalent cations, occurs from the extracellular space, 
and that these divalent cations can fully replace Ca
2+
 and support the mechanism 
caused by LPHN1 activation. In the presence of these divalent cations, LTX
N4C
 is 
able to cause increased neurotransmitter release and bursts of exocytosis in a 
manner not distinguishable from what happens in Ca
2+
 (see Figures 6.19 and 
6.21). The only difference found was in the delay between the addition of the 
toxin and the rise in exocytosis. In Ca
2+
, the effect of LPHN1 activation normally 
takes about 20 minutes to begin; in Ba
2+
 this time goes up to about 40 minutes and 
in Sr
2+
 it further increases to about 90 minutes. This could be due to the fact that, 
although these cations can enter the cells during the initial phase and are then 
capable of stimulating Ca
2+
 release from intracellular Ca
2+
 stores (Gregoire, 
Loirand and Pacaud 1993; Przywara et al. 1993; Verhage et al. 1995; Spencer and 
Berlin 1997; Yeromin et al. 2004; Parekh and Putney 2005; Ma et al. 2008; 
Moreno and Vaca 2011), the extent of this release is not as high as that caused by 
the initial influx of Ca
2+
 and more time is necessary to reach the level of store 
depletion  needed to start the SOCC-mediated Ca
2+
 influx and bursts of exocytosis 
(see Figure 6.22).  
The bursting exocytosis observed upon activation of LPHN1 can still be 
explained by the mechanism involving the depletion of intracellular Ca
2+
 stores. 
Store depletion starts the influx of Ca
2+
 from the extracellular space via SOCCs; 
however, when the stores are refilled, the influx would stop. Consistent with this, 
the elevated cytosolic [Ca
2+
] flowing into the terminals through SOCCs would 
lead to the elevation of MEPP frequency during the bursts; this frequency would 
then go down close to control levels once the stores have been refilled, SOCCs are 





inactivated and the cytosolic [Ca
2+
] is decreased by the normal maintenance 
mechanisms. The stimulation of IP3R, however, still persists as long as LPHN1 is 
activated, therefore the stores would start depleting again, and the cycle of 
activation and inactivation of the SOCCs and exocytosis would start again giving 





Figure 6.23. Schematic representation of the molecular mechanisms involved in 
LPHN1 activation. As described previously (Chapter 5, Figure 5.15), activation of 
LPHN1 activates the Gαq protein pathway, involving activation of PLC (arrow 1), 
stimulation of IP3Rs by IP3 (arrow 2), and release of Ca
2+
 from the ER 
intracellular stores (arrow 3). Depletion of the stores is sensed by STIM1, a 
transmembrane protein located at the ER, that under these circumstances 
dimerises and translocates close to the plasma membrane (arrow 4). Here, STIM1 
contacts and opens store-operated Ca
2+ 
channels (TRPCs and Orais), that start 
the influx of Ca
2+
 that allows the refilling of the stores (arrow 5). At this point 
STIM1 goes back to its monomeric conformation and SOCE stops. 





Although these experiments support the hypothesis that the store depletion 
– opening of SOCCs is the mechanism used by LPHN1 to achieve the burst-like 
regulation of exocytosis observed upon addition of LTX
N4C
, they were unable to 
clearly identify the nature of the channels responsible for this effect. Preliminary 
data obtained from differentiated neuroblastoma (Nb2a) cells can give us some 
suggestions about it, however. Nb2a cells stably expressing LPHN1 do not 
normally respond to LTX
N4C
 unless they are induced to differentiation by serum 
deprivation or dibutyryl-cAMP. In this condition, the mRNA levels were 
measured by RT-PCR, and the level of expression of different SOCE proteins in 
LPHN1 expressing cells were compared to wild type and undifferentiated cells to 
see if the response to LTX
N4C
 in LPHN1-expressing differentiated cells was due 
to the upregulation of some SOCE gene/s and consequently to higher expression 
of particular proteins. Results suggest that the proteins being upregulated in 
differentiated LPHN1-expressing Nb2a cells are STIM1, SARAF, Orai 3 and 
TRPC2 (Blackburn, Ushkaryov, data not published). This suggests that all the 
proteins necessary for a functional SOCE are upregulated in these cells, therefore 
this could be the reason why they are able to respond to LTX
N4C
 upon 
differentiation only.  
Although this model system can give some suggestions on what channels are used 
by LPHN1 in a model system, they could be very different in neurons, which can 
possibly express other Orais and TRPCs, and where LPHN1 could activate more 
than one type of SOCCs, if not all of them. Experiments on motor neurons 
cultures where knock down of specific genes is possible would be necessary to 
clearly identify the specific proteins used by LPHN1 to produce its effects.  
Finally, the role of the Ca
2+
 channels crucially involved in the initial 
activation of the intracellular stores by LTX
N4C
 via LPHN1 remains unexplained 
by this mechanism of cyclical store depletion/SOCC activation. The next chapter 
of this dissertation will be dedicated to exploring the involvement of other types 
of Ca
2+
 channels in the effects on exocytosis caused by the activation of LPHN1. 
 











In the previous chapters I delineated part of the mechanism activated by 
LPHN1 that causes the increase in exocytosis and the bursting behaviour observed 
when LTX
N4C
 is used to stimulate the receptor. 
 As we discussed, the G protein associated to LPHN1 that starts the 
molecular pathway leading to increased intracellular [Ca
2+
] is Gαq/11, that in turn 
activates PLC promoting the hydrolysis of PIP2 in IP3 and DAG. IP3 then activates 
IP3R on the ER, and this leads to the release of Ca
2+
 from intracellular stores into 
the cytosol. As cytosolic [Ca
2+
] rises, the frequency of spontaneous exocytosis 
greatly increases, but then subsides when cytosolic Ca
2+
 is sequestered or 
chelated. The depletion of the stores in turn causes the activation of SOCE, which 
allows Ca
2+
 influx, causing a new increase in the intracellular [Ca
2+
], 
replenishment of the stores and eventual Ca
2+
 removal from the cytosol. This rise 
and fall in [Ca
2+
] produces a new wave of exocytosis. Once the stores have been 
replenished, the influx of Ca
2+
 from SOCCs stops and the mechanism starts again 
with the IP3-induced release of Ca
2+
 from the stores. This causes oscillations in 
the intracellular [Ca
2+
], going from relatively low levels when the SOCCs are 
closed, to higher levels when they are open: these oscillations supposedly give 
rise to the bursting behaviour that I extensively described in this work. 
 However, as the experiments using TG and other divalent cations revealed, 
the initial elevation in cytosolic [Ca
2+
] caused by LPHN1 through IP3R activation 
is not enough to start this whole mechanism: some other source of Ca
2+
 needs to 
be postulated, which at least at the beginning of LPHN1 activation helps to 
activate the IP3R sufficiently to bring the intracellular [Ca
2+
] to a level high 
enough to further stimulate the release from the stores and the activation of 
SOCE. 





In this chapter, I investigated the involvement of VGCCs in this 
mechanism. The potential involvement of VGCCs was hypothesised on the basis 
of the previous publications which reported the observation of L-type Ca
2+
 current 
appearing in pancreatic β-cells in response to LTX
N4C
-induced activation of 
LPHN1 (Lang et al. 1998; Lajus et al. 2006) 
VGCCs, widely expressed in excitable cells, mediate Ca
2+
 influx in 
response to depolarisation of cells. In neurons, this is achieved after an action 
potential reaches the terminals and it is the stimulus needed to start synaptic 
transmission. 
Composed of different subunits, VGCCs are classified according to the 
pore-forming α subunit, which generates diverse Ca
2+
 currents with peculiar 
physiological and pharmacological characteristics. According to this 
classification, VGCCs can be divided into Cav1 (1 – 4), Cav2 (1 – 3) and Cav3 (1 
– 3), that give rise to L-, P/Q, N-, R- and T-type currents (for a review see Chapter 
1, Section 1.5). 
  







7.2.1 P/Q VGCCs are involved in the activity of LPHN1 
 
To investigate the potential role of VGCCs in the effects observed upon LPHN1 
activation, I used drugs and toxins directed to block the major classes of neuronal 




Nimodipine is a dihydropyridine compound used in medicine for the treatment of 
deficits caused by cerebral vasospasm following subarachnoid haemorrhage. 
Although it is known that Nimodipine is a selective blocker of L-type VGCCs, its 
precise mechanism of action is still unknown (http:// 
www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=summary&li
gandId=2523). 
In my experiments, I used Nimodipine both after and before the addition of 
LTX
N4C
 and the consequent activation of LPHN1.  
When added after the effects of LPHN1 activation had been already present, 
Nimodipine was not able to stop or attenuate them (15.58 ± 5.48 Hz vs 15.50 ± 
7.07 Hz with LTX
N4C
 only). The cells continued to show bursting behaviour, with 
the frequency during burst reaching an average of 34.15 ± 5.49 Hz and an 
interburst frequency of 0.829 ± 0.23 (Figure 7.2 A and B). 
The average amplitude of MEPPs was significantly higher when Nimodipine was 
added to the extracellular buffer (0.82 ± 0.11 mV in Ca
2+
 buffer, 0.92 ± 0.04 after 
the addition of LTX
N4C
, and 1.54 ± 0.01 mV in the presence of Nimodipine, 
Figure 7.2 C). 
 








Figure 7.1. Single traces of MEPPs recordings in Ca
2+
 buffer after the addition of 
LTX
N4C
 (A) and Nimodipine (B). Nimodipine does not stop the effects due to 
LPHN1 activation; bursts and interburst intervals are still present. 
 
 


























Figure 7.2. A. Frequency plot of a MEPPs recording in a buffer containing 2 mM 
Ca
2+
, and after the consecutive addition of LTX
N4C
 and Nimodipine. The block of 
L-type VGCCs is not able to suppress LPHN1-mediated exocytosis. B. Average 
frequency of MEPPs in Ca
2+
 buffer, and after the addition of LTX
N4C
 and 
Nimodipine. The difference between the conditions is not statistically significant. 
C. Average amplitude of MEPPs in Ca
2+
 buffer and after the addition of LTX
N4C
 
and Nimodipine (N = 2, n = 5 cells recorded in Ca
2+
 buffer, 17 cells after 
addition of LTX
N4C
, and 11 cells after the addition of Nimodipine; ***, P < 0.001, 
Mann – Whitney U test). 
 
 
In a reverse order when added before LTX
N4C
, Nimodipine itself decreased the 
basal MEPPs frequency, but was not effective in inhibiting the increase in 
exocytosis typical of the activation of LPHN1 (14.88 ± 2.29 Hz), and the cells 
showed bursting behaviour with an average of MEPPs of 24.29 ± 0.68 Hz during 
the bursts, and an interburst frequency of 0.68 ± 0.05 Hz (Figure 7.4 A and B). 
Also in this case, addition of Nimodipine itself caused a slight increase in the 
average MEPPs amplitude that went from the 0.82 ± 0.11 mV of the control in 
Ca
2+
 buffer, to 1.36 ± 0.55 mV after addition of Nimodipine which did not 
significantly change after the addition of LTX
N4C
 (1.22 ± 0.02 mV, Figure 7.4 C). 
























































Figure 7.3. Single traces of MEPPs recordings in Ca
2+
 buffer in the presence of 
Nimodipine (A) and after the addition of LTX
N4C
 (B). The presence of Nimodipine 













Figure 7.4. A. Frequency plot of a MEPPs recording in a buffer containing 2 mM 
Ca
2+
, and after the addition of Nimodipine and LTX
N4C
. Nimodipine is not able to 
prevent the manifestation of the effects due to LPHN1 activation. B. Average 
frequency of MEPPs in Ca
2+
 buffer, and after the addition of Nimodipine and 
LTX
N4C
. C. Average amplitude of MEPPs in Ca
2+
 buffer, and after sequential 
addition of Nimodipine and LTX
N4C
 (N = 1, n =7 cells recorded in Ca
2+
 buffer, 6 
cells recorded with Nimodipine, and 10 cells after the addition of LTX
N4C
; ***, P 






































































































ω-Conotoxin MVIIC (ω-Con MVIIC) is part of a group of neurotoxic peptides 
isolated from the venom of the marine cone snail. This specific toxin is known to 
be an inhibitor of P/Q-type VGCCs, and of N-type VGCCs with a lower affinity, 
although the inhibition of the latter happens much faster compared to the 
inhibition of the former. In addition, ω-Con MVIIC blocks N-type VGCCs more 
potently when neurons are at rest compared to the block seen in depolarised 
neurons (Liu et al. 1996; McDonough et al. 1996; Stocker et al. 1997). 
For my experiments, neuromuscular preparations were incubated in Ca
2+
-
containing buffer with ω-Con MVIIC (1 µM) and recording were taken in order to 
evaluate the basal frequency of exocytosis in the presence of the toxin (0.39 ± 
0.09 Hz). 0.25 nM LTX
N4C
 was then added and recordings continued for 
evaluation of the changes in exocytosis due the activation of LPHN1. The 
presence of ω-Con MVIIC in the buffer prevented the increase of exocytosis 
usually observed upon addition of LTX
N4C
 (0.75 ± 0.17 Hz, Figure 7.6 A and B). 
The presence of ω-Con MVIIC in the buffer did not significantly change the 
average amplitude of MEPPs compared to the control in Ca
2+
 buffer (0.82 ± 0.11 
mV in Ca
2+
 buffer, 0.94 ± 0.02 mV in the presence of ω-Con MVIIC), neither 
does the subsequent addition of LTX
N4C
















Figure 7.5. A. Single traces of MEPPs in Ca
2+
 buffer after the addition of ω-Con 
MVIIC (A) and of LTX
N4C
 (B). When LPHN1 is stimulated in the presence of ω-













Figure 7.6. A. Frequency plot of a MEPPs recording in the presence of 2 mM 
Ca
2+
, and after the consecutive addition of ω-Con MVIIC and LTX
N4C
. ω-Con 
MVIIC successfully inhibits the increase in exocytosis due to the activation of 
LPHN1. The LTX
N4C
 control was recorded on the same day on a different 
preparation not treated with ω-Con MVIIC. B. Average frequency of MEPPs in 
Ca
2+
 buffer and after the addition of ω-Con MVIIC and LTX
N4C
. The difference 
between the conditions is not statistically significant. C. Average amplitude of 
MEPPs in Ca
2+
 buffer, and after sequential addition of ω-Con MVIIC and LTX
N4C
 
(N = 3, n = 19 cells recorded in Ca
2+
 buffer, 21 cells with ω-Con MVIIC, and 39 
cells after the addition of LTX
N4C
; ***, P < 0.001, Mann – Whitney U test). 



































































































The situation changed, however, when ω-Con MVIIC (1 µM) was added after 
LPHN1 had been activated by LTX
N4C
 (0.25 nM), and its effects on exocytosis 
already started. In this case, ω-Con MVIIC was not able to stop or even attenuate 
this increase (15.48 ± 0.64 Hz vs. 22.06 ± 9.65 Hz in Ca
2+
 buffer), and the cells 
continued to burst in the same way they usually did in Ca
2+
 buffer only (32.81 ± 
2.65 Hz during bursts and 0.61 ± 0.13 Hz during interburst intervals, Figure 7.8, A 
and B). 
The average amplitude of MEPPs was not significantly different between the 
conditions considered (0.94 ± 0.01 mV after the addition of LTX
N4C
, and 0.95 ± 





Figure 7.7. Single traces of MEPPs recordings in Ca
2+
 buffer after the addition of 
LTX
N4C
 (A) and ω-Con MVIIC (B). ω-Con MVIIC is not able to inhibit the effects 
of LPHN1 activation if added when they have already developed. 
A 
B 









Figure 7.8. A. Frequency plot of a MEPPs recording in a buffer containing 2 mM 
Ca
2+
, and after the addition of LTX
N4C
 and ω-Con MVIIC. ω-Con MVIIC added 
once the increase in exocytosis took place is not able to successfully inhibit it. B. 
Average frequency of MEPPs in Ca
2+
 buffer, and after the addition of LTX
N4C
 and 
ω-Con MVIIC. The difference between the conditions is not statistically 
significant. C. Average amplitude of MEPPs in Ca
2+
 buffer and after sequential 
addition of LTX
N4C
 and ω-Con MVIIC. The difference is not statistically 
significant (N = 2, n = 13 cells recorded in Ca
2+
 buffer, 20 cells after the addition 
of LTX
N4C
, and 20 after the addition of ω-Con MVIIC, Mann – Whitney U test). 



































































































Interestingly, when considering the frequency of MEPPs during interburst 
intervals after the addition of both LTX
N4C
 and ω-Con MVIIC, this was 




 buffer only). In fact it 
went down from a control level of 0.95 ± 0.12 Hz to 0.61 ± 0.13 Hz (Figure 7.9). 
!
!
Figure 7.9. Comparison between the average frequency of MEPPs during 




 buffer) and in the 
presence of both LTX
N4C
 and ω-Con MVIIC (n = 5 cells for the control condition 






























ω-Conotoxin GVIA and ω-Agatoxin IVA 
 
The experiments with ω-Con MVIIC suggested an involvement of N-type and/or 
P/Q-type VGCCs in LTX
N4C
-induced activation. However, it was impossible to 
discriminate the individual contributions of these VGCC types on LPHN1 effects, 
using this VGCC blocker. To make this distinction possible I used ω-Conotoxin 
GVIA (ω-Con GVIA), a specific blocker of N-type VGCCs and ω-Agatoxin IVA 
(ω-Aga IVA), a specific blocker of P/Q-type VGCCs. 
Considering that ω-Con MVIIC was able to stop the effects of LPHN1 activation 
on exocytosis only when added to the preparations before LTX
N4C
, I used this 
condition in experiments in order to discriminate the involvement of N-type and 
P/Q-type VGCCs. 
The neuromuscular preparations were incubated in Ca
2+
 buffer with 50 nM ω-Con 
GIVA and recordings were taken in order to calculate the effects of this toxin on 
the basal frequency of exocytosis (0.42 ± 0.11 Hz). 0.25 nM LTX
N4C
 was then 
added and recordings continued for evaluation of the changes in exocytosis due 
the activation of LPHN1 (12.89 ± 7.12 Hz). The cells showed the typical bursting 
behaviour observed when LPHN1 was activated by LTX
N4C
 (36.48 ± 8.98 Hz 
during bursts and 0.92 ± 0.20 Hz during interburst intervals, Figure 7.11 A and 
B). 
The average amplitude of MEPPs was not significantly different between the 
conditions considered (0.82 ± 0.11 mV in Ca
2+
 buffer, 0.90 ± 0.07 mV in the 
presence of ω-Con GIVA, and 0.83 ± 0.02 mV after the addition of LTX
N4C
, 
Figure 7.11 C). 









Figure 7.10. Single traces of MEPPs recordings in Ca
2+
 buffer in the presence of 
ω-Con GVIA (A) and after the addition of LTX
N4C
 (B). The effects of LPHN1 
activation are not inhibited by ω-Con GVIA. 
A 
B 








Figure 7.11. A. Frequency plot of a MEPPs recording in a buffer containing 2 
mM Ca
2+
, and after the addition of ω-Con GVIA and LTX
N4C
. The presence of ω-
Con GVIA in the buffer does not inhibit the effects of LPHN1 activation. B. 
Average frequency of MEPPs in Ca
2+
 buffer, and after the addition of ω-Con 
GVIA and LTX
N4C
. C. Average amplitude of MEPPs in Ca
2+
 buffer, and after the 
sequential addition of ω-Con GVIA and LTX
N4C
. The difference is not statistically 
significant (N = 2, n = 11 cells recorded in Ca
2+
 buffer, 12 cells with ω-Con 
GVIA, and 30 cells after the addition of LTX
N4C
; ***, P < 0.001, Mann – Whitney 
U test).  































































































The same protocol was used when applying ω-Aga IVA; the preparations were 
incubated in Ca
2+
 buffer with 200 nM ω-Aga IVA and the basal frequency of 
exocytosis was calculated (0.477 ± 0.05 Hz). The recordings continued after the 
addition of 0.25 nM LTX
N4C
, and no significant changes in the frequency of 
neurotransmitter release were observed in this instance (0.29 ± 0.19 Hz, Figure 
7.13 A and B). 
The average amplitude of MEPPs was not significantly different between the 
conditions considered (0.82 ± 0.11 mV in Ca
2+
 buffer, 0.84 ± 0.07 mV in the 








Figure 7.12. Single traces of MEPPs recordings in Ca
2+
 buffer in the presence of 
ω-Aga IVA (A) and after the addition of LTX
N4C
 (B). The presence of ω-Aga IVA 













Figure 7.13. A. Frequency plot of a MEPPs recording in a buffer containing 2 
mM Ca
2+
, and after the addition of ω-Aga IVA and LTX
N4C
. ω-Aga IVA is able to 
fully abolish the effects due to the activation of LPHN1. B. Average frequency of 
MEPPs in buffer A and after the addition of ω-Aga IVA and LTX
N4C
. The 
difference between the conditions is not statistically significant. The control of 
N4C was recorded on the same day on a different preparation not treated with ω-
Aga IVA. C. Average amplitude of MEPPs in Ca
2+
 buffer and after the sequential 
addition of ω-Aga IVA and LTX
N4C
 (N = 3, n = 18 cells recorded in Ca
2+
 buffer, 
14 cells with ω-Aga IVA, and 31 cells after the addition of LTX
N4C
; ***, P< 
0.001, Mann – Whitney U test). 

































































































To summarise, of all the VGCCs tested in my experiments, only P/Q-type VGCCs 
were effective in inhibiting the effects due to the activation of LPHN1. In fact, the 
frequency of exocytosis was significantly inhibited when using ω-Aga IVA, but 
not when using Nimodipine or ω-Con GVIA (Figure 7.14 A). Furthermore, my 
results suggest that the inhibition on exocytosis caused by P/Q VGCCs is effective 
only if these channels are blocked before LPHN1 gets activated (Figure 7.14 B). 
This could be therefore the pivotal first Ca
2+
 channel activated by LPHN1, 
without which the elevation in intracellular [Ca
2+
] is not sufficient to start the 
increase in exocytosis. 








Figure 7.14. A. Comparison between the averaged frequencies of MEPPs after the 
addition of LTX
N4C 
in 2 mM Ca
2+
, and after the addition of VGCCs inhibitors 
(Nimodipine, ω-Con GVIA, and ω-Aga IVA). Only ω-Aga IVA, a specific blocker 
of P/Q VGCCs, is able to inhibit the activation of LPHN1 (***P<0.001, Mann – 
Whitney U test). B. The block of P/Q VGCCs is effective in inhibiting the 
activation of LPHN1 only when added prior to the addition of LTX
N4C
. If added 
once the effects of LPHN1 already developed, blocking these channels does not 
























































































7.2.2 P/Q-type VGCCs are needed to completely abolish the effects of 
LPHN1 activation 
 
As shown in Chapter 5 (Section 5.2.1), the inhibition of Gαq/11 protein drastically 
and significantly reduces the frequency of neurotransmitter release caused by 
activation of LPHN1. However, LPHN1 effect is not completely blocked with the 
inhibition of Gαq/11, and some cells continue firing MEPPs at a relatively high 
frequency, with a minority of cells (approximately 30% of the recorded cells) 
showing a frequency of exocytosis from 6 to 20 Hz. In the light of the results 
described above (Section 7.2.1), this can be due to the activation of P/Q-type 
VGCCs, which, by allowing the entry of Ca
2+
 into the cells, cause some cells to 
respond to it to some extent, although not as strongly as in control, without any 
inhibition. To test this hypothesis, I performed experiments where the activation 
of Gαq/11 and P/Q VGCCs was inhibited at the same time by UBO-QIC and ω-Aga 
IVA. 
The neuromuscular preparations were bathed in a buffer containing 2 mM Ca
2+
 
with the addition of 1µM UBO-QIC and 200 nM ω-Aga IVA. Recordings were 
initially taken in order to evaluate the basal frequency of neurotransmitter release 
in the presence of both inhibitors (0.34 ± 0.04 Hz). Subsequently, 0.25 nM 
LTX
N4C 
was added, and no significant changes in the frequency of exocytosis 
were detectable (0.29 ± 0.06 Hz). No cells showed any signs of effects due to the 
activation of LPHN1 by LTX
N4C
 (Figure 7.16 A and B).  
The average amplitude of MEPPs did not significantly differ between the 
conditions considered (0.82 ± 0.11 mV in Ca
2+
 buffer, 0.82 ± 0.03 mV after 
addition of UBO-QIC and ω-Aga IVA, and 0.85 ± 0.04 mV after the addition of 
LTX
N4C
, Figure 7.16 C). 
 
 








Figure 7.15. Single traces of MEPPs recordings in Ca
2+
 buffer in the presence of 
UBO-QIC and ω-Aga IVA (A) and after the addition of LTX
N4C
 (B). Whilst when 
only UBO-QIC is present about 30% of the cells continue responding to LTX
N4C
 
with increased exocytosis, the concomitant presence of ω-Aga IVA completely 
abolishes the effect. 
A 
B 







Figure 7.16. A. Frequency plot of a MEPPs recording in 2 mM Ca
2+
 and after the 
addition of UBO-QIC and ω-Aga IVA, with subsequent stimulation with 0.25 nM 
LTX
N4C
. B. Average frequency of MEPPs in Ca
2+
 buffer and after the addition of 
UBO-QIC and ω-Aga IVA, and LTX
N4C
. The difference between the conditions is 
not statistically significant. The control for LTX
N4C
 was recorded the same day on 
a different preparation not treated with UBO-QIC and ω-Aga IVA. C. Average 
amplitude of MEPPs in Ca
2+
 buffer, and after the addition of UBO-QIC and ω-
Aga IVA, and after stimulation with LTX
N4C
. The difference between the 
conditions is not statistically different (N = 1, n = 5 cells recorded in Ca
2+
 buffer, 
12 cells with UBO-QIC and ω-Aga IVA, and 9 cells after the addition of LTX
N4C
; 


























































































































1 µM UBO-QIC + 
























In a similar way, I wanted to explore the possibility of VGCCs being involved in 
the residual LPHN1 signalling still detectable with Gαq/11 inhibition. This was 
accomplished by blocking the P/Q VGCCs with ω-Aga IVA. I incubated the 
neuromuscular preparations with 1 µM UBO-QIC (0.34 ± 0.9 Hz) and then added 
0.25 nM LTX
N4C
. Although the overall average frequency was low (1.49 ± 0.60 
Hz) some cells (approximately 30%) still showed a MEPPs frequency of up to 5 
Hz, indicating that they were to some extent responding to the activation of 
LPHN1, and that this response was not mediated by the Gαq/11. Addition of 200 
nM ω-Aga IVA stopped this residual response and completely inhibited the 
effects of LPHN1 (0.17 ± 0.01 Hz Figure 7.17). 
These results suggested that the signalling induced by LPHN1 activation occurs 
along two independent pathways: the activation of Gαq/11 with subsequent sub-
threshold activation of IP3Rs on the calcium stores and the opening of P/Q-type 
VGCCs. Activation of both signalling pathways is required for the full exocytotic 
effect of the LPHN1-mediated LTX
N4C
 signalling.  








Figure 7.17. A. Frequency plot of a MEPPs recording in 2 mM Ca
2+
 and after the 
addition of UBO-QIC, LTX
N4C
 and ω-Aga IVA. B. Average frequency of MEPPs 
in Ca
2+
 buffer, and after the addition of UBO-QIC, LTX
N4C
 and ω-Aga IVA (N = 
1, n = 6 cells recorded in Ca
2+
, 6 with UBO-QIC, 10 after stimulation with 
LTX
N4C
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7.2.3 Cadmium supports the activation of LPHN1 
 
As part of the experiments done to investigate the involvement of the influx of 
Ca
2+
 in the activation of LPHN1, Cd
2+
 was also used as a blocker of VGCCs. In 
these experiments I used a buffer where 2 mM Cd
2+
 was used instead of Ca
2+
, and 
the effects of the activation of LPHN1 on spontaneous neurotransmitter release 
were studied using the same protocol as the experiments with Ca
2+
. 
Compared to the basal frequency of exocytosis observed in Ca
2+
 buffer, no 
significant changes in frequency (0.36 ± 0.03 Hz in Ca
2+
 buffer vs. 0.34 ± 0.06 Hz 
in Cd
2+
 buffer, Figure 7.18 B) and amplitude (0.82 ± 0.11 mV in Ca
2+
 buffer vs. 
0.84 ± 0.16 mV in Cd
2+







Figure 7.18. A. Single traces of MEPPs recorded at the mouse NMJ in 2 mM 
Cd
2+




 buffer. The difference 





 buffer. The difference is not statistically significant (N 
= 6, n = 23 cells recorded in Ca
2+



























































 buffer, LPHN1 was still able to 
elicit an increase in exocytosis similar in frequency to the one observed in Ca
2+
 
(15.50 ± 7.07 Hz in Ca
2+
 buffer vs. 18.94 ± 1.07 Hz in Cd
2+
 buffer). However, the 
cells did not show bursting behaviour, rather the frequency of release increased 
gradually, after about 10 min reaching a peak that lasted for approximately 30 
minutes (29.52 ± 6.15 Hz) and then slowly decreased until cessation (Figure 7.20 
A and B). 
The MEPPs average amplitude was not significantly different between the 
conditions (0.84 ± 0.16 mV in Cd
2+
, and 0.85 ± 0.33 mV in after the addition of 
LTX
N4C





Figure 7.19. Single traces of MEPPs recorded at the mouse NMJ in Cd
2+
 buffer 
after the addition of LTX
N4C
. This buffer completely supports the increase in 
exocytosis caused by the activation of LPHN1. 
 








Figure 7.20. A. Frequency plot of a MEPPs recording in Cd
2+
 buffer and after the 
addition of LTX
N4C
. B. Average frequency of MEPPs in Cd
2+
 buffer and after the 
addition of LTX
N4C
. C. Average amplitude of MEPPs in Cd
2+
 buffer and after 
addition of LTX
N4C
 (N = 6, n = 18 cells recorded in Cd
2+
 buffer and 35 after the 
addition of LTX
N4C
; ***, P < 0.001, Mann – Whitney U test). 
 
 






























































































As described previously, LTX
N4C
 caused no effect in a Ca
2+
-free buffer, but the 
subsequent addition of Ca
2+
 triggered massive bursting exocytosis (see Chapter 4, 
Section 4.2.4, Figure 4.10). Similarly, the frequency of neurotransmitter release 
rapidly increased upon the addition of 2 mM Cd
2+
 to preparations bathed in a 
Ca
2+
-free buffer supplemented with 0.25 nM LTX
N4C
. The effect was comparable 
to the one observed when LTX
N4C
 was added in Cd
2+
-containing buffer, with no 
bursting behaviour and gradual cessation of release (Figure 4.21). 
 
 
Figure 7.21. A. Frequency plot of a MEPPs recording inCa
2+
-free buffer, and 




. B. Average frequency of MEPPs in Ca
2+
-




 (N = 2, n = 7 cells 
recorded in Ca
2+
-free buffer, 9 cells after the addition of LTX
N4C
, and 26 cells 
after the addition of Cd
2+













































































, as a universal blocker of VGCCs, were initially meant to 
test the involvement of VGCCs in LPHN1-mediated exocytosis of 
neurotransmitter. However, Cd
2+
 seem to support LPHN1-mediated signalling, 
and the effects of its activation were still present although with different 
characteristics than that observed in Ca
2+
. It is therefore likely that Cd
2+
 was able 
to permeate through some of the channels that caused the increase in exocytosis 
when LTX
N4C
 was used in Ca
2+
. To investigate the involvement of the SOCCs and 
VGCCs in LPHN1 signalling in the presence of Cd
2+
, I used the pharmacological 
agents that appeared to be the best blockers of the LPHN1-evoked 
neurotransmitter release. 
Doing this, it was possible to understand that SOCCs are equally involved in the 




 (Figure 7.23). In fact, 2APB 
(50 µM) was able to significantly reduce the frequency of exocytosis (0.76 ± 0.66 






Figure 7.22. Single traces of MEPPs recordings in Cd
2+
 buffer after the addition 
of LTX
N4C
 and 2APB (A) or SKF96365 (B). These SOCCs blockers are successful 
in inhibiting LPHN1-mediated increase in exocytosis when Ca
2+
 is replaced by 
Cd
2+
 in the extracellular buffer. 
A 
B 









































Figure 7.23. Comparison between the averaged frequency of MEPPs in Cd
2+
 
buffer, and after the addition of LTX
N4C
 and of SOCCs blockers 2 APB and 
SKF96365. Both drugs successfully inhibit LPHN1-mediated exocytosis (n = 15 
cells recorded in Cd
2+
, 29 cells after the addition of LTX
N4C
, 32 cells after the 
addition of 2APB, and 15 after the addition of SKF96365; **, P < 0.010; ***, P 
< 0.001, Mann – Whitney U test). 
 
To test the involvement of VGCCs, I used ω-Con MVIIC (1 µM) before the 
activation of LPHN1 by LTX
N4C
 (0.25 nM). Differently to what happened in Ca
2+
 
buffer, however, ω-Con MVIIC was less effective in inhibiting the frequency of 
neurotransmitter release when used in Cd
2+
 buffer (8.37 ± 2.75 Hz, Figure 7.25 
A). 
The average amplitude of MEPPs was not significantly different between the 
conditions considered (0.84 ± 0.16 mV in Cd
2+
 buffer, 0.81 ± 0.05 mV in the 
presence of ω-Con MVIIC, and 0.84 ± 0.02 mV after the addition of LTX
N4C
, 















Figure 7.24. Single traces of MEPPs recording in Cd
2+
 buffer in the presence of 
ω-Con MVIIC before (A) and after (B) the addition of LTX
N4C
. The inhibition of 
exocytosis exerted by ω-Con MVIIC is Cd
2+ 























Figure 7.25. A. Average frequency of MEPPs in 2 mM Cd
2+
, and after the 
addition of ω-Con MVIIC and LTX
N4C
. B. Average amplitude of MEPPs in Cd
2+
 
buffer and after the addition of ω-Con MVIIC and LTX
N4C
. The difference is not 
statistically significant (N = 1, n = 6 cells recorded in 2 mM Cd
2+
, 8 cells after 
the addition of ω-Con MVIIC, and 20 after the addition of LTX
N4C
; ***, P < 
0.001, Mann – Whitney U test). C. Comparison between the effects on frequency 




 buffer in the absence or presence 

































































































 buffer are similar to the 
effects that TG has when it is used in this same Cd
2+
-containing buffer (see 
below) or indeed in the Ca
2+
-free buffer (see Chapter 6, Section 6.2.3, Figure 
6.17). However, in contrast to what happens in the presence of extracellular Ca
2+
, 
addition of 10 µM TG in Cd
2+
 causes a fast increase in exocytosis (within 1 min) 
that reaches an average frequency not significantly different from that in Ca
2+ 




 buffer, the average amplitude of MEPPs after addition of TG was 
significantly higher (1.81 ± 0.05 mV) than the amplitude in Cd
2+
 buffer only (0.84 





Figure 7.26. Single traces of MEPPs recordings in Cd
2+
 buffer after the addition 
of TG. Under this condition, exocytosis goes through a gradual increase, then 
reaches a pick that remain stable for some time before decreasing until cessation. 
 








Figure 7.27. A. Frequency plot of a MEPPs recording in 2 mM Cd
2+
 and after the 
addition of TG. B. Average frequency of MEPPs in Cd
2+
 buffer and after the 
addition of TG. C. Average amplitude of MEPPs in Cd
2+
 buffer and after the 
addition of TG (N = 3, n = 18 cells recorded in Cd
2+
 buffer and 24 cells after the 
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Similarly to my experiments in Chapter 6 on the role of Ca
2+
 in LPHN1 
signalling, I used TG to test the role of intracellular Ca
2+
 stores and Cd
2+
 in the 
rise of exocytosis due to the activation of LPHN1. 0.25 nM LTX
N4C
 was added in 
Cd
2+
-containing buffer, and 10 µM TG was then added once the increase in 
exocytosis reached its peak, but before the frequency started to decrease (as 
demonstrated above, Figure 7.27). In the presence of extracellular Cd
2+
, I 
observed the same immediate drop and cessation in neurotransmitter release (0.10 
± 0.07 Hz) as was observed in Ca
2+
 buffer (Figure 7.29).  
These experiments suggest that TG very quickly blocks the influx or transport of 
Cd
2+
 into the nerve terminals, which is crucial for the toxin-triggered exocytosis. 
Interestingly, because TG causes exactly the same abrupt cessation of LTX
N4C
-
induced exocytosis in the presence of extracellular Ca
2+
, I can conclude that the 









Figure 7.28. Single traces of MEPPs recordings in Cd
2+
 buffer after the addition 
of LTX
N4C
 (A) and TG (B). TG causes the immediate cessation of release when 
LTX
N4C 
effects have developed. 
A 
B 









Figure 7.29. A. Frequency plot of a MEPPs recording in 2 mM Cd
2+
, and after 
the addition of LTX
N4C
 and TG. Addition of TG after the rise in exocytosis due to 
LTX
N4C 
causes a sudden block of release. B. Average frequency of MEPPs in Cd
2+
 
buffer, and after the addition of LTX
N4C
 and TG (N = 2, n = 8 cells recorded in 
Cd
2+
 buffer, 12 cells after the addition of LTX
N4C
, and 15 cells after the addition 
















































































7.2.4 Comparison of LPHN1- and depolarisation-mediated neurotransmitter 
release 
 
As mentioned previously (see Chapter 4, Section 4.2.10, Figure 4.31), to study 
depolarisation-induced exocytosis I can stimulate nerve terminals using KCl, 
which is known to cause depolarisation of the neuronal plasma membrane and 
subsequent influx of Ca
2+
 through VGCCs. To compare the involvement of 
VGCCs in LPHN1- and depolarisation-induced exocytosis I performed current 
clamp experiments on neuromuscular preparations stimulated with 20 mM KCl 
using the pharmacological agents previously used to study LPHN1-mediated 
neurotransmitter release. 
I already described above that normally the addition of 20 mM KCl caused an 
approximately 50-fold increase in the frequency of exocytosis when used in a 
buffer containing 2 mM Ca
2+
 (see Chapter 4, Section 4.2.10, Figure 4.31). In this 
part of the project I conducted similar control experiments, which showed that on 
the addition of KCl, the frequency of MEPPs gradually increased and reached an 
average of 16.13 ± 5.34 Hz in about 30 s; nerve terminals maintained this 
frequency for about 40 min, and then MEPPs frequency started to decrease until 
all miniature events stop in about 40 min (Figure 7.31).  
Upon addition of KCl the resting membrane potential becomes more positive, 
however the MEPPs average amplitude was not significantly different between 
the Ca
2+-
free and the 20 mM KCl conditions (0.90 ± 0.18 mV and 0.88 ± 0.18 mV 
respectively), whilst is slightly lower when Ca
2+
 is added (0.58 ± 0.01 mV, P < 
0.05, Mann – Whitney U test). 








Figure 7.30. Single traces of MEPPs recordings in Ca
2+
-free buffer (A), and after 




Figure 7.31. Average frequency of MEPPs in Ca
2+
-free buffer, and after the 
addition of 20 mM KCL and 2 mM Ca
2+
. The increase in exocytosis does not start 
until Ca
2+
 is added to the extracellular buffer (N = 5, n = 10 cells recorded in 
Ca
2+
-free buffer, 21 cells after the addition of KCl, and 38 cells after the addition 
of Ca
2+

































In experiments with depolarisation-induced exocytosis, I used several VGCCs 
blockers: Nimodipine (an inhibitor of L-type VGCCs), ω-Aga IVA (an inhibitor 
of P/Q-type VGCCs), ω-Con MVIIC (an inhibitor of P/Q and N-type VGCCs), 
and Cd
2+
. Inhibitors were used one at a time or in conjunction in order to test the 
contribution of different channel types.  
The addition of only Nimodipine (10 µM), ω-Aga IVA (200 nM), or ω-Con 
MVIIC (1 µM) was not sufficient to significantly decrease the effect of KCl (20 
mM) on exocytosis (21.50 ± 1.95 Hz, 14.32 ± 3.32 Hz and 12.18 ± 3.23 Hz 
respectively, Figure 7.33). 
Adding Nimodipine and ω-Con MVIIC at the same time caused an increase in the 
baseline even in the absence of KCl (5.02 ± 1.05 Hz). Considering this 
background release, the frequency of KCl-evoked exocytosis significantly 
dropped (to 3.52 ± 1.78 Hz, Figure 7.33). 
Cd
2+
 was either used as a replacement of Ca
2+
 (2 mM), as in previous 
experiments, or added to Ca
2+
-containing buffer (500 µM). In both cases, Cd
2+
 
completely blocked the effect of KCl on exocytosis (0.12 ± 0.11 Hz and 0.21 ± 
0.05 respectively, Figure 7.33). 
None of the drugs tested caused a significant change in the amplitude of MEPPs 
(0.58 ± 0.02 mV in Nimodipine, 0.52 ± 0.01 mV in ω-Con MVIIC, 0.64 ± 0.01 
mV when Nimodipine and ω-Con MVIIC were used together, 0.60 ± 0.01 mV in 
ω-Aga IVA, 0.78 ± 0.16 mV in 2 mM Cd
2+
, and 0.60 ± 0.06 mV when 500 µM 
Cd
2+
 was added in Ca
2+


























Figure 7.32. Single traces of MEPPs recordings in the presence of 20 mM KCl 
after the addition of Nimodipine (A), ω-Aga IVA (B), ω-Con MVIIC (C), 
Nimodipine + ω-Con MVIIC (D), 2 mM Cd
2+
 (E), and 500 µM Cd
2+
 (F). 







Figure 7.33. Average frequency of MEPPs in 20 mM KCl, and after the addition 
of VGCCs blockers Nimodipine, ω-Aga IVA, ω-Con MVIIC, Nimodipine and ω-
Con MVIIC, and Cd
2+
 (*, P < 0.05; ***, P < 0.001, Mann – Whitney U test). 
 
When comparing the LTX
N4C
 and depolarisation-triggered exocytosis, both 
stimuli absolutely require the influx of Ca
2+
 into the nerve terminals. However, 
my findings in this section also show that the two stimuli may either use different 




























































































The experiments described in this chapter were directed at investigating the 
role of VGCCs in the effects observed upon the activation of LPHN1. As 
discussed previously (see Chapter 6, Section 6.3), the release of Ca
2+
 from 
intracellular stores and subsequent opening of SOCCs only cannot explain all the 
effects on exocytosis cause by LPHN1 activation. In fact, when compared to the 
effects of TG in the absence of extracellular Ca
2+
, it is clear that even if LPHN1 
signalling causes any Ca
2+
 release from the stores, this amount of Ca
2+
 release is 
not high enough to start the increase in exocytosis observed. Another source of 
Ca
2+
 is needed in order to increase the cytosolic [Ca
2+
] to a point where the whole 
mechanism can potentiate and produce the 160-fold increase in exocytosis 
described.  
The involvement of VGCCs was, therefore, investigated as a possible 
source of Ca
2+
 influx. Blockers of the major neuronal VGCCs were used to test 
their ability to stop the exocytosis increase upon addition of LTX
N4C
. Of all the 
channels tested, only the block of P/Q-type VGCCs was successful in inhibiting 
the signalling downstream of LPHN1 (see Figure 7.13). In fact, the blockade of 
the other channels did not significantly decrease the frequency of MEPPs nor did 
it bring changes to the bursting behaviour observed upon activation of LPHN1 
(see Figure 7.14, A).  
Interestingly, the block of P/Q-type VGCCs is successful in inhibiting the 
effects of LPHN1 activation only when the P/Q-types blockers are applied before 
the addition of LTX
N4C
, while the block of these channels after the effects of 
LPHN1 activation already started does not bring about any significant changes in 
the overall frequency of exocytosis or bursting behaviour (see Figure 7.14, B). 
The only difference observed in this case is the frequency of MEPPs during the 
interburst intervals. Application of P/Q blockers to terminals already responding 
to LTX
N4C
 leads to a significantly lower average frequency of release in between 
the bursts (see Figure 7.9).  
I discussed in the previous chapter how the opening of the SOCCs can 
explain the increased frequency of exocytosis during the bursts. The opening of 





P/Q VGCCs can, instead, explain the frequency during the interburst intervals, 
which, although not as high as during the bursts, is still much higher than that 
observed in the absence of LTX
N4C
. This observation, together with the finding 
that the blockade of P/Q VGCCs can stop the effects of LPHN1 activation only if 
applied before the addition of LTX
N4C
, helps to delineate a more complex, but 
possibly more complete scheme of the molecular elements activated by LPHN1.  
First, the activation of LPHN1 starts the molecular pathway involving Gαq/11 
that leads to the activation of IP3Rs located at the ER; this in itself, however, is 
not sufficient to induce Ca
2+
 release, most likely because of the subthreshold 
activation of the Ca
2+
 release channels (IP3Rs). At the same time, LPHN1 
activation causes the opening of P/Q VGCCs. This triggers an initial increment of 
cytosolic Ca
2+
 coming from the extracellular space. Although this increase is not 
enough to cause the dramatic bursts of exocytosis that develops later, it is still 
sufficient to increase the frequency of MEPPs by about 2 times compared to the 
basal frequency. More importantly, this P/Q VGCCs-mediated increase in 
cytosolic Ca
2+
 further stimulates the IP3Rs, now leading to their massive opening 
and a further increase in cytosolic [Ca
2+
]. This mechanism leads to the depletion 
of Ca
2+
 stores, thus, allowing for the opening of SOCCs. At this point, the 
elevation in cytosolic [Ca
2+
] reaches a level that translates into the development of 
a proper burst of exocytosis (when the frequency of spontaneous exocytosis 
reaches values up to 150 times higher than at rest). The burst continues until the 
SOCCs are inactivated by the refilling of the stores, and cytosolic Ca
2+
 is largely 
sequestered or chelated. At that point the burst stops, and the frequency of 
exocytosis drops to about 2.5 times of that during the rest, being caused by the 
small but apparently constant and pivotal influx of Ca
2+
 via the P/Q VGCCs.  







Figure 7.34. Schematic representation of the full mechanism activated by LPHN1.  
As extensively discussed previously (Chapter 5, Figure 5.15) the stimulation of 
LPHN1 causes the activation of the Gαq protein signalling pathway, ultimately 
leading to the release of Ca
2+ 
from IP3Rs located at the ER (arrows 1 to 5). The 
decreased concentration of ER intraluminal Ca
2+ 
is detected by STIM1, that 
dimerises in proximity to the plasma membrane and contacts SOCCs (TRPCs and 
Orais), opening them and allowing influx of Ca
2+
 (arrows 4 – 5, Chapter 6, 
Figure 6.23).  In parallel, activation of LPHN1 causes the opening of P/Q VGCCs 
(arrow 6), that supply the initial influx of Ca
2+
 necessary to elevate the 
intracellular Ca
2+
 concentration to a level sufficient to further stimulate IP3Rs 




 as a replacement of Ca
2+
, initially designed to test 
the involvement of VGCCs in the activation of LPHN1, were instead useful in 





, does not inhibit the effects of LPHN1 activation; 
however, it changes their characteristic. Nerve terminals still respond to the 
addition of LTX
N4C
 with a high increase in the frequency of exocytosis, that can 
be compared to the overall increase in the presence of Ca
2+
 (see Figure 7.20, B). 





However, the bursts cycles are never produced; instead, the frequency of release 
gradually increases and then decreases, followed by a complete cessation of 
exocytosis. This effect can be explained, by postulating that rather than blocking 
the VGCC conductance, Cd
2+
 acts by interacting with other extracellular proteins. 
In fact, outside the cells Cd
2+
 is able to upregulate the cytosolic [Ca
2+
] by 
activating cell surface G protein-coupled metal binding receptors (Faurskov and 
Bjerregaard 2002; Martelli et al. 2006). This activates PLC and leads to the 
production of IP3, leading to the release of Ca
2+
 from intracellular stores. 
Moreover, whilst it is certainly true that Cd
2+
 is a blocker of VGCCs at high 
concentration, this cation is still able to enter the cell through them, especially, but 
not only, through L-type VGCCs. In other words, Cd
2+
 inhibits the Ca
2+
 current 
through VGCCs, but it can permeate them itself, and once inside the cells it can 
fully support exocytosis (Hinkle, Shanshala and Nelson 1992; Usai et al. 1999; 
Gavazzo, Morelli and Marchetti 2005). To further complete the picture, Cd
2+
 is 
also able to pass through SOCCs, therefore, allowing the full activation of the 
LPHN1-mediated exocytosis. In this way, Cd
2+
 may be able to activate all the 
molecular components that seem to be involved in the exocytosis caused by 
LPHN1 activation. The only difference in the phenomenology of the effect of 
Cd
2+
 when compared to Ca
2+
, is the absence of bursting behaviour, which can be 
explained by the incapacity of Cd
2+
 to refill the stores, so that the increase in 





is available in the cytosol.  
The question that remains to be addressed is the kind of relationship 
between LPHN1 and P/Q VGCCs. In fact, several kinds of interactions are 
possible. First of all, one has to consider that usually VGCCs become activated by 
depolarisation of the cells; however, as I suggest with my experiments using TTX 
(see Chapter 4, Section 4.2.11), opening of TTX-sensitive voltage-gated Na
2+
 
channels and depolarisation of the cells is not needed for the effects of LPHN1 
activation (although also other channels might be involved in depolarisation and 
this conclusion will need more investigation). P/Q channels can also be regulated 
by G proteins, particularly by the βγ subunits. However, the regulation in this case 
is inhibitory, switching the state of the channel from the “willing” state (easy to 





activate) to the “reluctant” state. This inhibition can be reversed by, among other 
factors, phosphorylation of the channel by PKC (Herlitze et al. 2001; Colecraft, 
Brody and Yue 2001). It is therefore possible that LPHN1 facilitates the opening 
of P/Q VGCCs by activating PKC, which in turn phosphorylates the channel. 
Another possibility is that the interaction between LPHN1 and P/Q, in addition to 
being functional, is also physical. If these two proteins physically interact, the 
conformational changes due to LPHN1 activation might cause the opening of the 
channel, possibly leading to its continuous activation. If this hypothesis is true, 
then other question would arise about the nature of this interaction: do LPHN1 
and P/Q VGCC normally interact or is the interaction present only upon the 
activation of LPHN1 with LTX
N4C
? One way to address this hypothesis would be 
to perform pull down experiments using a LTX column in order to see if P/Q 
VGCCs is pulled down together with LPHN1 (although in this case LPHN1 
would be at least partially activated by LTX, which might increase the interaction 
between LPHN1 and VGCC). Other methods to pull down LPHN1, would be 
needed to ascertain if the interaction between the two proteins is constitutive or it 
occurs only upon LPHN1 activation. Moreover, patch clamp experiments on cells 
expressing LPHN1 and P/Q channels are needed in order to evaluate the influx of 
Ca
2+
 through these channels when LPHN1 is activated. 
 
 








The main purpose of this work was to delineate the molecular mechanisms 
responsible for the control of spontaneous exocytosis by LPHN1. 
 First, we studied the physiological effects that LPHN1 exerts on 
spontaneous exocytosis at the mouse NMJ and in cultured hippocampal neurons 
in the absence of LPHN1 activation. By comparing LPHN1 WT and KO mice 
(see Chapter 4, Sections 4.2.2 and 4.2.3), it was possible to observe a consistent 
increase in the frequency of spontaneous exocytosis in the row from WT, to Het, 
to KO preparations. This result alone already gives us the idea of LPHN1 as a 
regulator of neurotransmitter release. When LPHN1 is not activated, it controls 
the activity of neurons and maintains the basal frequency of spontaneous 
exocytosis at lower levels. However, as we will see below, the activation of 
LPHN1 very strongly increases spontaneous neurotransmitter release. This 
behaviour is fully consistent with a central role of LPHN1 in controlling the 
resting and induced spontaneous secretion. 
Other suggestions about the physiological role of LPHN1 come from the 
experiments on central synapses. Here, LPHN1 KO neurons showed reduced 
connectivity and low survival compared to WT neurons. This can suggest a role 
for LPHN1 in neuronal development, a possibility that has been directly supported 
by experiments with soluble LPHN1 constructs (Boucard, Maxeiner and Sudhof 
2014) and that finds further ground also considering that Lasso, an endogenous 
ligand of LPHN1, is a member of the teneurin family (Silva et al. 2011), a class of 
proteins involved in neuronal development, axon guidance and synaptogenesis 
(Tucker et al. 2007; Young and Leamey 2009). 
Second, using the non-pore forming mutant of α-LTX, LTX
N4C
, as an 
LPHN1 agonist, we studied the effects of LPHN1 activation on spontaneous 
exocytosis. Activation of LPHN1 using this toxin causes an increase in exocytosis 
that goes through bursts of intense release that can reach frequencies of 100 Hz, 
interspersed with intervals of moderate activity, where the frequency of release 





goes back almost to the resting level (see Chapter 4, Section 4.2.5). The bursts and 
inter-burst intervals are irregular in length, but are always present in each cell 
recorded when LPHN1 is activated by this agonist. So far this behaviour could not 
be explained, as the mechanisms underlying these effects were not known. The 
results we will discuss further in this chapter provide the first most plausible 
molecular basis for the burst-like spontaneous exocytosis induced by the 
activation of LPHN1. 
However, LTX
N4C
 is known to bind both LPHN1 and NRX-Iα (Ichtchenko 
et al. 1998; Volynski et al. 2003). Therefore, before investigating the details of the 
mechanisms underlying LPHN1 activation, it was important to demonstrate that 
LPHN1 is the α-LTX receptor responsible for the effects described. This was 









 (conditions in which the binding of 
LTX
N4C
 to all NRXs is not possible; Volynski et al. 2003) causes an increase in 
exocytosis generally comparable to that described in Ca
2+ 
(see Chapter 4, Section 
4.2.8).  
More importantly, when LTX
N4C
 is used on LPHN1 KO NMJ 
preparations, none of the effects described in WT preparations are observed (see 
Chapter 4, Section 4.2.9). The overall frequency of exocytosis does not 
significantly change with the addition of the toxin, although very few occasional 
bursts are present. This could be explained, however, if we take into consideration 
that LPHN2 is also present in these preparation, and that in the absence of LPHN1 
the affinity of LPHN2 to LTX
N4C 
is higher than in WT animals, probably due to 
different post-translational modification of LPHN2 (Yuri Ushkaryov, personal 
communication). A partial compensation mechanism can, therefore, take place, 
where LPHN2, taking over some functions of LPHN1, can react to LTX
N4C
, 
causing the rare bursts of exocytosis, but not the overall frequency of release.  
Furthermore, LTX
N4C
 causes no effect when the interaction between the 
NTF and the CTF of LPHN1 is prevented by low concentrations of PFOA (see 
Chapter 4, Section 4.2.10). In this case, in fact, the binding of LTX
N4C
 to the NTF 
still occurs, however, it cannot cause the conformational changes in the CTF that 





are necessary to transduce the signal and to start the molecular pathway 
responsible for the increased spontaneous exocytosis. 
Finally, we delineated the molecular mechanisms responsible for LPHN1-
mediated effects using several inhibitors of the G protein pathway and blockers of 
SOCE and VGCCs. 
Figure 8.1 summarises the main findings of this study, delineating the molecular 
players that are responsible for the elevation in the frequency of spontaneous 
exocytosis observed upon LPHN1 activation. Our results revealed three main 
molecular players that work together to generate the effects observed: 
 
- Gαq/11 protein and its signalling pathway (see Chapter 5); 
- Intracellular Ca
2+
 store depletion and activation of SOCE (see Chapter 6); 
- P/Q VGCC (see Chapter 7). 
 
The binding of LTX
N4C
 to LPHN1 causes the activation of Gαq/11 protein; this, in 
turn, activates PLC, that promotes the hydrolysis of PIP2 in IP3 that, binding to 
IP3R in the endoplasmic reticulum, ultimately causes the release of Ca
2+
 from 
intracellular stores and the consequent elevation in cytosolic [Ca
2+
] (for a review 
see Kamato et al. 2015). The decrease in the ER [Ca
2+
] causes the dimerization of 
STIM, that, aggregating into puncta close to the plasma membrane, contacts and 
leads to the opening of Orai and TRPC channels, starting SOCE that permits the 
refilling of the stores and that further increases the cytoplasmic [Ca
2+
] (Salido, 












Figure 8.1. Block diagram summarising the molecular mechanisms responsible 
for the increased exocytosis observed after stimulation of LPHN1 with LTX
N4C
. 
Activation of LPHN1 causes the stimulation of the Gαq protein signalling pathway 
and, in parallel, the opening of P/Q VGCCs. The first leads to the efflux of Ca
2+
 
from IP3-sensitive intracellular Ca
2+
 stores and subsequent opening of SOCCs 
and initiation of SOCE; the periodic opening/closing of SOCCs is what give rise 
to the bursts, and it will go on as long as LPHN1 is stimulated. The latter causes 
the initial influx of Ca
2+
 needed to further stimulate the release of Ca
2+
 from 
IP3Rs and start the increase in the frequency of exocytosis; the constant influx of 
Ca
2+
 from P/Q VGCCs is responsible for the increased frequency of spontaneous 
release observed during interburst intervals. 
 






 None of these mechanisms, however, is able to cause the increase in 
exocytosis without the initial involvement of the P/Q-type VGCC. In fact, the 
effects of LPHN1 activation are completely inhibited when this channel is 
blocked before the increase of release induced by LTX
N4C
 has started. 
Furthermore, activation of LPHN1 in the absence of extracellular Ca
2+
 also causes 
no increase in spontaneous exocytosis. These data could mean that the G protein 
pathway activated by LPHN1 alone is not able to activate IP3R to an extent where 
the elevation in Ca
2+
 causes the depletion of the stores and the activation of 
SOCE; more Ca
2+
 is needed, and this is provided by the activation of the P/Q 
VGCCs, in order to further stimulate the release of Ca
2+
 from IP3R and start 
SOCE. The cyclical process of stores depletion – activation of SOCE and stores 
refilling – deactivation of SOCE most likely causes the waves in increased – 
decreased intracellular Ca
2+
 concentration that constitutes the mechanism 
responsible for the bursting behaviour of spontaneous exocytosis induced via 
LPHN1. Specifically, the increased cytosolic Ca
2+
 concentration due to its influx 
through SOCCs is likely to be responsible for the fast increase in exocytosis 
characterising bursts, that lasts until the refilling of the stores is complete, the 
SOCCs close again, and the intracellular Ca
2+
 concentration goes back to 
physiological level. On the other hand, the activation of the P/Q-type VGCC does 
not seem to follow this burst-like pattern, and therefore, the basal increased 
cytosolic [Ca
2+
] caused by the continuous opening of P/Q VGCCs could account 
for the slightly increased frequency in exocytosis during interburst intervals. 
What remains to be understood is the nature of the interaction between 
LPHN1 and P/Q VGCCs. In fact, regulation of VGCC channels by G proteins has 
been widely described in the literature (for a review see Dolphin 2003). These 
channels are operated by direct interaction with the βγ subunit or by 
phosphorylation through activation of the Gα subunit (Herlitze et al. 2001; 
Colecraft, Brody and Yue 2001). However, in both cases the interaction with P/Q-
type VGCCs is inhibitory in nature. However, the activation of LPHN1, instead, 
leads to an excitatory effect. This could be due to a novel form of VGCCs 
modulation. Alternatively, LPHN1 may physically interact with the P/Q VGCC, 





leading to channel opening in response to a conformational change in LPHN1 
caused by its activation. 
 
8.1 Toxicological aspects of the LPHN1 NTF and CTF dissociation caused 
by PFOA  
 
Perfluorooctanoic acid (PFOA) is a synthetic, non-biodegradable compound 
belonging to the perfluorinated compound family (PFCs). Being used as a 
surfactant in several industrial applications, such as in clothing, carpets, food 
packaging and cookware, the exposure to these compounds is pervasive and its 
effects have been studied under different aspects. PFCs have been detected for the 
first time in human tissues in the 1960s (Taves, 1968) and since then numerous 
studies have been undertaken to investigate their accumulation in tissues and their 
potential toxicity. Although less than in other tissues such as blood and liver, 
PFCs have been found accumulating in the brain, with PFOA reaching levels of 
0.5 ng/g (Maestri et al. 2006). 
The presence of PFCs in brain tissues has led to concerns about the potential 
neurotoxicity of these compounds. It has been shown that neonatal exposure to 
PFCs can lead to altered expression of proteins such as Tau, GAP-43, CaMII and 
synaptophysin involved in synaptogenesis and neuronal growth; the cholinergic 
system is also affected, with animals showing a hypoactive response to 80 µg/kg 
of nicotine 4 month after a single exposure to 1.4 – 21 µM/kg PFOA. Following 
the same treatment, also spontaneous behaviour (locomotion, rearing and total 
activity) were deregulated, as well as habituation, a kind of non-associative 
learning (Johansson, Fredriksson and Eriksson 2008; Johansson, Eriksson and 
Viberg 2009). 
Neonatal exposure to PFOA can also cause alteration of the immune system that, 
given the predisposition, could lead to the development of symptoms associated to 
autism and ADHD (Hu et al. 2012). 
In vitro, exposure of N2a cells to > 200 µM PFOA and PFOS mediates the 
disintegration of 3D cultured spheroid into single cell populations, increases the 
level of necrosis and apoptosis and has inhibitory effect on retinoic acid-induced 





differentiation (Choi et al. 2013); the same concentration is able to disrupt 
calcium homeostasis in cultured hippocampal neurons, stimulating the release of 
Ca
2+
 from intracellular Ca
2+
 stores (Liu et al. 2011). Exposure to 10 – 30 µM 
PFCs induces changes in cerebellar Purkinje cells membrane potentials and 
reduces the rate of fired action potentials (Harada et al. 2006).  
In the present work, we showed that PFOA is able to dissociate and 
differentially solubilise the NTF and CTF of LPHN1, and we described the 





Figure 8.2. Dissociation of LPHN1 NTF and CTF by PFOA. LPHN1 NTF and 
CTF normally exist as separate fragments independent from each other, and they 
associate upon binding of an agonist. PFOA supposedly disrupts this association, 
preventing the effects of LPHN1 activation to develop. 
 
 
Here, PFOA inhibited, and at 100 µM completely blocked the toxin-
evoked exocytosis in a dose-dependent manner. Increasing concentrations of 
PFOA also delayed depolarisation-induced neurotransmitter release. These results 
provide new insights into the neurotoxic effect of PFOA on neuronal 
transmission. The effects described in our experiments can be only compared to 
an acute intoxication, as the preparations are suddenly exposed to relatively high 
PFOA concentrations and the effects are observed straight away. Although this 
type of exposure may not occur in less artificial conditions, the major concern is 
that PFOA accumulates in tissues; for example, levels of about 2 µg/ml have been 





found in the blood of chronically exposed workers (Ehresman et al. 2007). The 
slow and gradual exposure is likely to lead to the development of compensation 
mechanisms that, although restoring the impaired function (in our case slow 
reaction time) to level close to control, may in the long term disrupt some other 
function changing the balance that characterises the normal physiology. 
Caution must be used when using this compound on the large scale, as its 
effects on human population could cause a general increase in the reaction time of 
neurons, and consequently a slower response in the action of individuals, that may 
result in dangerous situations especially when they are involved in activities such 
as driving or using work-related tools. 
 





8.2 Future work 
 
The work discussed so far allowed us to answer some questions about 
LPHN1 that were never explored in depth before. However, new questions arise 
that could not be answered due to limitations in time and in the experimental 
methods used, and therefore will need to be addressed in the future.  
First, it will be interesting to explore in depth the phenomenon of reduced 
survivability of neurons lacking LPHN1. It could be that the interaction between 
LPHN1 and Lasso is necessary for the synapse to fully develop and therefore 
neurons KO for LPHN1, an adhesion molecule, fail to establish functional 
connections with postsynaptic partners. Interesting suggestions about the role of 
LPHN1 could also arise studying the survivability of neurons lacking Lasso 
instead. The same reduced connectivity could be observed, confirming the 
importance of the LPHN1 – Lasso interaction for synapse formation, or 
alternatively, if no differences are found compared to WT neurons, it could mean 
that a molecule different from Lasso (probably FLRT3) also interact with LPHN1 
in vivo regulating synaptic formation, and this could reveal new functions of the 
receptor.  
Second, fully formed synapses lacking LPHN1 are more active than the WT 
ones, showing increased spontaneous neurotransmitter release at rest. This aspect 
might be crucial for the constitution of functional neuronal networks in the 
developing nervous system. In fact, there is evidence that we are born with more 
synaptic connections than we retain, and that the interaction with the environment 
helps the system to select the synapses that, being more active, have to be 
maintained (Edelman 1987; Edelman 1992). It is therefore possible that mice 
lacking LPHN1 (and probably humans with expressing a defective form of it) 
develop abnormal neuronal networks, that in the long run could lead to 
pathological outcomes such as autism, where subjects affected have been shown 
to have more synapses than the control (Tang et al. 2014), or Alzheimer’s disease, 
in which hyperactivity of the medial temporal regions and a general increased 
magnitude of brain activation (especially hippocampal, parietal and prefrontal 
regions) during memory tasks have been shown to be common in subjects at risk 





of the disease, and could be able to predict the subsequent future decline in 
memory (Bookheimer et al. 2000; Putcha et al. 2011). 
Third, more precision is needed in defining the molecular partners involved 
in LPHN1 activation, particularly in respect of SOCCs. First of all, having the 
limitation of not allowing genetic manipulations of the specimen, the experiments 
on NMJ did not allow us to test if the defective expression of particular SOCCs 
would alter the response of LPHN1 to LTX
N4C
. As mentioned in Chapter 4, 
differentiated Nb2a cells acquire the ability to respond to LTX
N4C
 when 
expressing LPHN1 (response that is not present in non-differentiated Nb2a cells, 
even when expressing LPHN1). Preliminary data suggest that the proteins 
necessary for a functional SOCE are upregulated in these cells, particularly 
STIM1, SARAF, Orai 3 and TRPC2 (Blackburn and Ushkaryov, data not 
published). Whether or not these are the major SOCE proteins involved in LPHN1 
activation at the NMJ or in other tissues is not clear at the moment, and 
experiments where it will be possible to knock down single genes to analyse the 
possible changes in the response of LPHN1 to its agonist are needed, using for 
example motor or pyramidal neurons primary cultures. 
Finally, the regulation operated by LPHN1 on P/Q VGCCs needs to be 
investigated with more attention. In this regard, two possibilities are plausible: on 
the one hand LPHN1 could facilitate the opening of P/Q VGCCs by activating 
PKC, which in turn phosphorylates the channel allowing its transition from a 
“reluctant” to a “willing” state (Herlitze et al. 2001; Colecraft, Brody and Yue 
2001). Alternatively, the interaction between LPHN1 and P/Q could be physical. 
In this case, conformational changes of LPHN1 would physically open the 
channel, leading to a much faster Ca
2+
 influx than in the case of phosphorylation 
by PKC. If this is true, other questions present themselves for future investigation, 
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